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Abstract 
The GroE heat shock proteins (GroEL and Gr0ES) of Escherichia coli 
represent major molecular chaperones that participate in folding and assembly of a 
variety of proteins and are essential for cell growth at all temperatures. From in vitro 
studies, GroEL is thought to be highly promiscuous in substrate binding, interacting 
with almost any non-native model protein. However, in vivo, GroEL is involved in 
the folding of only 10-15% of newly translated polypeptides, suggesting specificity 
for a defined set of substrates. 
In an attempt to identify GroE substrates, a strain of E.coli has been 
constructed in our laboratory in which expression of GroE can be turned off. 
Previous work from our laboratory had suggested that DapA, the first enzyme on the 
lysine biosynthetic pathway, was affected by GroE depletion in Escherichia coli. 
Native DapA is present as a homotetramer; in this study, work is described that 
suggests that DapA achieves a homotetrameric state in GroE depleted cells but lacks 
enzymatic activity. Work is also described that suggests that native DapA cannot be 
overproduced in GroE depleted cells as it becomes highly susceptible to aggregation. 
Work in chapter 4 suggests that the lac inhibitor protein, Lad, is also affected 
by GroE depletion. In vitro footprinting studies in GroE depleted cells suggest that 
Lacl remains bound to the lac operator sequence in the presence of the gratuitous 
inducer IPTG. 
Previous work in other laboratories had suggested that dapA is not regulated 
at the level of expression. In this work data is presented that suggests that dapA is 
regulated at the level of expression, possibly by a transcriptional activator, in 
response to intracellular levels of the molecule diaminopimelic acid. 
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1.1 The protein folding problem 
Protein folding is arguably the single most important process in biology 
because it converts linear polypeptide chains into 3-dimensional structures that 
endow proteins with their activities. Traditionally the protein-folding problem has 
been studied in vitro with purified, chemically denatured polypeptides as substrates. 
The pioneering studies of Anfinsen and his colleagues (Anfinsen, 1973) with the in 
vitro refolding of purified ribonuclease A left the long-lasting impression that the 
folding of a newly synthesised polypeptide was an intrinsic feature of its primary 
structure, independent of other factors (Jaenicke, 1991). The wealth of in vitro 
studies that followed these key experiments has indeed shaped our understanding of 
the general kinetic and thermodynamic principles of protein folding, at least for 
small, globular proteins (Baldwin, 1994; Matthews, 1993; Ptitsyn, 1995). Briefly, 
within a few milliseconds of the initiation of folding, the extended polypeptide chain 
collapses, driven primarily by hydrophobic forces, to a compact folding intermediate. 
This intermediate, named the molten globule, is stabilised by flexible interactions 
between hydrophobic residues in the core of the molecule and possesses elements of 
secondary structure, such as a.-helices and j3-sheets, but lacks the ordered interactions 
between these elements which form the tertiary structure in the native state 
(Christensen et al, 1991; Creighton, 1990; Radford et al, 1992). This leads to the 
exposure of hydrophobic protein surfaces to solvent, which makes this intermediate 
prone to aggregation, an off pathway folding reaction that is considered irreversible 
under most conditions. Folding from the molten globule intermediate towards the 
native state is a comparatively slow process that occurs on the time scale of seconds 
to minutes. As the polypeptide progresses along this pathway, it is believed to pass 
through various incompletely folded intermediates via a series of structural 
rearrangements. 
The probability that a given unfolded polypeptide will fold properly increases 
at relatively low protein concentration (which limits interpolypeptide aggregation) 
and low temperature (which attenuates hydrophobic interaction). However the 
relatively high protein concentration in the cytososl (300 mg ml') subjects the 
growing polypeptide to premature interactions with other intra- or interpolypeptide 
domains, thereby leading to misfolding and aggregation (Jaenicke, 1991). To deal 
with these problems, a set of proteins, collectively called chaperones, has evolved, 
their primary function is to ensure that polypeptides will fold properly in the cell. 
These chaperone proteins act primarily by binding to the reactive surfaces (mostly 
hydrophobic) of polypeptides. In doing so, chaperones sequester these reactive sites 
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and prevent interactions with other reactive sites in their vicinity, effectively 
preventing aggregation and favouring the proper folding pathway. In general the 
chaperone proteins act without covalently modifying their polypeptide substrates and 
without being part of the finished product (Ellis et a!, 1991). Because high 
temperature tend to favour protein unfolding and hydrophobic interactions, there is 
an extra need for chaperones to prevent protein aggregation in vivo. This is most 
likely the reason why many chaperones are expressed at much higher levels in cells 
after heat shock (Georgopoulos et al, 1993). 
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1.2 The E.coli GroE chaperonin machine 
1.2.1 Discovery of the groE locus 
In the 1970s, a number of laboratories reported the isolation of E.coli mutants 
that block growth of either bacteriophage ? or T4, specifically at the level of head 
assembly, and bacteriophage T5 at the level of tail assembly (Table 1.2.1). These 
mutants were variously termed groE (Georgopoulos et al, 1973; Georgopoulos et al, 
1972; Sternberg, 1973a; Sternberg, 1973b), tabB (Coppo et al, 1973; Takahashi et al, 
1975), mop (Takano et al, 1972), hdh (Revel et al, 1980), and hdh (fatA)  (Simon et 
al, 1974). The groE, mop, tabB, and hdh alleles turned out to be mutations at the 
same locus and are referred to here collectively as groE. The groE mutants were so 
named because they blocked bacteriophage ? growth (gro), and the first 
bacteriophage X mutants able to propagate on these mutant bacteria were shown to 
have amber mutations in gene E, whose product is the major capsid protein of 
bacteriophage 2, hence the designation groE (Georgopoulos et al, 1973; Sternberg, 
1973b). The mechanism by which these mutations in gene E bypassed the groE 
imposed block was by lowering the amount of the 2E gene product, thus enabling the 
mutated GroE to concentrate on fewer bacteriophage capsid structures 
(Georgopoulos et al, 1973; Sternberg, 1973a) 
The molecular characterisation of the groE locus was aided by the isolation of 
2groE transducing bacteriophages. The XgroE1 transducing bacteriophages were 
selected directly out of a pool of ? transducing bacteriophages, each carrying a 
different segment of the E. coli chromosome, simply based on their ability to form 
plaques on various groE mutant hosts (Georgopoulos et al, 1978; Hendrix et a!, 
1978). These ?groE transducing bacteriophages also served to produce high levels 
of GroE protein, thus leading not only to the preliminary identification of the GroE 
product as a 60 kDa protein, but also to its purification (Hendrix, 1979; Hohn et al, 
1979). However, further deletion and point mutation analysis of the various ?groE 
transducing bacteriophages demonstrated that the groE locus is actually made up of 
two genes, groES, encoding a protein with an apparent mass of 15 kDa, and groEL, 
encoding the previously identified 60 kDa protein (Tilly et al, 1981). Interestingly, 
the isolated groE mutations were approximately equally distributed between the 
groES and groEL genes. Since mutations in either groES or groEL affected 
bacteriophage ? and Mu head morphogenesis, Mu and T5 tail morphogenesis 
(Georgopoulos et al, 1973; Sternberg, 1973b; Grimaud et al, 1998; Zweig et al, 
1973), as well as bacterial growth at high temperature, qualitatively and 
quantitatively to the same extent, the GroES and GroEL proteins must function in the 
same biochemical pathway. Furthermore, the realisation that the Rubisco binding 
protein of plants, necessary for the proper assembly of Rubisco, is homologous to 
GroEL exemplified their universal sequence conservation, as well as their function in 
promoting oligomeric protein assembly (Hemmingsen et a!, 1988). 
It took a long time before it was realised that the GroES and GroEL proteins 
constitute a molecular chaperone machine. First the original groE alleles were 
isolated on the basis of blocking bacteriophage X or T4 growth, and the fact that they 
defined two distinct but adjacent genes was not discovered until 10 years later. 
Because the groE mutation blocked the head protein morphogenic cleavages intrinsic 
to ? and T4 (Georgopoulos et al, 1973; Grimaud et a!, 1998), and the tail 
morphogenic cleavage associated with T5 tail assembly (Zweig et a!, 1973), this left 
the impression that the GroE protein itself might be a protease or a component of a 
protease. The purification and characterisation of GroE and the realisation that it is a 
tetradecameric structure with sevenfold symmetry encouraged the notion that its 
symmetric surface acts like a scaffold to allow the proper oligomerisation of some 
structural proteins to give rise to the correct morphogenic structure, which in turn is 
the correct substrate for protease cleavage. 
Host Mutation 	k 	 Mu 	 T4 	 T5 
groES 	Head assembly Head assembly No effect 	Tail assembly 
(genes B and 	(gene 11); tail 	 (gene D19) 
E) 	assembly 
groEL 	Head assembly Head assembly Head assembly Tail assembly 
(genes B and 	(gene X); tail 	(genes 31 and 	(gene D19) 
E) 	assembly 23) 
Table 1.2.1 Effects of E.coli groE mutations on bacteriophage growth. The various 
groE mutations block either head assembly and/or tail assembly. Also shown, in 
parentheses, are the bacteriophage-encoded genes in which mutations can occur, thus 
permitting growth on the groE mutants. Adapted from Ang et at. which should also 
be consulted for individual references (Ang et a!, 2000). 
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1.2.2 The GroE proteins are molecular chaperones 
The term 'molecular chaperone' was first used to describe the role of 
nucleoplasmin, a protein involved with assembling DNA and histories isolated from 
Xenopus oocytes into ordered nucleosomes (Laskey et al, 1980). Without the 
nucleoplasmin the DNA and histones formed an unorganised aggregate in vitro. Ellis 
adopted the term to describe a protein associated with Rubisco (ribu!ose-1-5-
bisphosphate carboxylase oxygenase), an enzyme involved in fixing CO2 in higher 
plant chloroplasts. Rubisco is a multimer of eight small and eight large subunits and 
can amount to as much as 50% of a plant's total cell protein. The large subunits are 
encoded by plastid genes and the small subunits by nuclear genes, and are thus 
imported from the cytoplasm. For attainment of the correct Rubisco conformation, 
another protein called the Rubisco subunit binding protein (RSBP) is required. RSBP 
does not form a part of the final Rubisco enzyme, but is required during the assembly 
of the large subunit octamer from four dimers (Barraclough et a!, 1980). Ellis called 
his RSBP a molecular chaperone and showed that it was made up of two types of 
subunit ((x and J3) found in equal amounts. The a and 3 subunits showed 50% 
sequence similarity to each other, and interestingly RBSP shares 50% sequence 
similarity with GroEL (Hemmingsen et a!, 1988). RSBP was shown to have the same 
tetradecameric ring structure and sevenfold symmetry as GroEL. 
The original definition of a molecular chaperone was a protein that brings 
potentially complementary surfaces together, but makes sure that no improper or 
premature interactions occur. Ellis' adoption of the term 'molecular chaperone' to 
explain the action of RSBP has now been extended to cover a growing list of 
different proteins that bind polypeptides and mediate their folding and/or assembly. 
Ellis proposed that molecular chaperones of the GroEL/HSP-60 type (which are 
required for cell viability at all temperatures) should be designated the chaperonins, 
which seemed more appropriate than terminology that implies their involvement 
solely during heat-shock (Ellis eta!, 1991; Ellis, 1993). 
It is interesting to note that while many bacteria species are reported to have 
only one copy of the groEL/hsp6O gene, a number are reported to have two or more 
copies. Bacteria which exhibit multiple copies of the groEL/hsp6O gene include 
several Streptomyces species, Mycobacterium tuberculosis, M leprae, Rhizobium 
meliloti, Bradyrhizobium japonicum, Synechocystis sp. PCC 6803 and Rhizobium 
leguininosarum (Guglielmi et a!, 1991; De Wit et al, 1992; Kong et at, 1993; 
Rusanganwa et a!, 1993; Fischer et a!, 1993; Lehel et al, 1993; Wallington et a!, 
1994). While the functional significance of these multiple copies remains unknown, 
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it has been suggested that multiple Hsp60 proteins may serve different functions 
within the bacteria (Wallington et al, 1994). 
1.2.3 In vitro studies of GroEL 
The realisation that GroEL acts solely at the level of preventing the 
aggregation and aiding the correct folding of a single polypeptide chain had to await 
subsequent work from many laboratories. The first in vitro demonstration of 
polypeptide binding by GroEL was by Bochkareva et al (Bochkareva et al, 1988). 
They showed that E. coli GroEL protein bound newly translated unfolded pre-J3-
lactamase (pre-3-lac) and chloramphenicol acetyl transferase (CAT), both of which 
need to be in an unfolded conformation in order to traverse the bacterial plasma 
membrane into the periplasmic space. A transcription/translation system was used to 
produce the pre--lac and CAT polypeptides; an NacylMettRNArnet  with the acyl 
group containing a precursor of the highly photoreactive carbene radical was used to 
add the initial N-terminal methionine residue, resulting in polypeptides that are 
labelled at one site only. The E. coli translation extract (S30) contained GroEL, but 
this could be removed (up to 95%) by passing the extract through an anti-GroEL 
sephadex affinity column. Exogenous GroEL was then added to the translation mix. 
Photoactivation led to the pre-3-lac or CAT polypeptides binding to the GroEL 
tetradecamers. Furthermore, it was shown that the protein was binding only when it 
was in an unfolded state. Addition of Mg-ATP, but not a non-hydrolysable analogue, 
to the GroEL-peptide complex resulted in the dissociation of the polypeptide, 
indicating a role for GroEL's previously observed weak ATPase activity. 
A more detailed study of the interaction between pre-13-lac and GroEL was 
conducted by Zahn and Plückthun (Zahn et al, 1992). They showed that an early 
folding intermediate of pre-3-lac is recognised by GroEL and thus protected from 
aggregation. The form that is discharged from GroEL by Mg-ATP hydrolysis is 
another folding intermediate, which can misfold to a non-native conformation (but 
does not form an aggregate) in a pH-dependant fashion. This intermediate is not 
bound to GroEL and would fold correctly under normal physiological conditions 
without any external assistance. They therefore suggest that GroEL prevents 
aggregation by binding polypeptides that have the capacity to aggregate, and 
processing the polypeptides to conformations that will not aggregate. Interestingly 
they also showed that mature--lac does not bind to GroEL under any folding 
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conditions and so proposed that the N-terminal signal sequence is a motif recognised 
by GroEL. 
The binding of unfolded polypeptides by GroEL seems consistent with its 
proposed role in the heat-shocked cell, in that thermally denatured proteins are being 
sequestered and thus prevented from aggregating. However, the work of Bochkareva 
(Bochkareva et al, 1988) also suggests a role for GroEL in membrane translocation 
of proteins, and indeed Kusukawa (Kusukawa et al, 1989) has shown that the export 
of pre-J3-lac is defective in groEts  mutants in vivo, although protein export is not 
thought to be a major function of the GroE proteins as other specialised export 
systems are normally employed (Kumamoto, 1991). 
Lissin (Lissin et al, 1990) examined the assembly of the GroEL tetradecamer 
itself in vitro. It was shown that GroEL tetradecamers could be formed from GroEL 
monomers in the presence of ATP and Mg2 ions at 23°C. Assembly intermediates 
were not found, suggesting that the assembly of the GroEL tetradecamer is highly 
cooperative. Assembly of the GroEL monomers was also found to be enhanced by 
the presence of GroEL tetradecamers. The authors refer to this as 'self-chaperoning'. 
An attempt to determine how many E. coli proteins could bind to GroEL was 
performed by Viitanin (Viitanen et al, 1992). Here they used a soluble protein cell 
extract labelled with 35S-methionine and denatured in 5 M guanidine-HC1, to show 
that about half of the unfolded protein complex could be bound to GroEL 
tetradecamers and subsequently released on addition of Mg-ATP. This rather crude 
analysis showed that a wide variety of denatured E. coli proteins have the potential to 
bind to GroEL, but did not attempt to address the question of which proteins are 
bound and which are not. 
Landry and Gierasch (Landry et al, 1991a; Landry et al, 1991b) observed that 
the experimental in vitro GroEL substrates Rubisco, f3-lactamase, citrate synthase 
and rhodanese all contain solvent-exposed amphipathic amino-terminal a-helices and 
suggest that it was this secondary structure that was recognised by GroEL; others 
(Brazil et al, 1997; Kobayashi et al, 1999) have also obtained similar results. 
However, Schmidt and Buchner (Schmidt et al, 1992) reported that a protein 
fragment consisting entirely of 3-sheet secondary structure elements is bound and 
released by the GroEL-ES-ATP system in vitro [also reported by Chen (Chen et al, 
1999)]. While it is now generally accepted that GroEL tetradecamers interact with 
polypeptides that are essentially unfolded but still contain a reasonable amount of 
secondary structure (Martin et al, 1991) no sequence specificity has been found in 
substrates, and the nature of the binding interactions has only recently been 
addressed in stereochemical terms (Chatellier et al, 1999; Kobayashi et al, 1999; 
N. 
Tanaka et al, 1999). It is also accepted that exposed hydrophobic surfaces on 
substrates are primarily responsible for recognition by GroEL (Chatellier et al, 1999; 
Itzhaki et al, 1995; Lin et al, 1995), consistent with the ability of GroEL to recognise 
the exposed hydrophobic surfaces that are characteristic of non-native proteins. In 
addition GroEL prefers substrates bearing net positive charges (Chatellier et a!, 1999; 
Dessauer et al, 1994; Itzhaki et a!, 1995; Rosenberg et al, 1993; Koll et al, 1992), 
indicating an electrostatic component in GroEL-substrate interactions (Perrett et al, 
1997). 
1. 2.4 In vivo studies of GroEL 
Demonstration of the formation of complexes between certain proteins and 
GroEL in E. coli has been reported by several groups (Carrillo et a!, 1992; Dolan et 
al, 1992; Lee et al, 1992; Dionisi et al, 1998). All of these examples have used 
proteins foreign to E. coli, but have shown that the protein of interest would not be 
functional and/or assembled in groE-mutant bacteria. More interestingly it was 
shown that proteins that normally form insoluble aggregates when overexpressed in 
E. coli can be largely solubilised by concomitant overexpression of the groE genes. 
These results suggest that the GroE proteins are not highly selective in their choice of 
substrate and will help foreign proteins to assemble correctly. This fact has been used 
to obtain functional foreign proteins from genes cloned in E. coli (King et al, 1996; 
Hahm et al, 2001; Goenka et al, 2001). 
From in vitro work it was assumed that GroEL is highly promiscuous and will 
interact with any protein (Coyle et al, 1997) that can be accommodated in the cis-
cavity (Sakikawa et al, 1999). But calculations have suggested that there is only 
enough GroEL present in the cell to fold 5-10% (Lorimer, 1996) or 10-15% (Ewalt et 
al, 1997) of all newly synthesised proteins; thus suggesting that GroEL may have 
specificity for a defined set of substrates. There have been a number of attempts to 
identify GroE substrates in vivo in E. coli. Horwich (Horwich et al, 1993) made a 
groEL mutant that was severely temperature sensitive, and therefore unable to form 
colonies above 35°C. Using this mutant he was able to demonstrate the loss of 
solubility of 16 diverse polypeptides on 2D protein gels, of which three were 
identified and found to be citrate synthase, ketogluterate dehydrogenase and 
polynucleotide phosphorylase. Overall, 30% of all the polypeptides were affected by 
the loss of GroEL function in the mutant cells at restrictive temperatures. These 
results suggest that there is a specific set of proteins that rely on GroEL to allow their 
folding to the native conformation. Since, in this study, extracts were prepared from 
cells containing substantial quantities of inactive mutant GroEL, it is possible that the 
reduced solubilities observed result from interaction with inactivated GroEL 
molecules, rather than because of failure of assisted folding. 
Kanemori (Kanemori et a!, 1994) attempted to identify GroE substrates by 
reducing the levels of GroE in E. coli. A strain was constructed in which the GroE 
protein level was manipulated by placing groE under the control of the lacUV5 
promoter on a multicopy plasmid in a strain lacking the chromosomal groE operon. 
When the strain was grown with a limited concentration of inducer (IPTG) at 37°C, 
the GroE level and growth rate were comparable to those of the wild type. When the 
cells were depleted of IPTG, they continued to grow at or below 37°C albeit at 
reduced rates, despite the reduced levels of GroE (- 25% of wild type). Under these 
conditions the cellular contents of at least 13 polypeptides were affected. Among the 
most striking effects was the enhanced synthesis of a set of heat shock proteins, 
which resulted from the increased level of a 32  which is required for the transcription 
of heat shock genes. Other proteins affected by the reduced GroE level included two 
proteins [enzymes of the Entner-Doudoroff pathway (Egan et al, 1992)] encoded by 
the edd-eda operon and the ribosomal protein S6, suggesting that the GroE 
chaperones are involved in regulating expression of genes for carbohydrate 
metabolism and in modulating biogenesis or function of ribosomes. Note that in this 
study GroE levels were only reduced to 25% of the wild type level, a far cry from 
complete GroE depletion. 
Ewalt (Ewalt et al, 1997) performed experiments to determine the polypeptide 
flux through the bacterial chaperonin system. To determine the extent to which 
GroEL interacts with newly synthesised proteins, GroEL and its bound substrates 
were isolated by immunoprecipitation from pulse labelled E. coli. Cells were labelled 
at temperatures between 30°C and 42°C for 15 seconds with 35S-methionine 
followed by the addition of excess nonradioactive methionine. At specific times, 
cells were removed, rapidly cooled to 4°C, converted to spheroplasts, and lysed in 
EDTA-containing buffer [low temperature and chelating Mg2 stop ATP-dependant 
polypeptide release from GroEL (Martin et al, 1991)]. The data showed that a diverse 
set of newly synthesised polypeptides, predominantly between 10-55 kDa, interacts 
with GroEL, accounting for 10-15% of all cytoplasmic protein under normal growth 
conditions, and for 30% or more upon exposure to heat stress. Most proteins were 
reported to leave GroEL rapidly within 10-30 seconds. Three classes of substrate 
protein were distinguished: (i) proteins with a chaperonin independent folding 
pathway; (ii) proteins, more than 50% of total, with an intermediate chaperonin 
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dependence for which only a small fraction transits GroEL; and (iii) a set of highly 
chaperonin dependent proteins many of which dissociate slowly from GroEL and 
probably require sequestration of aggregation-sensitive intermediates within the 
GroEL cavity for successful folding. 
Houry (Houry et al, 1999) extended the experiment mentioned above to 
determine GroE substrates in vivo. Pulse-chase labelling experiments were 
performed with live E. co/i cells at 30°C in order to analyse the flux through GroEL 
of individual newly synthesised proteins. At different times of chase, cells were lysed 
on ice in the presence of EDTA, which prevented the ATP-dependent release of 
protein substrates from GroEL, and GroEL substrate complexes were isolated by 
immunoprecipitation with GroEL antibodies. Total soluble cytoplasmic proteins and 
GroEL bound proteins were separated on 2D gels. A number 
('-S 
300) of newly 
synthesised polypeptides were reported to interact strongly with GroEL, some of 
which are structurally unstable and repeatedly rebind to GroEL. The identity of 52 
(16%) of the polypeptides was determined by peptide-mass fingerprint analysis and 
MALDI-TOF mass spectroscopy; these included a number of essential components 
of the transcription/translation machinery, such as subunits of the RNA polymerase 
elongation factor Tu (EF-Tu) and several aminoacyl tRNA synthetases, as well as 
metabolic enzymes participating in a variety of important biosynthetic and catabolic 
pathways. From this data a structural motif was suggested for a 'typical' GroE 
substrate; it was suggested that a typical GroE substrate falls within the size range of 
20-60 kDa and consists preferentially of multiple c43 domains with hydrophobic 
sheets. It was hypothesised that the non-native states of these topologically complex 
proteins are likely to expose extensive hydrophobic surfaces that could be recognised 
by GroEL, either during folding or upon misfolding. While these data suggest a 
possible architecture for GroE substrates, it is worth mentioning that 87% of all 
E.coli proteins are smaller than 50 kDa (Ewalt et al, 1997) and the c43 topology is 
one of the most common folds found in proteins ( 80% of all E.coli protein 
structures have at least one 4 domain). From these figures, 69.6% of all E.coli 
proteins have a cj3 topology and are under 50 kDa! Therefore, while these 
experiments may have identified some GroE substrates, it may be a little premature 
to assign a typical architecture to GroE substrates. 
1.2.5 Structure qfGroES 
GroES was isolated by Chandrasekhar et al. and characterized as a ring 
structure with approximately seven 10-kDa subunits that forms a complex with 
GroEL (Chandrasekhar et al, 1986). Crystallographic analysis of GroES has recently 
been completed [(Xu et al, 1997); Fig 1.2.1]. Each subunit consists of a P barrel 
region that forms most of the contacts around the ring, and a n-hairpin pointing 
slightly upwards and towards the centre of the ring. The n-hairpin region is loosely 
packed, with little intersubunit contact, and forms the roof of the dome-like structure 
of the oligomer. Earlier NMR work showed that a mobile domain in GroES became 
ordered upon binding to GroEL (Landry et al, 1993). This region (residues 17-32) is 
not seen on the X-ray structure of GroES, but is expected to form at least part of the 
binding contact. The visible ends of the mobile loop point downwards and radially 
outwards from the bottom of the J3-barrel domain (dashed arrows, Fig 1.2.1b). EM 
reconstruction of the GroEL-GroES complex shows that the dome caps the opened 
apical domains of GroEL. In the complex, the mobile loop is expected to be in 
contact with GroEL, because its accessibility to trypsin is reduced in the complex 
and a synthetic peptide with the loop sequence binds to GroEL (Landry et al, 1993). 
Furthermore, all the GroES mutations originally isolated by their inability to support 
bacteriophage growth map to the mobile loop region of the sequence (Georgopoulos 
et al, 1973). 
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Fig. 1.2.1 Ribbon diagrams of the GroES structure viewed (a) from above and (b) 
from the side, showing the -barrel structure of the subunit with a 13-hairpin forming 
the roof of the dome-like heptamer. The N and C termini are labelled and point 
radially outward. The broken ends of the disordered mobile loop, which is not seen 
in this map, are indicated by dashed arrows in (b). Image from, The Chaperonins 
(Ellis, 1996). 
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1.2.6 Structure of GroEL 
GroEL is a tetradecameric complex of identical 57 kDa subunits. Early 
electron microscopic analysis revealed its double toroidal structure, composed of two 
stacked heptameric rings with approximate dimensions of 14 nm in diameter and 16 
nm in height (Hendrix, 1979; Hohn et al, 1979). This peculiar symmetry has been 
confirmed many times (Hutchinson et al, 1989; Langer et al, 1992; Zwickl et al, 
1990), but, more recently, Saibil et al. performed a high resolution electron 
microscopic analysis of the Hsp60 from Rhodobacter sphaeroides (Saibil et al, 
1993). This analysis enabled the clear visualisation of the two seven membered (7-
mer) rings and supported the long held view that the Hsp60 monomer consisted of 
two major domains. The domains of each monomer are linked on the exterior of the 
cylinder, giving Hsp60 a cagelike structure (Saibil et al, 1993). The central cavity of 
the cylinder, intuitively the site of polypeptide binding, is 4 to 6 nm in diameter and 
can expand considerably upon binding of the GroES cofactor. Braig et al. 
accomplished the enormous task of solving the structure of the GroEL tetradecamer 
by X-ray crystallography (Braig et al, 1993) (Fig. 1.2.2). Each monomeric unit is 
composed of an apical, an intermediate, and an equatorial domain (Fig 1.2.3). The 
equatorial domain is the largest of the three and provides the majority of the subunit-
subunit interactions and all of the interactions between the rings across the equatorial 
plane of the cylinder. The N and C terminal residues (about 30 residues) protrude 
into the cavity from the equatorial domain: they are disordered and are not 
crystographically resolved; however, the 'missing' 30 residues per subunit appear to 
form a central constriction to the channel as seen in cryo EM images (Chen et al, 
1994). Mutation of Lys4-Glu (sequence beginning at Meti) completely blocks 
oligomer assembly (Horovitz et al, 1993), suggesting an important structural role for 
this apparently disordered region. Truncation of the carboxyl-terminus of GroEL by 
16 amino acids resulted in a form of GroEL that hydrolysed ATP at a slower rate 
than wild type GroEL (McLennan et al, 1993). Mutagenesis later confirmed that this 
domain contains the ATP binding site (Fenton et at, 1994). 
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Fig. 1.2.2 Schematic model of the GroEL structure. Principal dimensions of the 
GroEL double toroid determined from the three dimensional crystal structure. The 
top panel shows a view down the central cavity, while the bottom panel represents a 
vertical cut through the cylinder. Image from Braig etal. (1994). 
Fig 1.2.3 Atomic resolution structure of the GroEL subunit (Braig et al., 1994). (a) 
alpha-carbon and (b) full structure, colour coded in rainbow colours from N (red) to 
C (blue). In this view, the equatorial domain is the large mass containing both 
termini at the bottom of the subunit, connected by the antiparallel intermediate 
domain (cyan and yellow) to the large apical domain (green and cyan) at the top. 
Image from The Chaperonins (Ellis, 1996). 
15 
At the top of the equatorial domain, there is a well-defined junction with the 
intermediate domain, a small, antiparallel domain connecting the top and bottom 
large domains. It comprises a pair of crossed helices and a small 13-strand region that 
contacts the neighbouring apical domain. This is followed by another junction 
leading to the large apical domain, which contains a and 13 structures and has poorly 
defined density in regions lining the channel, the site of residues involved in 
substrate and GroES binding, as identified by mutagenesis (Fenton et al, 1994). A 
conspicuous feature is that much of the apical domain surface is not in close contact 
with neighbouring domains, and that there is little barrier to its movement, both 
locally in some parts and in the overall orientation of the domain. It is this part of the 
structure that deviates most from 7-fold symmetry in the crystal. Very interesting 
potential hinge sites are found at the upper and lower domain junctions. These 
provide the possibility of large hinge movements allowing rigid body rotations 
(Gerstein et al, 1994) of the apical and equatorial domains. In these regions of 
exposed antiparallel chain, there are conserved glycine residues. Fig. 1.2.4 shows a 
schematic diagram representing the subunit domain arrangement in the oligomer, in 
which the potential hinge sites are marked with black dots. 
An extensive mutational study (Fenton et al, 1994) has enabled the mapping 
of several important functional sites onto the atomic structure, including nucleotide, 
substrate and GroES binding sites. Results from other mutant studies (Baneyx et al, 
1992; Yifrach et al, 1994) can now also be interpreted in terms of the 3D structure. 
The helix bundle in the equatorial domain contains the ATP binding pocket, 
which is bordered by a highly conserved sequence motif, and lined by other stretches 
of highly conserved residues (Fenton et al, 1994). The structure with nucleotide 
bound has been solved (Xu et al, 1997), and confirms that nucleotide occupies this 
pocket. Mutations in Asp87 completely abolish ATPase activity, although ATP 
analogue binding is relatively unaffected. The ATP-binding pocket is adjacent to the 
lower hinge region, and mutations in the intermediate domain just beyond this hinge 
region, also abolish ATPase activity, as does mutation of residue 383, near the upper 
hinge region. These strategic locations of key residues around the hinge regions 
strongly suggest that hinge movements are involved in the hydrolysis mechanism. 
The mutagenesis study defines a set of hydrophobic residues on the apical 
domain, lining the channel, that provide the binding surface for substrates, a region 
that is flexible in the GroEL structure. The binding surface is shown as a wavy 
profile on the apical domains in the diagram (Fig. 1.2.4a). Single amino acid 
substitutions of these residues abolish binding of the substrates ornithine 
transcarbamylase and dihydrofolate reductase. Density of the substrate malate 
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dehydrogenase (MDH) is found in exactly the same region, by cryo EM, held 
between the ends of the claw-like domains and protruding outwards (Chen et al, 
1994). The ring of 7 binding sites is easily accessible from outside, being very near 
the surface of the cylinder, but the inward-facing orientation may protect GroEL 
from self-aggregation. Mutation of residue 152, near the lower hinge region, also has 
a strong effect on substrate binding. The ability of monomeric cpn60, missing 78 N-
terminal residues, to bind substrates and partially promote their folding is consistent 
with the apical location of substrate binding sites (Taguchi et a!, 1994). 
Many of the same mutations to the apical channel-lining surface also interfere 
with GroES binding, suggesting that the binding sites for GroES and substrate 
overlap. In addition, the GroES binding surface appears to extend further over the top 
surface of the apical domain. Looking at the GroEL crystal structure, it would appear 
impossible to fit the GroES heptamer [diameter 	70 A, Hunt et al., in The 
Chaperonins (Ellis, 1996)] into the cavity to contact most of these binding sites. 
However, an explanation for this is found in the low-resolution structure of the 
GroEL-GroES complex from cryo EM (Fig 1.2.4b). A large rotation of at least the 
upper hinge region in the GroEL subunits is clearly evident, to give a reorientation of 
the apical domains, placing the substrate binding surfaces adjacent to the bases of the 
3-barrel domains of the GroES subunits (Fig 1.2.1b). 
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Fig. 1.2.4 Schematic diagram of the subunit arrangement in a hypothetical slice 
through the GroEL oligomer, showing the major functional sites. (a) GroEL, based 
on the crystal structure with bound substrate (shaded light to dark) as imaged by 
cryo-EM. A, apical domain; I, intermediate domain; E, equatorial domain. The apical 
domains form a ring of hand-like structures with the substrate binding sites on the 
fingers protruding into the central channel. Sites of potential hinge rotations are 
indicated by black dots. The notch in the equatorial domain represents the ATP-
binding cleft. The interaction across the equatorial plane is shown as pairs of wavy 
surfaces. (b) The folding complex GroEL-MDH-GroES-ATP, rotating the subunit 
domains and adding the GroES (dark gray) and substrate (shaded) densities 
according to cryo EM observations. Image from The Chaperonins (Ellis, 1996). 
1.2.7 The GroEL reaction cycle 
GroEL is thought to function as a double ring two-stroke complex (Lorimer, 
1997). Both rings partake in a negative allosteric mechanism that synchronises the 
binding and release of GroES with the hydrolysis of ATP (Rye et al, 1997; Xu et al, 
1997) to prevent misfolding and aggregation. 
The double ring structure and the transmission of allosteric information 
between the rings of GroEL are thought to be key features for chaperonin activities 
(Rye et a!, 1997; Xu et al, 1997). On the binding of GroES and ATP, the cis ring 
becomes expanded into a crown like structure (Roseman et al, 1996) doubling the 
volume of the GroEL cavity and hiding the hydrophobic binding surface (Xu et al, 
1997). The apical domain moves 600  upwards and also rotates 90° (Fig 1.2.5), thus 
many of the GroEL hydrophobic residues that were involved in substrate binding are 
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now involved in the new GroEL inter-subunit interactions (Fig. 1.2.6). The thrusting 
apart of substrates via the ATP-driven rotation and translation of the apical and 
intermediate domains weakens further the binding of (Corrales et al, 1996) and 
forcibly unfolds, the protein substrates (Buckle et al, 1997; Shtilerman et al, 1999). 
An ATP-dependent conformational change in the opposite (trans) ring induces the 
release of GroES and, subsequently, of the folded protein substrates from the cis ring 
(Rye et al, 1997). GroEL undergoes ATP-induced conformational changes with a 
positive cooperativity between the subunits of each ring and with a negative 
cooperativity between the two rings (Yifrach et al, 1994). The binding of ATP to the 
trans ring, which primes the GroES for release, is possible only when the hydrolysis 
of ATP on the cis ring has occurred, i.e. the model of nested cooperativity (Yifrach et 
al, 1998; Yifrach et al, 2000). The reaction cycle of GroE is summarised in figure 
1.2.7. 
In support of the model described above, the single ring mutant (Gr0ELSRI ) of 
GroEL is functionally inactive in vitro (Weissman et al, 1996) and in vivo (Weber et 
al, 1998). This mutant contains four amino acid substitutions at the equatorial 
interface of the GroEL heptameric rings (Xu et al, 1997) that prevents the formation 
of double rings (Weissman et al, 1995). Effective folding of chemically denatured 
rhodanese occurs within the cavity of Gr0ELsRI , but no release of GroES and of the 
folded enzyme is observed under physiological conditions (Weissman et al, 1996). 
The inability of GrOELSRI to release GroES is attributed to the absence of signal 
transmitted via the binding of ATP to the opposite ring (Weissman et al, 1996; Rye 
et al, 1997; Xu et al, 1997). 
In contrast, a single-ring suffices for the mammalian mitochondrial 
homologue Hsp60 (Nielsen et al, 1998). Indeed, Hsp60 and the variants thereof 
created by fusing it with the equatorial domain of Gr0ELSRI , function in E. co/i as the 
sole GroEL (Nielsen et al, 1999). One possible explanation of this one-stroke engine 
could lie in the low affinity of Hsp60 for HsplO, eliminating the requirement for 
ATP binding to a trans ring of the chaperonin in order to release the cochaperonin 
(e.g. in the case of GroEL/GroES). Furthermore, seven-membered single-ring 
minichaperones [i.e. fragments encompassing the apical domain of GroEL which are 
devoid of ATPase activity (Zahn et al, 1996)], have a slightly lower affinity for 
GroES compared with that of wild type GroEL and are more active than Gr0ELSRI 






Fig. 1.2.5 A single subunit from the crystal structure of the asymmetric GroEL-
Gr0ES-(ADP)7 chaperonin complex at 3.OA resolution from (a) the cis ring and (b) 
the trans ring. The translation and rotation of the apical and intermediate domains 
serve both to increase the size of the GroEL-GroES cavity and to hide the substrate 
binding surfaces. The loop above image (a) represents the mobile loop of GroES. 
The R452E, E461A, S463A and V464A amino acids changes in GroELsRlare also 
highlighted. Image from Chatellier et al. (Chatellier et al, 2000a). 
Off 
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Fig. 1.2.6 One heptameric ring of the GroEL tetradecamer showing the seven 
polypeptide binding sites. (a) A large, continuous hydrophobic surface at the upper 
rim of the central cavity in the unliganded form. (b) Separated binding sites by the 
large scale movements of the apical domains upon the binding of nucleotide and 
GroES. GroEL subunits are coloured around the ring from blue to yellow, and the 
polypeptide binding sites are coloured from yellow to red. Image from Wang et al. 
(Wang et al, 2000) 
Fig. 1.2.7 Simplified representation of the GroEL folding cycle. T represents ATP 
and D represents ADP. GroES binds rapidly to the cis ring of GroEL after ATP 
binding. Following ATP hydrolysis to ADP in the cis ring, another substrate and 
ATP rapidly bind to the trans ring. Such binding results in the destabilisation and 
release of GroES and substrate from the cis ring. Those protein substrates that have 
not properly folded will rebind to the same or another GroEL ring. Image adapted 
from Ang et al. (Ang et al, 2000) 
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1.3 Mitochondrial Hsp60s 
The eukaryotic mitochondrion is a membrane-bound organelle, and the site of 
several important metabolic pathways, the most notable being oxidative 
phosphorylation. Mitochondria possess their own genomes but most mitochondrial-
associated proteins are actually encoded by nuclear genes, and subsequently 
imported into the organelle. Indeed some yeast cell can survive under certain 
conditions without mitochondrial DNA, but cells cannot survive without 
mitochondria, indicating the essential nature of some proteins that are imported into 
the mitochondria and their role within its confines. 
A eukaryotic GroEL homologue was first seen as a heat inducible ribosome-
associated protein in Tetrahymena thermophila. Antibodies raised against this 58 
kDa protein showed that it was located in the mitochondria. Further analysis 
involving antibody cross-reactivity showed that the protein was indeed a Hsp60 
homologue (McMullin et al, 1988). Hsp60 from Saccharomyces cerevisiae was 
cloned and sequenced, and shown to share 54% sequence identity with E. co/i GroEL 
(Reading et al, 1989). Like E. co/i GroEL, the protein demonstrates sevenfold 
rotational symmetry, exists as a homomeric tetradecamer, is induced by heat shock 
(although not as strongly as in E. co/i) and is essential for cellular viability at all 
temperatures (Reading et al, 1989; Hallberg, 1990). Mitochondria are thought to be 
the remnants of a symbiotic relationship between a bacterium and the earliest 
eukaryotic cell; the finding of GroEL-related proteins solely in mitochondria (and 
chloroplasts in higher plants) goes some way to confirming this theory. 
In chloroplasts, the cellular organelle in plants involved in photosynthesis, the 
GroEL homologue is the Rubisco subunit binding protein mentioned previously. It 
has been shown that this protein binds several imported polypeptides and its 
substrates are not just Rubisco subunits (Lubben et al, 1989). 
While the range of in vivo substrates for the mitochondrial and chloroplast 
Hsp60s remain largely unknown, they are homologous to GroEL, having a 
requirement for both ATP hydrolysis and cofactor (HSP 10) binding for the folding of 
polypeptides (Ranson et al, 1998). 
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1.4 The CCT chaperonins 
Eukaryotic GroEL-homologues are found in cellular organelles. This has led 
to the search for molecular chaperones in the eukaryotic cytosol and the discovery of 
a second group of chaperonins. These group II chaperonins (Willison et al, 1994), 
found in archaebacteria and eukaryotes, are highly related to one another since they 
share up to 40% amino acid identity. They are weakly, but significantly, related in 
sequence to the group I chaperonins GroEL, Hsp60 and RSBP (Gupta, 1990; Ellis, 
1990; Lewis et al, 1992). The archaebacterial chaperonins TF55 (Trent et al, 1991) 
and the thermosome (Phipps et al, 1993), are composed of only two-subunit species 
(Knapp et al, 1994) but the eukaryotic chaperonin CCT is composed of up to nine-
subunit species (Rommelaere et al, 1993; Kubota et a!, 1994). This situation is 
reminiscent of the 20S proteasome which is a multi-toroidal, multi-subunit complex 
involved in proteolysis; the archaebacterial proteasome is constructed from two 
subunits whereas the eukaryotic proteasome may have up to 14 different subunit 
types (Peters, 1994). 
CCT is the only chaperonin identified so far in the eukaryotic cytosol and it 
has 16-18 subunits in a particle (Lewis et al, 1992). With the molecular cloning of all 
eight constitutively expressed subunits completed by Kubota's group (Kubota et al, 
1995) the name was revised from TCP-1 complex (Lewis et al, 1992) to CCT, 
though it is also known as cytosolic chaperonin (Gao et al, 1992) or TriC (Frydman 
et al, 1992). It has been shown that CCT binds newly synthesised actin, tubulin and 
some other unidentified polypeptides in vivo (Sternlicht et al, 1993). CCT also 
redistributes in developing neurites of neuronal cells (Roobol et al, 1995) and binds a 
neurofilament peptide fragment in vitro (Roobol et al, 1993), suggesting that CCT 
may play a role in the organisation of the neuronal cytoskeleton. However, Lingappa 
(Lingappa et al, 1994) indicated that a TCP-1 like cytosolic chaperonin is involved in 
hepatitis B virus capsid assembly. These observations suggest that CCT may be 
involved in the folding and assembly of a wide range of cytosolic proteins. 
As mentioned above, one of the striking differences between CCT and all the 
other chaperonins is the very heteromeric nature of the CCT particle. There are at 
least 7-9 major polypeptide constituents of CCT (Rommelaere et al, 1993; Kubota et 
al, 1994) and they are each independently encoded by highly diverged genes (Kubota 
et al, 1995). Because the other chaperonins only have one- or two-subunit species, 
this genetic complexity suggests that CCT may function as a more elaborate folding 
machinery that the other one or two-subunit-species chaperonins. 
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1.5 Previous work on GroE depletion in our laboratory 
In an attempt to identify GroE substrates in E. coli a system was developed 
which would avoid the physiological consequences of shifting temperature 
(Kanemori et al, 1994), of using a mutant form of GroEL, or of burdening the cells 
with inactivated GroEL (Horwich et al, 1993). The system also allows the 
temperature to be retained at 37°C throughout and the synthesis of GroE to be 
completely shut off, allowing observation of the consequences of GroE depletion at 
optimum growth temperature. To do this a strain of E. coli was produced in which 
GroE synthesis was put under arabinose control (MGM 100). Transcription of the 
groELS operon normally proceeds from a sigma-70 promoter and, after heat-shock, 
from a strong sigma-32 promoter (Kusukawa et al, 1988). This promoter region was 
replaced with the araC gene and araBAD promoter from pBAD-18 (Guzman et al, 
1995), making production of GroE and continued viability of the construct dependant 
on added arabinose (McLennan et al, 1998). 
The araBAD operon contains, moving upstream from the transcriptional start 
site, the aral, araOi, and ara02 control sites (Reeder et a!, 1993). The aral site 
consists of two identical 1 7bp subsites, arali and aral2, which are direct repeats 
separated by 4bp, and are oriented such that aral2, which overlaps the —35 region of 
the araBAD promoter, is downstream of aral1. In the absence of AraC, RNA 
polymerase initiates transcription of the araC gene in the direction away from its 
upstream neighbour, araBAD. The araBAD operon is expressed at a low basal level 
(Fig 1.5.1 a). 
When AraC is present, but neither L-arabinose nor CAP-cAMP (high glucose) 
(Kolb et al, 1993), AraC binds to araOi, ara02, and aral1 . araOi is the operator for 
the araC gene; its association with AraC blocks araC transcription so that this 
process is autoregulatory, although this requires high levels of AraC. The binding of 
AraC to aral1 represses the expression of araBAD (negative control) (Fig. 1.5.1 b). A 
series of deletion mutations indicate that the presence of ara02 is also required for 
the repression of araBAD. This remarkably large 21 lbp separation between ara02  
and aral1 therefore suggests that the DNA between them is looped such that a 
dimeric molecule of AraC protein simultaneously binds to both ara02 and aral1 . 
This is corroborated by the observation that the level of repression is greatly 
diminished by the insertion of 5bp (half a turn) of DNA between these two sites, 
thereby transferring ara02 to the opposite face of the DNA relative to aral1 in the 
putative loop. Yet the insertion of 1 lbp (one turn) of DNA has no such affect (Lobel 
et al, 1990). 
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When L-arabinose is present, it allosterically induces the AraC subunits 
bound to ara02 to instead bind ara12. This activates RNA polyrnerase to transcribe 
the araBAD genes (positive control). When the cAMP level is high (low glucose) 
(Kolb et a!, 1993), CAP-cAMP binds to a site between ara01 and aral1 (although in 
most other CAP-binding operons, CAP-cAMP binds adjacent to RNA polymerase), 
where it functions both to help break the loop between ara02 and aral1 and to 
increase the affinity of AraC for aral2. araC remains repressed by AraC-L-arabinose 
at ara01 (Schleif, 1992) (Fig 1.5.1 c). 
Experiments on MGM100 showed that an arabinose concentration of 0.2% 
was found to give normal growth both on plates and in liquid, and close to normal 
levels of GroE (Fig. 1.5.2). After arabinose removal, and the addition of 0.2% 
glucose, GroE levels halve with each generation (Fig. 1.5.2). Figure 1.5.3 shows that 
when arabinose is removed, and glucose added, growth of MGM 100 remains 
exponential for about 1.5 hours (GroE levels will be reduced to 2-3% of wild type 
level by this time). Growth continues at a decreasing rate for another hour (at this 
time, GroE levels will be reduced to 	0.25% of wild type level); the cells then 
abruptly lyse. 
Lysis indicated the development of a defect in the cell envelope. To determine 
if the cellular membranes remained intact the GroE depleted cells were grown in 
osmotically protected medium. In the presence of 10 mM Mg2 lysis did not occur, 
also the normally rod-shaped cells were converted to spherical protoplasts instead of 
lysing completely. This result was characteristic of a defect in synthesis of the 
peptidoglycan cell wall, responsible for the rigid rod-shape of coli cells (Heijenoort, 
1996). It was therefore suspected that an enzyme or enzymes concerned with the 
synthesis or maintenance of the peptidoglycan layer required GroE for synthesis or 
continued integrity. 
Damage to the peptidoglycan layer could result either from failure of 
peptidoglycan synthesis or enhanced peptidoglycan breakdown (controlled breakage 
and resealing of peptidoglycan bonds is necessary to allow cell growth). In order to 
distinguish between these two possibilities, the rate of incorporation of 3H-
diaminopimelic acid (DAP), a specific precursor, into peptidoglycan (Höltje et a!, 
1975) was measured. It was expected that uptake of DAP would either be reduced (if 
synthesis of peptidoglycan was affected) or constant (if degradation of peptidoglycan 
was affected). It was therefore surprising that DAP uptake was actually greatly 
increased in GroE depleted cells (Table 1.5.1), suggesting that the cells may be DAP 
starved. 
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Fig. 1.5.1 The proposed mechanism for araBAD regulation: (a) in the absence of 
AraC, RNA polymerase initiates the transcription of araC. AraBAD is also expressed 
at a low basal level. (b) When AraC is present, but not L-arabinose or cAMP, AraC 
binds to araOi and links together ara02 and arali to form a DNA loop, thereby 
repressing both araC and araBAD. (c) When AraC and L-arabinose are both present 
and cAMP is abundant, CAP-cAMP stimulates the AraC-arabinose comples to 
release ara02 and instead bind aral2, thereby activating araBAD transcription. AraC 
remains repressed. (Image taken from Biochemistry, 2' ed. Voet and Voet. John 
Wiley & Sons, Inc. pub.) 
MGM100 
Time after arabinose removal (mm) 
C, 
0 20 40 60 80 100 120 
GroEL - 	- 
Fig 1.5.2 GroEL depletion after arabinose removal. MGM 100 grown in the presence 
of 0.2% arabinose produces slightly less GroEL than does MG1655 (- 85%). Image 
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Fig. 1.5.3 Growth curves of MGM100 growing in LB + arabinose, glucose or 
glucose + DAP. 
















Table 1.5.1 Incorporation of 3H-DAP into peptidoglycan by GroE depleted cells. 
Data from N. McLennan (pers. comm.). 
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In confirmation of this it was found that the addition of DAP to the growth 
medium completely prevents cell lysis (Fig. 1.5.3), although exponential growth does 
not persist for longer than in DAP free broth. Western analysis showed that the 
addition of DAP did not increase or stabilise GroEL levels. Furthermore, although 
addition of DAP to solid medium did not allow colony formation in the presence of 
glucose, confirming that GroE is essential for processes other than cell wall 
formation, when DAP is present, colony formation requires less arabinose than 
normally (Table 1.5.2). This suggested that at least part of the cellular complement of 
GroE is dedicated to ensuring that DAP is available and that GroE is likely to have a 
role in maintaining the levels of an enzyme or enzymes involved in DAP synthesis. 
Further confirmation that cell wall synthesis is adversely affected in GroE 
depleted cells came from an experiment in which the enzyme which adds DAP to the 
growing peptidoglycan precursor is overproduced. It was reasoned that, if this 
enzyme (not implicated in DAP-deficiency induced lysis because it uses rather than 
synthesizes DAP) were expressed from a high copy number plasmid extra enzyme 
would be present before GroE depletion, which might partly compensate for reduced 
levels of DAP. This proved to be so. It was shown that lysis is delayed in depleted 
cells with extra copies of the murE gene (MurE is the enzyme which adds DAP to 
UDP-N-acetylmuramyl-L-alanine-D-glutamic acid). Providing extra copies of murD, 
murF or mraY, other enzymes of murine monomer synthesis, which do not use DAP 
as a substrate (Heijenoort, 1996) did not delay lysis. 
The same approach was used to discover at what step in DAP synthesis there 
might be a deficiency of enzyme resulting from GroE depletion. DAP is synthesized 
in a 6-step pathway from aspartic semialdehyde (Cohen et al, 1987). Deficiency of 
any of the enzymes DapA-E has been reported to lead to cell lysis (Patte, 1996). It 
was hypothesized that if a critical enzyme were to be synthesized in excess before 
GroE depletion, lysis might be delayed. At the time of the experiments the position 
of dapC had not been defined, but PCR was used to separately clone dapA, B, D, and 
E into pBR325. The presence of the dapA plasmid was shown to delay lysis after 
GroE depletion by several hours (Fig. 1.5.4) while the other dap plasmids had no 
delaying affect. This suggested that GroE might influence levels of DapA. Western 
blotting was used to look at the fate of DapA in GroE depleted cells. Cultures were 
sampled at 160 minutes after arabinose removal, just before lysis occurs. At this time 
DapA levels were reported to be reduced to 16% of normal. 
M. 
Number of colonies 
Arabinose concentration I 	+ DAP 	I 	-DAP 
0.2 404 400 
0.1 383 394 
0.08 455 151 
0.07 474 78 
0.06 396 5 
0.05 85 1 
0.04 0 0 
Table 1.5.2 The presence of DAP reduces the cells' requirement for GroE. Data 
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Fig 1.5.4 Cloned dapA (pBRA6) delays the onset of GroE depletion induced lysis. 
Data from N. McLennan (pers. comm.). 
29 
1.6 The lysine biosynthetic pathway 
The work described in this thesis is mainly a continued investigation into the 
effects of GroE depletion on DapA; therefore DapA and the lysine biosynthetic 
pathway will be discussed here in further detail. 
Work's discovery in 1950 of the unusual amino acid meso-diaminopimelate in 
acid hydrolysates of Corynebacterium diphtheriae (Work, 1950), and subsequently 
in Mycobacterium tuberculosis (Work, 195 1) led to the systematic study of its 
biosynthesis and the description of the bacterial lysine biosynthetic pathway 
(Gilvarg, 1960). Not only was diaminopimelate found to be the immediate precursor 
of L-lysine, but it was subsequently demonstrated to be a component of the bacterial 
cell wall (Cummins et al, 1956): specifically, the peptidoglycan portion. In 
Escherichia coli, and other bacteria, not only L-lysine, but also L-threonine, L-
methionine, and L-isoleucine are derived from L-aspartate (Fig. 1.6.1) The common 
portions of the biosynthetic pathway include the enzymes aspartokinase and aspartate 
semialdehyde dehydrogenase, which generate aspartate semialdehyde. The reduction 
of aspartate semialdehyde by homoserine dehydrogenase yields homoserine, the 
precursor to threonine, methionine and isoleucine. 
Bacteria have evolved three slightly different strategies for the biosynthesis of 
diaminopimelate, and thus lysine, from aspartate (Scapin et al, 1998). After 
generation of aspartate semialdehyde, it is condensed with pyruvate by the action of 
the dapA-encoded synthase to generate dishydropicolinate. This compound is 
reduced by the dapB-encoded reductase to yield tetrahydropicolinate. The acyclic 
form of tetrahydropicolinate, L-2-amino-6-keto-pimelate, can be directly converted 
to diaminopimelate by the reduced nicotinamide adenine denucleotide (NADPH) and 
ammonia-dependent reductive amination of the 6-keto group, a reaction catalysed by 
diaminopimelate dehydrogenase (Misono et al, 1976). 	Diaminopimelate 
dehydrogenase has a very limited occurrence, having only been identified in 
Corynebacterium glutamicum (Misono et al, 1986), Bacillus sphaericus (White, 
1983) and a Pseudomonas and Brevibacteriurn species (Misono et al, 1986). As an 
alternative to the direct reductive amination reaction, two alternative pathways exist 
in bacteria, which involve the N-acylation of L-2-amin-6-ketopimelate to prevent 
cyclisation. By far, the most prevalent pathway involves N-succinylation of the a-
amino group by succinyl CoA, catalysed by the tetrahydropicolinate/succinylCoA N-
succinyltransferase (Fig. 1.6.2). Once the acyclic form is stabilized by succinylation, 
a pyridoxal phosphate (PLP) dependent transaminase generates a second amino acid 
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center of the L configuration, using L-glutamate as the amino group donor. The 
product of the transaminase, N-succinyl-L-L-diaminopimelate is desuccinylated by 
the dapE-encoded desuccinylase to generate succinate and L-L-diaminopimelate. 
The epimerisation of this intermediate form to D-L-diaminopimelate is catalysed by 
the dapF-encoded diaminopimelate epimerase, one of the rare examples of a non-
PLP-dependent amino acid epimerase. While many amino acid biosynthetic enzymes 
are clustered into multigenic operons, including the enzymes of isoleucine 
biosynthesis, the genes encoding the lysine biosynthetic enzymes are not clustered, 
and in fact are scattered over both the E. coli and Haemophius influenzae circular 
chromosomes (Bukhari et al, 1971). 
The alternate pathway involving N-acetylated intermediates instead of N-
succinylated intermediates proceeds through an identical series of steps, and is, like 
the dehydrogenase pathway, extremely limited in its bacterial distribution. The 
deacylation of N-acetyldiaminopimelate has only been described in Bacillus species, 
with the acetylase pathway of B. megaterium being the best characterized system 
(Sundharadas et al, 1967). 
In contrast to bacterial lysine biosynthesis, yeast synthesise L-lysine via the 
a-ketopadipate pathway, in which acetyl CoA and a-ketoglutarate are condensed to 
form homocitric acid (Strassman et al, 1964). Isomerisation generates homoisocitric 
acid (Strassman et al, 1966), which is oxidized to oxaloglutaric acid and 
decarboxylated to yield a-ketoadipate (Strassman et al, 1965). (X-Ketoadipate is 
transaminated to a-aminoadipate (Broquist et a!, 1961), reduced to a-aminoadipate 
semialdehyde (Sagisaka et al, 1961), and condensed with L-glutamate to generate 
saccharopine (Jones et al, 1966) named for the yeast Saccharomyces cerevisiae, from 
which the compound was first identified. Oxidation and hydrolysis of the imine 
yields L-lysine and a-ketoglutarate (Saunders et a!, 1966). 
In the following sections the enzymes involved in lysine biosynthesis in 
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Fig. 1.6.2 Bacterial L-lysine biosynthetic pathway. Image from Scapin and 
Blanchard (Scapin et at, 1998) 
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1.6.1 Aspartokinase and aspartate semialdehyde dehydrogenase 
In all species of bacteria, aspartokinase and aspartate semialdehyde 
dehydrogenase (EC 2.7.2.4 and 1.2.1.11) act sequentially to generate the early, 
common intermediates in L-threonine, L-isoleucine, L-methionine and L-lysine 
biosynthesis. Aspartokinase has been the subject of intense genetic and biochemical 
interest due to the presence of three isozymes in E. co/i, which are end-product 
inhibited by the three amino acid products: L-threonine, L-methionine and L-lysine 
respectively (Patte, 1996). The most abundant isozyme is the thrA-encoded 
aspartokinase I, a bifunctional aspartokinase-homoserine dehydrogenase (Stadtman 
et al, 1961). This 820 amino acid E. co/i protein is composed of an amino terminal 
aspartokinase domain and a carboxy terminal homoserine dehydrogenase domain 
(Truffa-Bachi et al, 1968). Threonine exhibits competitive inhibition versus aspartate 
and noncompetitive inhibition versus homoserine, but the inhibition curves are both 
sigmoidal suggesting cooperative binding to the homotetramer (Cohen, 1985). 
Threonine and isoleucine also regulate the expression of the thrA-encoded 
aspartokinase. The E. co/i metL-encoded aspartokinase II is also a bifunctional 
aspartokinase-homoserine dehydrogenase, which in contrast to aspartokinase I, is not 
inhibited by methionine (Patte et al, 1967). The enzyme exists as a homodimer of 
809 amino acid long monomers, and expression of the gene is repressed by 
methionine. Finally, the lysC-encoded aspartokinase III is a monofunctional 
aspartokinase, which is noncompetitively and cooperatively inhibited by lysine and 
other amino acids (Patte et al, 1965; Stadtman et al, 1961). The E. co/i aspartokinase 
III is a homodimer of 449 amino acid long monomers that are homologous to the 
amino terminal domains of the aspartokinase I and II. 
The asd-encoded aspartate semialdehyde dehydrogenase (EC 1.2.1.11) 
catalyses the reversible NADPH-dependent reduction of aspartyl phosphate to 
generate aspartate semialdehyde. The E. co/i gene has been sequenced (Haziza et al, 
1982), and encodes a 367 amino acid monomer that exists as a homodimer in 
solution (Biellmann et al, 1980). Homology is observed between the Asd protein 
from E. co/i and other sequences from different species (Chen et al, 1993). 
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1. 6.2 Dihydropicolinate Synthase 
The dapA-encoded dihydropicolinate synthase (DHDPS) (EC 4.2.1.52), 
located at min 53 on the chromosome (Bukhari et al, 1971) catalyses the first unique 
step in lysine biosynthesis: the aldol condensation between pyruvate and aspartate 
semialdehyde. The activity was first described in extracts of E. co/i in 1965 (Yugari 
et al, 1965), and the enzyme was purified 5000-fold to apparent homogeneity from E. 
co/i in 1970 (Shedlarsky et al, 1970). Since it catalyses the committed step in L-
lysine biosynthesis it is perhaps not surprising that all synthases studied to date are 
feedback inhibited by L-lysine. The extent of inhibition has been used to group the 
synthases into three classes: gram positive bacterial synthases are only modestly 
inhibited by high concentrations of lysine; plant synthases are strongly inhibited at 
lysine concentrations less than 50 j.iM; while the E. co/i and B. sphaericus enzymes 
are weakly inhibited by 0.2-1.0 mM concentrations of L-lysine (Patte, 1996). Early 
kinetic studies suggested that L-lysine was a competitive inhibitor versus aspartate 
semialdehyde, but more recent studies with the wheat enzyme suggest that lysine is a 
bona fide allosteric inhibitor (Shaver et al, 1996). 
The native E.coli enzyme was reported to have a molecular weight of 134 
kDa, and is now known to be a homotetramer of 31,372 Da monomers (Richaud et 
al, 1986). These early studies identified a lysine residue as being involved in the 
initial binding of pyruvate. A ping-pong mechanism has been proposed for DapA 
function; pyruvate binds to the enzyme, forming a Schiff base with the c-amino 
group of Lys-161, and is followed by the binding of aspartate semialdehyde (Laber et 
al, 1992). 
The three-dimensional structure of the E. co/i dihydropicolinate synthase has 
been solved using X-ray crystallography at 2.5 A resolution (Mirwaldt et a!, 1995). 
The asymmetric unit is composed of two monomers, and the tetramer is generated 
using crystallographic symmetry operations. The tetramer has a large solvent-filled 
cavity at its center (Fig. 1.6.3). Each monomer is composed of two domains: the 
amino terminal domain assumes an eight-stranded parallel ciJ (TIM) barrel ranging 
from residues 1-224, while the carboxy-terminal domain is composed predominantly 
of cc-helices ranging from residues 224-292 (Fig. 1.6.4). The catalytic site, as 
definied by the position of Lys-161, is at the carboxyl-terminal end of the barrel, 
with the c-amino group of Lys-161 almost exactly centered in the barrel. This site is 
the position of all catalytic sites in such parallel a/J3 barrel enzymes (Farber et al, 
1990), and is commonly used to stabilize developing negative charges on 
intermediates, or in the transition state, for enzyme-catalysed reactions. In a 
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continuation of these studies Farber and Petsko (Farber et al, 1990) successfully 
soaked a number of substrates and substrate analogues into the apoenzyme, and 
determined the structure of many of these complexes (Buckling et al, 1997). The 
pyruval complex of the enzyme showed the expected formation of the covalent 
Schiff base with Lys-161. 
Of substantial interest was the determination of the structure of the L-lysine 
complex of DHDPS. Two molecules of L-lysine were shown to bind at the 
monomer-monomer interface, with interactions between each lysine molecule and 
residues of both monomers potentially explaining the observed cooperative binding 
of L-lysine to the tetramer (Blickling et al, 1997). The a-carboxyl group of bound L-
lysine interacts predominantly with the phenolic oxygen of Tyr-106, and the a-amino 
group makes extensive interactions with Asn-80 and Glu-84. The c-amino group 
makes interactions with His-53 and His-56, and all of these residues are observed to 
move from their position in the apoenzyme upon lysine binding. Sequence 
alignments (Mirwaldt et al, 1995) of the derived protein sequences from plants and 
bacteria show that while Asn-80 and Tyr-106 are conserved in all synthases, Glu-84 
is only present in synthases that exhibit strong lysine inhibition, and is replaced by a 
threonine residue in gram-positive bacteria that are weakly inhibited by lysine. In 
support of the critical role of Glu-84 in L-lysine binding to the synthase, is the report 
that mutations of this residue in the maize synthase result in the synthesis of a 
synthase that has lost sensitivity to L-lysine inhibition (Shaver et al, 1996). This 
finding suggests that mutant synthases that are not feedback inhibited by lysine may 
be useful to generate transgenic plants with increased levels of free lysine for animal 
feedstock, allowing for this required, and limiting, amino acid to be more easily 
acquired. 
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Fig. 1.6.3 Three-dimensional structure of E. coli dihydropicolinate synthase tetramer. 
(Coordinate filename 1 DHP.pdb) 
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Fig. 1.6.4 Three-dimensional structure of E. coli dihydropicolinate synthase 
monomer. (Coordinate filename 1DHP.pdb) 
1.6.3 Dihydropicolinate Reductase 
The dapB-encoded dihydropicolinate reductase (EC 1.3.1.26), located at mm 
0.5 on the chromosome (Bukhari et a!, 1971), catalyses the thermodynamically 
favourable NAD(P)H-dependent reduction of dihydropicolininc acid (DHDP) to 
tetrahydropicolinic acid (THDP), the second step in the lysine biosynthetic pathway. 
The reductase was initially identified in E. coli mutants that required diaminopimelic 
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acid and lysine in their growth medium, and were subsequently show to lack the 
reductase (Farkas et al, 1965). The enzyme was subsequently purified 1900-fold 
(Tamir et al, 1974) to homogeneity. The enzyme exhibits a broad pH optimum 
around 7, and the enzyme's native molecular weight was found to be 110 kDa by gel 
filtration chromatography and sedimentation velocity measurements. The enzyme 
was shown to have a high affinity for its substrates, with reported Km values of 9 and 
10 M for dihydropicolinate and NADPH, respectively. 
The first dapB gene sequence was reported in 1984 for the E. coli enzyme 
(Bouvier et al, 1984). The DNA sequence predicted a 273 residue polypeptide, with a 
subunit mass of 28,798 Da. To date, eight additional sequences have been reported 
(Scapin et al, 1998). They all encode reductases of between 246 and 286 residues. 
All share several regions of homology, in particular the motif 
(8V/I)(A/G)(V/I)XGXXGXXG18, located at the extreme N-terminus of the protein, 
and the motif 157E(L/A)HHXXKXDAPSGTA171 (numbers are for the E. coli 
sequence). The first motif is found in a variety of dinucleotide-dependent 
dehydrogenases, and in the three dimensional structure of the E. coli enzyme is part 
of the nucleotide binding domain (Scapin et al, 1995). The second region has been 
suggested as a potential substrate-binding region on the basis of the conserved 
positively charged residues and its location in the three-dimensional structure of the 
E. coli enzyme (Pavelka et al, 1997). 
1. 6.4 Tetrahydropico/inate N-Succinyltransferase 
The dapD-encoded tetrahydropicolinate N-succinyltransferase (EC 2.3.1.117) 
is localised at 3.5 min clockwise from tonA (Richaud et al, 1984). The gene has been 
cloned and sequenced, and encodes an open reading frame of 274 amino acids 
(monomer molecular weight 30,040 Da) (Richaud et al, 1984). 
The native E. coli enzyme has been purified and extensively characterised 
(Simms et al, 1984). The purification to homogeneity required a 1900-fold 
purification from wild type E. coli, and the subunit molecular weight by SDS_PAGE 
analysis was about 31 kDa. The purified enzyme was shown to catalyse the 
reversible transfer of the succinyl group from succinyl CoA to tetrahydropicolinate, 
although the forward, physiologically important reaction was 380 times faster than 
the reverse reaction at the pH optimum of 8.2 (Simms et al, 1984). 
The three dimensional structure of the N-succinyltransferase has been 
reported at 2.2 A (Beaman et al, 1997). Primary sequence studies had previously 
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noted that the transferase was homologous to a family of enzymes that bore a 
signature motif, termed the 'hexapeptide repeat', or leucine patch (Vaara, 1992). The 
principal feature of this motif is the presence of multiply repeated sequences, (LIV)-
(GAED)-X-X-(STAV)-X, which has been structurally characterised in two previous 
cases: the E. co/i UDP-N-acetlyglucosamine acetlytransferase (Raetz et al, 1995) and 
the Methanosarcina thermophila carbonic anhydrase (Kisker et al, 1996). The 
homologous hexapeptide repeat sequences of both these enzymes form an unusual 
left-handed 3-helix. Both enzymes exist as trimers, as does the dapB-encoded 
tetrahydropicolinate N-succinyltransferase. The active site was proposed to be at 
each monomer-monomer interface, since this is where both pCMBS (a mercurial) 
and cobalt (II), inhibitors of the reaction, were bound. More recent studies of the 
enzyme crystallised in the presence of 2-aminopimelate [identified as an alternate 
substrate (Berges et al, 1986a)] and CoA have confirmed the presence of these two 
molecules at the monomer-monomer interface. 
1. 6.5 N-Succinyl-L-L-Diaminopimelate Aminotransferase 
Almost nothing is known about the aminotransferase (DapATase) (EC 
2.6.1.17) that catalyses the transfer of the amino group from L-glutamate to N-
succinyl-L-2-amino-6-ketopimelate to generate ketoglutarate and N-succinyl-L-L-
diaminopimelate. Furthermore, no sequence of any dapC gene has been reported 
from any source, although several reports have incorrectly identified the dapD gene 
as the dapC gene (Richaud et al, 1984). The enzyme was first partially purified from 
E. co/i (Peterkofsky et al, 1961), and could be purified approximately 110-fold 
(Peterkofsky, 1962). More recently, the enzyme has been purified 1500-fold to 
homogeneity (Cox et al, 1996). The enzyme has a subunit mass of 39,896 Da, and 
exists as a homodimer. The enzyme is absolutely specific for L-glutamate as the 
amino donor, but will use a number of N-acyl ketopimelates. 
A recent report suggests that the argD-encoded N-acetylornithine 
aminotransferase (NAcOATase) exhibits both NAcOATase and DapATase activity, 
with similar specificity constants for N-acetylornithine and N-succinyl-L-L-
diaminopimelate, suggesting that it can function in both lysine and arginine 
biosynthesis (Ledwidge et al, 1999). This finding may explain why numerous 
investigations have failed to identify genetically the bacterial dapC locus. 
1. 6.6 N-Succinyl-L-L-Diaminopimelate Desuccinylase 
Along with the preceding enzyme in the lysine biosynthetic pathway, the 
dapE-encoded N-succinyl-L-L-diaminopimelate desuccinylase (EC 3.5.1.18), 
localised at 53 mm, is poorly characterised. The substrate of the enzyme was first 
identified in 1959 (Gilvarg, 1959), but the enzyme was not purified until about 10 
years ago (Gelb et al, 1990). Enzyme levels do not appear to be regulated by lysine 
levels in the media, and the enzyme was purified to homogeneity from E. coli K12 
grown in rich medium. The enzyme was purified 7100-fold, and was found to be a 
mixture of dimeric and tetrameric 40 kDa monomers. The enzyme requires a divalent 
metal ion for activity, with cobalt being more effective than zinc on the basis of a 
2.2-fold higher maximum velocity in the presence of cobalt (Lin et al, 1988). 
The amino acid sequences of five bacterial desuccinylases have been reported, 
and alignment of the sequences from E. coli (375 amino acids), H. inJluenzae (377 
amino acids), C. glutamicum (369 amino acids), H. jannaschii (410 amino acids), 
and M. leprae (337 amino acids) reveals a highly homologous consensus sequence in 
the first 100 residues (Boyen et al, 1992). This consensus pattern has also been 
identified in several other metal-dependent enzymes that catalyse the hydrolysis of 
amide linkages (Meinnel et a!, 1992). These include the E. coli argE-encoded 
acetylornthinase, the Pseudomonas cpg2-encoded carboxypeptidase G2, the 
Lactobacillus pep V-encoded carnosinase, the bacterial pepT-encoded tripeptidase, 
and both the yeast yscS-encoded carboxypeptidase and the mammalian 
aminoacylase- 1 (Boyen et a!, 1992). This finding suggests that the conserved amino 
acid sequence may be structurally important for metal ligation and catalysis. The 
three dimensional structure of the Pseudomonas cpg2-encoded carboxypeptidase G2 
has been determined to 2.5 A (Rowsell et al, 1997). The structure revealed the 
presence of two zinc atoms at the presumptive active site that share a bridging 
water/hydroxide ligand, and also demonstrated that the conserved glutamate, 
aspartate and histidine residues were involved in metal ligation. 
1. 6.7 L-L-Diaminopimelate Epimerase 
The dapF-encoded diaminopimelate epimerase (EC 5.1.1.7), located at mm 
85 (Richaud et al, 1987), catalyses the interconversion of L,L-DAP, the product of 
the dapE-encoded desuccinylase reaction, and D,L-DAP, the substrate for the lysA-
encoded decarboxylase. The enzyme was initially identified in crude extracts of E. 
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co/i in 1957 by Work and co-workers using paper chromatographic identification of 
the formation of D,L-DAP from L,L-DAP (Antia et al, 1957) and only purified to 
homogeneity from E. co/i in 1984 (Wiseman et al, 1948). In this latter study, 
formation of D,L-DAP from L,L-DAP was followed spectrophotometrically by 
coupling the product to the diaminopimelate dehydrogenase, which is specific for the 
D,L-isomer. The homogenous enzyme was purified 6000-fold in 3% yield and shown 
to behave as a monomer on gel permeation chromatography. The subunit molecular 
weight determined by SDS-PAGE was 34 kDa, as subsequently confirmed by the 
cloning and sequencing of the gene from E. co/i (Richaud et al, 1988). Although 
earlier studies had yielded ambiguous data on the presence of pyridoxal phosphate as 
a cofactor in the epimerisation reaction, the homogenous enzyme exhibited no visible 
absorbance indicative of the presence of PLP, neither was the reaction stimulated by 
exogenously added PLP, nor inhibited by hydrazine or hydroxylamine, reagents 
known to inhibit PLP-dependent enzymes (Wiseman et al, 1948). Studies with the 
active site directed aziridine derivative, 2-(4-amino-4-carboxybutyl)-2-aziridine-
carboxylic acid, demonstrated the irreversible and covalent inactivation of the 
epimerase. Tryptic digestion followed by peptide separation and sequencing 
demonstrated that Cys-73 was alkylated by this compound (Higgins et al, 1989). This 
residue is conserved in the aligned sequences of four bacterial dapF-encoded 
epimerises (Scapin et al, 1998). 
Few effective inhibitors have been designed and tested against the purified 
epimerase. It is clear that the dapF-encoded epimerase is not an essential gene in E. 
co/i, since its disruption has no obvious lethal consequences to the organism 
(Richaud et al, 1987). While dapF mutants accumulate L,L-DAP intracellularly, it 
has been proposed that other enzymes may act to epimerise the L,L-DAP to generate 
sufficient D,L-DAP for incorporation into the peptidoglycan component of the cell 
wall. As described above, the aziridine derivative is a potent, active site directed 
irreversible inhibitor of the epimerase, although its antibacterial properties have not 
been explored. 
1. 6.8 D-L-Diain inopimelate Decarboxylase 
The activity of the /ysA-encoded D,L-diaminopimelate decarboxylase (EC 
4.1.1.20) was first demonstrated in crude extracts of E. co/i in 1952 (Dewey et al, 
1952). The enzyme has been purified from a number of bacteria (White et al, 1965) 
and plants, and catalyses the only PLP dependent decarboxylation of an a-amino 
acid of D configuration (Scapin et al, 1998). In addition to this unique substrate 
stereospecificity, it has been shown that both the B. sphaericus and wheat germ 
decarboxylases catalyse the decraboxylation reaction with inversion of configuration 
(Asada et al, 1981; Kelland et al, 1985). This is in contrast to all other stereochemical 
outcomes for PLP-dependent decarboxylases. 
Essentially no bona fide mechanistic studies have appeared for 
diaminopimelate decarboxylase, in spite of renewed interest in the potential 
antibacterial properties of inhibitors of this enzyme. 
In the last twenty years, a number of sequences of bacterial lysA genes have 
appeared, including those from E. coli (Stragier et al, 1983a), C. glutamicum (Yeh et 
al, 1988), P. aeruginosa (Martin et al, 1988), B. subtilis (Yamamoto et al, 1989) and 
M. tuberculosis (Andersen et al, 1993). In addition, the lysA genes of H. influenzae 
and M. jannaschii have been identified from genome sequencing projects by 
homology to those sequences reported above (Fleischmann et al, 1995; Bult et al, 
1996; Bult et al, 1996). Alignment of these bacterial decarboxylase sequences reveals 
three conserved lysine residues, one of which is likely to be the lysine that binds PLP 
cofactor. The bacterial diaminopimelate decarboxylase sequences are also 
homologous to other basic amino acid decarboxylases, including both bacterial and 
mammalian ornithine decarboxylases and arginine decarboxylase (Scapin et al, 
1998). An extensive alignment of PLP-dependent enzymes has been used to separate 
all such enzymes into four types, based on primary sequence homology (Alexander 
et al, 1994). Diaminopimelate decarboxylase is a member of the third type, which 
includes eukaryotic ornithine decarboxylases, plant and bacterial arginine 
decarboxylases, and bacterial alanine racemases (Grishin et al, 1994). Both sequence 
alignment and secondary structural predictions have been used to suggest that the 
type 3 PLP-containing enzymes assume an eight stranded a/13  barrel. The recent 
determination of the high-resolution three-dimensional structure of B. 
stearothermophilus alanine racemase (Shaw et al, 1997) provides support for this 
prediction. The racemase consists of an amino-terminal a1J3 barrel domain composed 
of residues 1-240, and a carboxyl-terminal composed of 13  strands. The lysine residue 
involved in Schiff base formation with the cofactor is located at the carboxyl 
terminus of the first of the eight central beta strands that make up the barrel. 
The chemistry catalysed by PLP-dependent enzymes has made them the 
subject of numerous mechanism-based inhibitor studies. Based on similar studies of 
ornithine decarboxylase, fluoromethyl diaminopimelates have been synthesised and 
shown to be inhibitors of the epimerase (Osterman et a!, 1995). The 13,y-unsaturated 
meso-diaminopimelate has been synthesised and shown to be a modest inhibitor of 
3] 
the decarboxylase (Girodeau et a!, 1986). More recently, inhibitors in which the 
carboxylic moiety undergoing decarboxylation has been replaced by the 
corresponding phosphonate have been prepared and shown to inhibit the 
decarboxylase, as well as the dehydrogenase and epimerase (Song et al, 1994). 
Unfortunately, these compounds are both poor inhibitors of the enzyme and exhibit 
negligible antibacterial activity against E. coli or Salmonella. However, tripeptides 
containing the phosphonate analogue exhibit some antibacterial activity, reminiscent 
of successful antibacterial studies in which L-2-aminopimelate was incorporated into 
tripeptides, presumably to enhance transport of these molecules across the cell wall 
and membrane (Berges et al, 1986b). The determination of the three-dimensional 
structure of the decarboxylase may allow some of these studies to be resuscitated. 
1.6.9 Regulation of lysine biosynthesis 
It has been clearly established, either directly or by the use of fusions with 
lacZ that the expression of several genes in the lysine biosynthetic pathway depends 
on the intracellular pool of lysine; this is true for lysC (Stadtman et al, 1961), asd 
(Boy et a!, 1972), dapB (Bouvier et al, 1984), dapD (Richaud et al, 1984) and lysA 
(Boy et al, 1979a). In contrast, expression of dapA (Butour et al, 1974), dapE and 
dapF (Patte, 1996) appears constitutive. Results are yet to be reported for dapC. 
However, even though regulation by lysine has been demonstrated, the molecular 
mechanism that correlates variations of lysine concentration with variations of gene 
expression remains to be established and differs quite certainly from one gene to 
another. 
The expression of LysC specific activity varies widely (over 100-fold 
between repression values and lysine-limited chemostat values) with the lysine 
intracellular pool. While a number of mutational studies have been performed on the 
lysC gene (Boy et al, 1979b) and the promoter region has been sequenced (Cassan et 
al, 1983), it is still not understood how lysine plays a role in its regulation. 
Expression of the asd gene varies in response to the concentration of lysine, 
threonine and methionine (Boy et a!, 1972), but lysine is a much more important 
effector (50-fold variation) than the other two (only 2-fold derepression) and 
therefore is included in the lysine regulon. Operon fusions with lacZ have indicated 
that regulation occurs at the transcriptional level (Patte, 1996). Observations of the 
sequence (Haziza et al, 1982) has led to the conclusion that a typical multivalent 
attenuation mechanism is not involved [such a mechanism exists for the 
Streptococcus asd gene (Cardineau et al, 1987)]. The molecular mechanism of 
regulation therefore remains unknown. It has been shown that another metabolite, 
glucose 6-phosphate, modifies asd expression (Boy et a!, 1979c), but again, no 
molecular mechanism has been proposed. 
Variations in the lysine pool also greatly affect dapB expression [20-fold 
derepression (Boy et al, 1978)]. Mutations in the relA gene (Patte et al, 1980) and in 
the iysS gene (Boy et al, 1976) indicate that ppGpp on the one hand and lysyl-tRNA 
on the other must play a role in this regulation. However, examination of the 
nucleotide sequence upstream of the dapB gene did not allow the proposal of a 
molecular mechanism. Some sequence similarities with the asd promoter sequence 
have been suggested (Bouvier et al, 1984). Binding of an unidentified cytoplasmic 
protein to the DNA promoter region has been observed in gel retardation 
experiments (Patte, 1996). 
Similarly, examination of the coding sequence upstream of the dapD gene 
gave no indication of the molecular mechanism by which lysine modifies the 
expression of this gene (Richaud et al, 1984). 
The only example in which a clear mechanism has been established is the 
regulation of the lysA gene. Expression of this gene depends on the intracellular 
concentration of both diaminopimelate, which acts as an inducer, and lysine, which 
acts as a corepressor. This double regulation reflects the special situation of 
diaminopimelate decarboxylase, as a catabolic enzyme for diaminopimelate and an 
anabolic enzyme for lysine (Boy et a!, 1979a). Moreover, ppGpp must play a role in 
lysA expression, which is modified in relA mutants (Patte et al, 1980). Mutants with a 
Lys phenotype were obtained outside the lysA structural gene. They had lesions in 
the lysR gene, specifying a positive regulatory protein for lysA expression (Stragier et 
al, 1983b). The lysR gene is located next to lysA and transcribed divergently (65 bp 
lie between the two sites of transcription initiation). Genetic evidence has shown that 
LysR (without diaminopimelate) binds to an intergenic sequence, allowing activation 
of the lysA promoter (Stragier et a!, 1983a) and repression of the lysR promoter 
(autoregulation). It has been proposed that lysine blocks LysR binding, but this point 
remains to be firmly established. The lysR sequence has been determined and found 
to encode a protein of 34 kDa (Stragier et al, 1983c). A characteristic helix-turn-helix 
sequence for DNA binding has been demonstrated. 
The respective roles of feedback inhibition and repression have also been 
studied, selecting, for example, mutants resistant to growth inhibition by analogues 
of lysine (S-aminoethyl cysteine). The LysC step is a crucial point of regulation for 
lysine biosynthesis. The feedback inhibition is 100%. Only desensitised lysC mutants 
could be isolated (with the exception of permeation mutants), and accumulation of 
lysine in the growth medium results from such mutations (Boy et al, 1972). 
The biological importance of feedback inhibition on the DapA enzyme has 
been questioned, in view of the high K1 of the ligands. However, it must play a role in 
vivo, in parallel with some channelling, as desensitised lysC mutants overproduce 
mainly lysine, and not threonine. 
Finally, in vivo determination of the limiting steps in the lysine pathway was 
made possible by the use of mutants and by gene amplification with multicopy 
plasmids carrying one of the genes of the pathway: the LysC activity is the first point 
of limitation of the flux, followed by the DapA step (Daucé-Lereverend et al, 1982) 
1.6.10 Summary 
The widespread occurrence of the bacterial biosynthetic pathway described in 
the preceeding sections has suggested that inhibition of the enzymes in this pathway 
may have antibacterial properties (Girodeau et al, 1986). The absence of the enzymes 
in this pathway in mammals and the dual biosynthetic importance of the pathway, in 
both protein and cell wall biosynthesis, bolster these arguments. Recent insertional 
inactivation of the ask gene has demonstrated that the biosynthesis of 
diaminopimelate is an essential function in Mycobacterium smegmatis, and that 
organisms lacking the ask gene product suffer 'DAP-less' death (Pavelka et al, 
1996). The demonstrated clinical effectiveness of inhibitors of enzymes involved in 
cell wall biosynthesis, particularly peptidoglycan synthesis, suggests that a more 
thorough enzymological and structural characterisation of these unique enzymes may 
yield new classes of inhibitors with therapeutic efficacy. The recent appearance of 
multiply antibiotic-resistant bacterial pathogens increases the urgency to find new 
and effective antibacterial compounds, with broad spectrum antibacterial activity. 
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1.7 The project 
Previous attempts have been made to determine the in vivo substrates of GroE 
in Escherichia co/i using a number of different approaches (Horwich et al, 1993; 
Kanemori et a!, 1994; Houry et al, 1999). In a further attempt to identify GroE 
substrates, McLennan and Masters constructed a strain of E. co/i, in which 
expression of the chaperonin GroE could be regulated by the presence or absence of 
exogenous arabinose (McLennan et a!, 1998). It was found that when E. co/i are 
GroE depleted they lyse, due to diarninopimelate starvation. It was further discovered 
that diaminopimelate was not being synthesised, as the protein DapA is not 
functional in GroE depleted cells. The work described in chapter 3 of this thesis is a 
continuation of the study of the effects of GroE depletion on DapA in E. co/i. Work 
in chapter 4 describes the analysis of another protein, which appears to be affected by 
GroE depletion, the lac repressor. 
During the initial investigations into DapA, it was found that expression of the 
dapA gene increased during GroE depletion. This was an unusual result, as dapA was 
not believed to be regulated at the level of expression (Bouvier et al, 1984). Further 
investigation revealed that, contrary to earlier reports, dapA is in fact regulated at the 
level of expression, and this is discussed in detail in chapter 5. 
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Chapter II 
Materials and Methods 
M. 
2.1 Bacterial strains, phage and plasmids 
2. 1.1 Growth Media and buffers 
Bacterial strains used in this study are listed in Table 2.1.1. Bacteria were 
either maintained on L-Broth plates stored at 4°C, or for longer-term storage, in 
frozen storage buffer [50% bacterial buffer + 50% glycerol (v:v)] at -70°C. 
Yeast strains used in this study are listed in Table 2.1.2. Yeast was maintained 
on YPD or DOB plates stored at 4°C. 
Bacteriophages used in this study are listed in Table 2.1.3. Phage lysates ofPl 
and X were stored at 4°C as broth suspensions to which a few drops of chloroform 
had been added to prevent microbial growth. 
Plasmids used and constructed in the course of this study are listed in Table 
2.1.4. 
Growth media and commonly used buffers are listed in Tables 2.1.5 and 2.1.6 
respectively. L-Broth and L-agar were used routinely for all bacterial manipulations, 
except where otherwise stated. For work with phage 2 the medium was 
supplemented with 10 mlvi MgSO4 and 0.2% maltose to maximise expression of the 
2 receptor protein; for phage P1, 2.5 mM CaC12 was added. VB minimal agar, 
supplemented with appropriate carbon sources, vitamins and amino acids 
(concentrations are defined later in the text), was used for selection of nutritional 
markers. For work with MGM 100 the media were supplemented with 0.2% 
arabinose or 0.2% glucose and DAP was added at a final concentration of 100ig 
m1'. 
2.1.2 Growth of Bacteria 
Bacteria were routinely grown as liquid cultures at 37°C (or 30°C for 
temperature-sensitive strains). Usually, fresh overnight cultures that had been 
inoculated from a single colony were diluted the following day and grown as 
required. 
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Table 2.1.1 Bacterial strains used in this study 
Strain 	 Genotype 	 Source/Reference 
AG3 1 	 F, groES13 1  ts 	 C. Georgopolous 
BL21(DE3) 	 E. coli B strain. F, ompT, hsdSB (rB- 	(Studier eta!, 
MB-), XDE3 	 1986) 
CAG18439 	 F, lam, rph-1, lacZl 18(0c), 
lacI3 042: :Tn I O(TetR) 
CAG18442 	 F, lain-, rph-1, thrA34::TnlO(TetR) 
DH5a 801acZAM 15, A(1acZYA-argF)U 169, 
recA, endA, hsdRl7 (rK- mK+), 
supE44, X-, thi- 1, gyrA96, relA 1 
ET505 F, lam, 1ysA::Tn10(Tet'), IN (rrnD- 
rrnE1 
INV1 10 F, (traA36, proAB, lad", /acZAM 15) 
rpsL (strR),  thr, leu, endA, thi-1, lacY, 
galK, gaiT, ara, tonA, tsx, dam, dcm, 
supE44, A(iac-proAB), A(mcrC- 
mrr) 102: :Tn 1 O(Tet') 
MG 1655 F, lam, rph-1, iacZ 
MG1655AdapA As MG 1655, except dapA<>cat 
MGM100 As MG1655 except 
PBADgrOESL: : Tn5(KanR) 
MGM 100 lacI::TnlO As MGM 100 except IacI::TnlO(TetR) 
MGM100DapAHis As MGM 100, except containing a 6 x 
His tagged version of dapA linked to a 
CmpR cassette 
MGM100DapAHSV As MGM 100, except containing a 
HSV tagged version of dapA linked to 
a CmpR  cassette 
MGM100AdapA As MGM 100 except dapA<>cat 
MGM100AdapAXPdapA- As MGM l00?PdapA-lacZ, except 
lacZ dapA<>cat 
(Singer et al, 
1989) 





(Guyer et al, 
1981) 
This work 








Strain 	 Genotype 	 Source/Reference 
MGM100/YSA2PdapA 	As MGM 100XPdapA-lacZ, except This work 
lacZ 	 /ysA::Tnl0(Tet') 
MGM100thrAXPdapA- 	As MGM100XPdapA-lacZ, except This work 
lacZ 	 thrA::Tn10(Tet') 
MGM 100?DE3 	As MGM 100 except 2DE3 	 This work 
MGM l00?PdapA /acZ As MGM 100, except 2PdapA-lacZ N. McLennan 
MGMIOOXRSPD72 As MGM100APdapA-lacZ except only This work 
70 bases of PdapA  upstream of ATG 
used 
NK6056 Hfr, DE (gpt-Iac)5, lam, N. Kleckner 
purC80: :Tn] O(TetR),  re/A 1, spoTl, 
thi-1 
NL131 F, thr20, 1eu32,proA35, codA2, N. McLennan 
lacYl, tsx70, gal6, ks, ?, rpsL125, 
xyl7, pyr63, groES13 1  ts 
NM621 Leu,proBl, hsdR, mcrA, mcrB, (Whittaker eta!, 
recD, supE, tsx, tonA 1988) 
TOP 10 F, mcrA, (Grant et a!, 
A(mrrhsdRMSmcrBC), 80/acZAM 15, 1990) 
AlacX74, deoR, recAl, araDl39, 
A(ara-leu)7 697, ga/U, ga/K, rpsL 
(strR), endAl, nupG 
TP8503 F, A(lac-proB), leu, thi, supE42,1huA Laboratory stock 
Table 2.1.2 Yeast strains used in this study 
Strain 	 Genotype 	 Source/Reference 
S. cerevisiae EGY48 	MATa, trpl, his3, ura3, leu2::6, MoBiTec 
LexAop-LEU2 
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Table 2.1.3 Bacteriophages used in this study 
Bacteriophage Description Source/Reference 
P1 P1 Kc Laboratory Stock 
XDE3 1mm21, Anin5, Sam7, T7 polymerase (Studier et a!, 
gene controlled by the lacUV5 1986) 
promoter 
2PSflA-lacZ ? phage containing the sulA promoter (Huisman et al, 
(PcjIA) transcriptionally fused to lacZ 1983) 
XPdapA-/acZ ? phage containing the dapA promoter Laboratory stock 
(PdapA) transcriptionally fused to lacZ 
?RS45 Transcriptional promoter fusion vector (Simons et al, 
with lacZ as reporter gene, 1mm21, 1987) 
ninR5 
Table 2.1.4 Plasmids used in this study 
Plasmid 	 Description 	 Source/Reference 
pBAD-18 	 AmpR,  4.6 kb, araC, PBAD, pBR322 	(Guzman eta!, 
replicon 	 1995) 
pBADLacZ 	 AmpR,  pBAD 18 + 4.0kb lacZ insert 	Laboratory stock 
pBR322 AmpR, TetR,  pMBI replicon (Bolivar, 1978) 
pBR325 AmpR, TetR,  Cmp', pMB1 replicon, (Bolivar, 1978) 
(oriT) 
pBRA6 AmpR,  pBR322 with 3.4 kb fragment Laboratory stock 
containing dapA 
pGEM-T Amp R,  3.0kb general purpose cloning Promega 
vector 
pGNG2 Amp', 6.7 kb, pBR ori, 2.im on, MoBiTec 
URA3, promoter GFPuv expression 
under control of GAL 1,10 
pGroEL CmpR,  pACYC + 2.1kb groES, (Goloubinoffet 
groEL insert al, 1989) 
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Plasmid Description Source/Reference 
pJF1 18(EH) Amp', ColE! replicon, tac promoter (Furste et al, 
and 1aci 1986) 
pJF! l8DapAHis As pJF1 18(EH), + 1.2 kb dapA.His This work 
cloned into the EcoRI and Hindill 
sites 
pJFI l8LacZ As pJF1 18(EH) + 4 k LacZ fragment This work 
cloned into EcoRI and HindIII sites 
pJG4-5 AmpR, 6.4 kb, pUC ori, 2.im on, MoBiTec 
TRP1, B42 under control of GAL  
pPRO SpcR plasmid carrying tetR and Clontech 
Piaci/lacJ 
pPROTet.E132DapA CmpR,  3.2 kb plasmid, dapA.His This work 
His expression under the control of PLtetO.I 
pRS551 AmpR,  Kan R,  12.5 kb plasmid (Simons et al, 
containing lacZ as a reporter 1987) 
pRS551-PD72 As pRS551 + 70 bp of dapA promoter This work 
DNA ligated into the EcoRI and 
BamHI sites 
pT7-5 AmpR,  2.4 kb, Col El replicon, 410 (Tabor et a!, 
promoter 1985) 
pT7-5DapAHis As pT7-5 + 1.2 kb dapA.His fragment. This work 
pUC18 General purpose cloning vector. 2.7 (Yanisch-Perron 
kb. AmpR et al, 1985) 
pUCAT18 pUC18 + 1.45 kb cat gene from Laboratory stock 
pBR322 
pUCDapA pUC18 + 3.4 kb fragment containing Laboratory Stock 
dapA 
pUCDapHis AmpR, CmpR,  as pUCDapA except This work 
dapA C terminal tagged with 6 x HIS 
and cat gene present 
pUCDapHSV Amp R, CmpR, as pUCDapHis except This work 
dapA C terminal tagged with HSV 
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L-broth 	 Difco bacto tryptone 
Difco bacto yeast extract 
NaCl 
pH to 7.2 with NaOH 
Distilled water to 1 litre 
LB - NaCl 	 As L-broth, omitting NaC1 
L-agar 	 L-broth + 15 g Difco agar per litre 
LB top agar 	 L-broth + 6.5 g Difco agar per litre 
Soc broth 	 Bactotryptone 
Difco bacto yeast extract 
5MNaCl 
1 M MgC12 
1 MKC1 
1 M Mg504 
glucose 
Distilled water to 200 ml 
Spizizen's minimal 	(NH4)2SO4 




Distilled water to 1 litre 
VB minimal media 	20x VB salts 
20% carbon source 
Thiamine HC1 (1 mg/ml) 
Supplements as required 
















VB minimal agar 	VB minimal media + 15 g difco agar 
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20x VB salts 	 Citric acid 	 40 g 
KH2PO4 400g 
NaNH4 HPO4 H2O 	 70 g 
Distilled water to 1 litre 
Store over 1 ml of chloroform 
YPD broth 	 Peptone 	 20 g 
Difco bacto yeast extract 	 10 g 
Glucose 	 20 g 
Distilled water to 1 litre 
YPD agar 	 YPD broth + 17 g Difco agar per litre 
DOB glucose 	 Yeast nitrogen base 	 1.7 g 
Ammonium sulphate 5 g 
Glucose 	 20 g 
Distilled water to 1 litre 
DOB galactose 	As DOB glucose, omitting glucose 
and adding: 
Galactose 	 20 g 
Raffinose lOg 
DOB agar 	 DOB glucose or galactose + 17 g Difco 
Agar per litre 
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Table 2.1.6 Commonly used buffers 
Phage buffer 	 Na2HPO4 7 g 
KH2PO4 3 g 
NaCl 5g 
1MMgSO4 Imi 
0.IMCaC12  10 ml 
1% (w:v) gelatin solution 1 ml 
Distilled water to 1 litre 
Bacterial buffer 	MgS04 7H20 	 2 g 
Na2HPO4 	 7 g 
KH2PO4 3 g 
NaCl 	 4g 
Distilled water to 1 litre 
TE buffer 	 10 mM Tris-HC1 (pH 8.0) 
1 mM EDTA (pH 8.0) 
TAE buffer 	 Working solution: 
40 mM Tris-acetate 
2 mM EDTA 
Tris base 	 242 g 
Glacial acetic acid 	 57.1 ml 
0.5 M EDTA (pH 8.0) 100 ml 
Distilled water to I litre 
TBE buffer 	 Working solution: 
89 mM Tris-borate 
89 mlvi boric acid 
Tris base 	 54 g 
Boric acid 27.5 g 
0.05 M EDTA (pH 8.0) 	 20 ml 
Distilled water to 1 litre 
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2.1.3 Minimal medium supplements 
Amino acid supplements were stored in stock solutions of pure amino acids at 
a concentration of between 2-10 mg/ml depending on the solubility of the particular 
amino acid. Sparingly soluble amino acids, such as tyrosine, were dissolved in 
0.01M NaOH. The final concentration of the amino acids in the media was usually in 
the order of 20-100 Vg/ml. If a rich minimal medium was required, vitamin free 
casamino acids (CAA) were used. The stock concentration of CAA was 100 mg/ml 
and the final concentration in the medium was typically 1-5 mg/mi. It should be 
noted that casamino acids lack tryptophan and this should therefore be added to the 
CAA medium if the bacterial strain to be used is auxotrophic for this amino acid. 
Purines and pyrimidines were added to minimal media when required. 
Thymine and uracil were stored at a concentration of 2 mg/ml in water, and their 
final concentration in minimal medium was usually 20-40 jig/ml. 
The only vitamin supplement used in this work was thiamine hydrochloride 
(vitamin BI). This was stored as a I mg/ml solution in water and its final 
concentration in minimal medium was 2 .tg/ml. 
2.1.4 Selection of antibiotic resistance 
The routine concentrations for the antibiotics used in this work are shown in 
Table 2.1.6. Those antibiotics dissolved in water were filter sterilised using a 0.45 
l.lm filter (Gelman). 
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Table 2.1.6 Antibiotic solutions 
Antibiotic Abbreviation Solvent Conc. of stock Final cone. in 
solution media (tg/ml) 
(mg/ml) 
Ampicillin Amp H20 100 50-100 
Chloramphenicol Cmp Ethanol 20 25 
Kanamycin Kan H20 25 25-50 
sulphate 
Naladixic acid Nal 0.1 M NaOH 20 20 
Spectinomycin Spc H20 50 25-50 
dihydrochloride 
Streptomycin Str H20 100 20 
sulphate 
Tetracycline Tet 50% ethanol 10 10 
hydrochloride 
2.2 DNA techniques 
2.2.1 Plasm id DNA preparation 
Plasmid DNA was prepared using the Qiaprep spin miniprep kit (Qiagen) 
according to the manufacturers instructions. 
2.2.2 Chromosomal DNA preparation 
Chromosomal DNA was prepared using the AquaPure Genomic DNA 
Isolation kit (Biorad Laboratories) according to the manufacturers instructions. 
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2.2.3 DNA precipitation 
DNA was precipitated from aqueous solution by: (i) adding 1/10 volume of 
3M sodium acetate (pH 5.0) and 3 volumes of absolute ethanol, mixing thoroughly 
and leaving on ice for a minimum of ten minutes. This was then centrifuged in a 
microcentrifuge at 14000 x g for 15 minutes. The supernatant was discarded, and the 
pellet washed in 70% ethanol by vortexing. This was recentrifuged as above for 10 
minutes, the supernatant again discarded and the pellet was dried under vacuum. The 
dried DNA pellet could then be resuspended in a suitable volume of TE buffer (with 
added RNase (20tg/ml) if required). (ii) Instead of 3 volumes of absolute ethanol, 1 
volume of isopropanol could be used. This had the advantage of keeping the total 
volume smaller, and was therefore the preferred method. After isopropanol 
precipitation and centrifugation, the pellet was washed with 70% ethanol as above. 
2.2.4 Determination of DNA concentrations 
DNA concentrations were determined by measuring the absorption of diluted 
DNA solutions at 260 nm. For double stranded DNA, an 0D260 value of 1.0 
represents a DNA concentration of 50 g/ml, and for single stranded DNA the same 
value represents a DNA concentration of 40 jig/ml. DNA purity can be determined 
by measuring absorption at 260 and 280 nm. Protein-free double stranded DNA 
should give a 260/280 ratio close to 1.8, and single stranded DNA should give a ratio 
nearer 2.0. 
2.2.5 Digestion of DNA with restriction endonucleases 
Endonuclease cutting of DNA was typically performed in volumes of between 
10 and 100 il. These contained the requisite amount of DNA (usually 1-10 tg) and 
the appropriate Boehringer Mannheim restriction buffer at a lx concentration. The 
restriction enzyme was usually present in a two - fivefold excess, i.e. 2-5 units per 
microgram of DNA. The digests were made up to their final volume using distilled 
water. The complete restriction digests were incubated at the recommended 
temperature (usually 37°C) for 1-3 hours. The products of the reaction were either 
directly analysed by agarose gel electrophoresis, or phenol extracted, ethanol 
precipitated and dissolved in a suitable volume of TE buffer for further manipulation. 
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2.2.6 Partial digestion of DNA 
For partial digestion of DNA, ten two-fold serial dilutions of restriction 
enzyme were added to fixed amounts of DNA, with 0.5 units of enzyme per 
microgram of DNA representing the highest enzyme:DNA ratio. The digests were 
incubated at the appropriate temperature for 1 hour and terminated by addition of 
tracking dye (Section 2.2.9). The products of the reactions could then be analysed by 
agarose gel electrophoresis. 
2.2.7 Ligation of DNA 
Ligations of DNA were typically performed in a final volume of 10 .tl. These 
contained lx Boehringer Mannheim ligation buffer, T4 DNA ligase and between 0.5 
and I ig total DNA with insert DNA in a 2 to 20 molar excess over the vector DNA. 
Ligase (0.2 units) was used for the ligation of cohesive DNA termini, and 1 unit of 
the enzyme was used for the ligation of blunt ended molecules. These reactions were 
incubated for at least 12 hours at 16°C. Between 5 and 10 pi of the reaction mixture 
was then used to transform competent cells of an appropriate strain of E. coli. 
2.2.8 'Filling in ' of recessed 3 ' termini 
DNA polymerase I Klenow fragment was used to fill-in the recessed 3' 
termini generated by various restriction enzymes to give blunt ended DNA 
molecules. Reactions were performed in a final volume of 20 pi containing 1 .tg 
DNA, lx Klenow buffer, all four dNTPs, each at a concentration of 20 j.iM and 2 
units of Klenow enzyme. The reactions were incubated at 16°C for 45 minutes. The 
reaction was stopped and the unincorporated nucleotides removed by increasing the 
reaction volume to 200 p.1 with TE buffer, phenol extracting and ethanol precipitating 
the DNA. 
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2.2.9 Agarose gel electrophoresis 
Agarose gel electrophoretic analysis of DNA was always performed using 
TAE buffer. The gels were made by melting the appropriate amount of agarose in lx 
TAE buffer using a microwave oven. For fragments of 300 bp to 1.5 Kb 1.5% (w:v) 
agarose was used, between 1.5 Kb and 4 Kb 1% agarose and above 4 Kb 0.8% (w:v) 
agarose. The molten agarose was poured into the gel tray, the comb inserted and the 
gels left to solidify for 30 minutes. Once set, the comb was removed from the gel and 
he DNA samples containing lx tracking dye (6x tracking dye is 0.25% bromophenol 
blue, 0.25% xylene cyanol and 40 % (w:v) sucrose in distilled water) were loaded 
into the wells. Gels were run in Pharrnacia gel electrophoresis tanks with their 
surfaces only just immersed in lx TAE buffer. Electrophoresis was either performed 
overnight with a constant current of 25 mA or in 2-3 hours with a constant current of 
80 mA. After completion of electrophoresis, gels were stained in water containing 2 
g/ml ethidium bromide for about 1 hour with constant shaking, and subsequently 
destained in fresh water for 30 minutes. The gels could then be photographed using 
Polaroid film and UV trans illumination. 
2.2. 10 Isolation of DNA from agarose gel slices 
To isolate DNA from agarose gel slices a low melting temperature agarose 
was used to separate the DNA fragment of interest and the DNA was then extracted 
from the gel using 13-Agarase I (NEB). 3-Agarase cleaves the agarose subunit, 
unsubstituted neoagarobiose (3,6-anhydro-(x-L-galactopyranosyl- 1 -3-D-galactose) to 
neoagaro-oligosaccharides (Yaphe, 1957). 
The DNA was run on a low melting temperature agarose gel. The agarose 
used depended on the size of the DNA fragment of interest, NuSieve GTG agarose 
was used for fragments less than 1 Kb and SeaPlaque GTG agarose was used for 
DNA fragments larger than 1 Kb (both NuSieve and SeaPlaque GTG agarose are 
available from FMC Bioproducts). The agarose gel was run using the protocol 
outlined in section 2.2.9, the appropriate DNA band was located using UV 
transillumination and cut out using a clean scalpel in as small a volume of agarose as 
possible. Gel slices were transferred to Eppendorf tubes, the weight determined and 
1/10 volume of lOx J3-Agarase buffer added. The gel slice and buffer were then 
placed at 65°C for 10 minutes to melt the agarose and then cooled to 40°C. 2 units of 
3-Agarase I were then added and the tube was incubated at 40°C for 1 hour. After the 
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1-hour incubation the DNA could be precipitated, leaving the carbohydrates in 
solution, using the protocol outlined in section 2.2.3. 
lOx 3-Agarase buffer: 	100 mM Bis-Tris-HC1 
10 m EDTA 
pH 6.5 
2.2. 11 Labelling DNA fragments using T4 Polynucleotide Kinase 
The DNA to be labelled was either a PCR product, which had been ethanol 
precipitated, or a commercially produced primer. 50 pmol of 5' termini were used in 
a 50 p1 reaction, this would correspond to 50 pmol of single stranded DNA or 25 
pmole double stranded DNA. A typical reaction would be as follows: 
DNA 	 25 or 50 pmol 
lOx T4 PNK buffer 	 5 jil 
[Y_12 P]ATP 	 5 j.tl (5 tCi) 
T4 Polynucleotide Kinase 	 20 units 
Water to 50 tl 
The reaction was incubated for 30 minutes at 37°C and the unincorporated [y-
32P] ATP removed by passing the reaction mixture through a MicroSpin G-25 
column (Amersham Pharmacia Biotech). 
2.2.12 DNA sequencing technique 
DNA sequencing was performed using the Pharmacia Sequenase quick-
denature plasmid sequencing kit. The kit is based on the chain-terminating 
dideoxynucleotide sequencing method developed by Sanger et al (Sanger et al, 
1977). In the original procedure, primer extension was catalysed by the Kienow 
fragment of E. coli DNA polymerase I. In the kit, however, the Kienow enzyme has 
been replaced by Sequenase DNA polymerase (Tabor et al, 1987), which has the 
advantage of creating longer chain-terminated fragments with a more even 
distribution of label between fragments. The major practical difference in using 
Sequenase DNA polymerase is that the primer extension reactions are performed in 
two stages, a labelling reaction and a termination reaction. Two stages are required 
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because the enzyme uses dideoxynucleotides very readily, and therefore in order to 
allow the synthesis of long chain-terminated fragments, dideoxynucleotides are 
excluded from the first stage of the reaction whilst being added for the second. 
Annealing of primer to double stranded template. The DNA templates used 
in the sequencing reaction were usually double-stranded plasmid or chromosomal 
DNA, purified as mentioned earlier. The concentration of the template was adjusted 
so that 5 Ill contained 0.5-3 tg DNA, and I tl of primer contained 2-4 pmol. To 
denature the double stranded template the following was added to an Eppendorf tube: 
Template DNA 	 5 tl 
1MNaOH 	 2 p 
Water 	 3 j.il 
Primer I il 
The tube was then vortexed briefly and allowed to incubate at 37°C for 10 
minutes. Plasmid DNA will denature (at any temperature) when exposed to pH 13. 
The method outlined in this protocol requires that the alkali used to denature the 
DNA be precisely neutralized by the addition of HC1. 
The tube was then put on ice and the following added: 
1MHC1 	 2 p 
Plasmid reaction buffer 	 2 tl 
The tube was then capped and returned to the 37°C water bath for 10 minutes 
to promote annealing of the primer to the single stranded DNA. 
Sequencing reaction. For each template to be sequenced, four Eppendorf 
tubes were labelled 'A', 'C', 'G' and 'T' respectively and 2.5 tl of the corresponding 
dideoxynucleotide mix added to each tube. To the tube containing the annealed 
template and primer the following was added: 
Annealed template/primer 	 15 jl 
0.1MDTT 	 lp.l 
Labelling mix 2 p1 
[a-32P] dATP 	 1 j.tl (10 tCi) 
Sequenase plasmid sequencing formulation 2 111 
The labelling reaction was incubated at room temperature for 5 minutes. 
While this was proceeding the previously dispensed sequencing mixes were 
incubated at 37°C for a minimum of 1 minute. After the 5 minute incubation of the 
labelling reaction, 4.5 p.1 was added to each of the prewarmed sequencing mixes and 
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returned to the 37°C water bath for a further 5 minutes to allow the chain-termination 
reaction to occur. Finally, 5 pi of Stop Solution was added to each reaction, which 
could then be stored at —20°C until required for electrophoresis. When the samples 
were needed for loading onto the sequencing gel they were heated to 80°C for 2 
minutes to denature the DNA. Immediately after this incubation 1.5-2.5 tl of each 
sample was loaded onto the gel. 
(iii) DNA sequencing gel electrophoresis. DNA sequencing was performed 
using a 30 x 40 cm BRL sequencing apparatus. The glass sequencing gel plates were 
thoroughly cleaned with ethanol and chloroform assembled using 0.2 mm spacers 
and taped together carefully to minimise the possibility of leakage. 
The gel was prepared by adding together the following: 
Bis-acrylamide (40% w:v) 	 30 ml 
Urea 	 43 g 
1OxTBE 	 10 ml 
Water 20 ml 
This was allowed to dissolve with the aid of magnetic stirring. Once dissolved 
1 ml of 10% ammonium persuiphate solution was added followed by 35 p1 of 
TEMED. This was stirred slowly for a few seconds and was then poured between the 
sequencing plates. The flat edge of a 60-well shark-tooth comb was pushed between 
the plates to layer the top of the gel. Clingfilm was wrapped around the exposed 
areas of the gel and each edge of the gel was clamped with bulldog clips. The gel 
was then set aside for at least 1 hour to allow polymerisation. Once set, the bulldog 
clips, tape and comb were removed and distilled water was squirted along the top of 
the gel. The shark-tooth comb was then replaced with the points downwards just 
touching the surface of the gel. The gel was then clamped into the sequencing 
apparatus and lx TBE solution poured into the top and bottom reservoirs. The gel 
was pre-run at about 50 W (1500 V) for 1 hour. After this the gel was ready to be 
loaded with the sequencing reactions. The samples were loaded immediately after 
denaturing the DNA (see above). The gel was then electrophoresed at 50 W until the 
blue dye front ran off the end of the gel. Once electrophoresis was complete the glass 
plates were removed from the apparatus and the top plate very carefully removed. 
The bottom plate (with gel attached) was placed in a fixing bath containing 40% 
methanol and 10% acetic acid in water for 20 minutes. The plate and gel were then 
removed and two damp sheets of blotting paper placed on top of the gel followed by 
two dry sheets of blotting paper. Even pressure was applied and the papers were 
peeled off the glass plates taking the gel with them. The gel and paper sandwich was 
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then dried in a vacuum gel drier for 1 hour at 80°C. When dry, the gel was placed in 
an autoradiography cassette and allowed to develop at ambient temperature. In most 
cases a good signal was achieved after 24 hours. 
2.2.13 AmplUlcation of DNA using the polymerase chain reaction 
The polymerase chain reaction (PCR) was performed to confirm gene 
replacements and to create engineered molecules for cloning. Primers were usually 
between 17-24 bases in length and were obtained commercially (Genosys). For all 
PCR reactions a commercial enzyme mix containing thermosTable Taq DNA 
polymerase and a proofreading polymerase was used (Roche). A typical reaction 
mixture might be: 
Enzyme mix 1 pi 
lOx buffer 5 jtl 
Primer 1 300 nM 
Primer 2 300 nM 
dNTP's 350 tM each 
Plasmid template 10 ng 
Chromosomal template 500 ng 
Distilled water to 50 iil 
The melting temperature used was 94°C for 2 minutes. Annealing temperature 
varied depending on which primers were being used. The annealing temperature (Tm) 
was gauged by the following formula. 
69.3 + 0.41(G + C)% - 650/L = Tm 
where L is the length of the oligonucleotide in nucleotides and (G + C)% 
represents the percentage guanine and cytosine content (Maniatis et al, 1983). The 
extension temperature used was always 68°C. As a rule of thumb, 30 seconds per Kb 
of extension was allowed. 
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2.2.14 Site directed mutagenesis ofplasmid DNA 
Site directed mutagenesis of plasmid DNA was performed using the 
QuikChange Site Directed Mutagenesis Kit (Stratagene). Mutagenesis was 
performed as per the manufacturers instructions. A brief summary of the protocol is 
described here; the QuikChange site-directed mutagenesis kit is used to make point 
mutations, switch amino acids, and to delete or insert single or multiple amino acids. 
The basic procedure utilises a supercoiled double-stranded DNA (dsDNA) vector 
with an insert of interest and two synthetic oligonucleotide primers containing the 
desired mutation. The oligonucleotide primers, each complementary to opposite 
strands of the vector, are extended during temperature cycling by using Pfu Turbo 
DNA polymerase. Incorporation of the oligonucleotide primers generates a mutated 
plasmid containing staggered nicks. Following temperature cycling, the product is 
treated with DpnI. The DpnI endonuclease is specific for methylated and 
hemimethylated DNA and is used to digest the parental DNA template and to select 
for mutation-containing synthesised DNA (Nelson et al, 1992). DNA isolated from 
almost all E. coli strains is dam methylated and therefore susceptible to DpnI 
digestion. The nicked vector DNA incorporating the desired mutations is then 
transformed into XL-1 Blue supercompetent cells, where the nicks in the mutated 
plasmid are repaired. The small amount of starting DNA template required to 
perform this method, the high fidelity of the PfuTurbo DNA polymerase, and the low 
number of thermal cycles all contribute to the high mutation efficiency and 
decreased potential for random mutations during the reaction. 
2.3 Bacterial Techniques 
2.3.1 Preparation and transformation of competent cells 
For transformation of plasmids and ligation mixtures the following procedure 
was followed. 5 ml of medium containing the appropriate selective antibiotics was 
inoculated with a single colony and incubated with shaking at the appropriate 
temperature overnight. 200 tl of the overnight culture was used to inoculate 20 ml of 
L-Broth, with appropriate selection, and incubated at a suitable temperature until the 
0D600  reached 0.6. The culture was then transferred to a sterile Universal bottle and 
placed on ice for 10 minutes. The chilled culture was centrifuged in a bench 
centrifuge at 1500 x g for 5 minutes. The supernatant was discarded and the universal 
was inverted to drain off excess media. The cells were resuspended in 10 ml ice-cold 
0.1 M MgC12/0.1 M RbC12 (9:1 v:v). The cell suspension was allowed to sit on ice 
for 10 minutes and was then re-centrifuged at 1500 x g for 5 minutes. The 
supernatant was removed and the cells then resuspended in 1 ml 0.1 M CaC12/0.1 M 
RbC12 (9:1 v:v). The cells were stored on ice in a 4°C cold room overnight and were 
ready for use the next day. Immediately before use 1.5 p1 dimethylsulphoxide 
(DM SO) was added per 100 tl of competent cells. 5 p1 of plasmid DNA or 10 p1 of 
ligation reaction were added to 100 p1 of competent cell, mixed gently and placed on 
ice for 30 minutes. The mixture was then transferred to a 42°C waterbath for 45 
seconds and then placed on ice for 5 minutes to recover from the heat shock. 250 tl 
of L-broth (containing 0.2 mM of an appropriate carbon source) was then added to 
the cells and the culture incubated on a rotating wheel at a suitable temperature for 1 
hour, to allow the expression of any antibiotic selection marker and then 350 p1 of 
the culture was plated on selective media. 
2.3.2 Frozen storage of bacterial strains 
It was found that strains of E. coli could be conveniently stored at -70°C 
without suffering a dramatic loss of viability; this included strains harbouring 
plasmids that might otherwise be lost. A fresh 5 ml overnight culture was prepared 
with antibiotic selection if required. This was centrifuged at 1500 x g for 10-15 
minutes, the supernatant discarded and the cells resuspended in 1/10 the original 
volume of frozen storage buffer. The cells were then left on ice for a couple of hours 
before storing at -70°C. 
Frozen storage buffer: 	50%Bacterial Buffer 
50% Glycerol (v:v) 
2.4 Bacteriophage techniques 
2.4.1 Preparation of A plate lysates 
Cells were grown in L-broth + 20 MM  MgSO4 and maltose at 0.2% until mid-
log phase. 200 p1 aliquots were then mixed with 106  phage, incubated at 37°C for 5 
minutes, and 3 ml of L-top agar containing 20 mlvi MgSO4 and 0.2% maltose added. 
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This was poured onto an L-agar plate, left to set and incubated at 37°C overnight or 
until visible lysis occurred. 5 ml of phage buffer was then added to the plate and the 
layer of top agar scraped off into a sterile 250 ml beaker. A few drops of chloroform 
were added and the beaker was incubated at 30°C with gentle swirling for 20 
minutes. The contents of the beaker was poured into a universal bottle and 
centrifuged at 1500 x g for 10 minutes. The supernatant was transferred to a fresh 
half ounce bottle and stored over a few drops of chloroform at 4°C. 
2.4.2 Preparation and selection of 2 lysogens 
A lawn of the bacterial strain to be lysogenised was made by mixing 0.2 ml of 
a mid-log phase L-broth culture and 3 ml of L-top agar with 20 mM MgSO4 and 
0.2% (w:v) maltose added. To this, approximately 200 2 phage particles were added, 
and the mixture poured onto a fresh L-agar plate. Once set the plate was incubated 
overnight at 37°C. This resulted in the appearance of isolated X plaques. The centre 
of a plaque was then touched with a sterile toothpick and streaked out onto another 
plate, which again was incubated overnight. The resulting single colonies could now 
be tested for the presence of the 2. phage. A lysogenised bacterium would be resistant 
to lysis by phages with the same immunity as the one used to lysogenise the strain, 
but will be sensitive to 2¼. phages that are virulent, or carrying a different immunity. 
This was initially done as a cross-streak on an L-agar plate, and positives from this 
test were checked more fully by trying to make isolated plaques in a similar way to 
that mentioned above. Strains that seemed to be lysogens were then finally tested by 
examining supernatants from L-broth cultures to see if they were producing the 
correct phage upon induction. 
2.4.3 UV induction of 2 lysogens 
Lysogenic bacteria were grown in L-broth + 20 mM MgSO4 at 37°C with 
vigorous agitation until an 0D600 of 0.4 was achieved. The cells were harvested by 
centrifugation and resuspended in 7 ml of 20 mM MgSO4. This was transferred to a 
sterile glass petri dish and the cells were exposed to 600 ergs/mm2/sec of UV 
irradiation before being diluted fivefold in fresh L-broth + 20 mM MgSO4. The 
culture was grown at 37°C with vigorous shaking until lysis occurred. A few drops 
of chloroform were added, and the lysate clarified by centrifugation prior to titration. 
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2.4.4 Preparation ofphage F] lysates 
Preparation of phage P1 lysates were as for phage ? except that 106  phage 
were added to 1 ml of late-log phase cells and this was incubated at 37°C for 30 
minutes prior to the addition of the top agar. The maltose was omitted and the 
MgSO4 was replaced with 2.5 mM CaCL2. The phage buffer was also replaced with 
the same volume of L-broth + 2.5 mM CaC12. 
2.4.5 Phage P1-mediated transduction 
The recipient strain of E. coli was grown up to late-log phase in L-broth. The 
cells were harvested by centrifugation and the bacterial pellet resuspended in 1/10 
the volume of L-broth + 2.5 mM CaC12. 100 p1 aliquots of this lOx culture were 
mixed with either 0.1 ml of phage P1 stock or 0.1 ml of a lOx dilution of the phage 
stock. These were incubated at 37°C for 15 minutes. If prototrophic transductants 
were to be selected, 0.4 ml of phage buffer was added to 0.2 ml aliquots of the cells 
and plated on the appropriate minimal media agar plates. If the selection was the 
acquisition of antibiotic resistance then 1 ml of phage buffer was added to the cells, 
the cells were centrifuged and resuspended in 0.6 ml of L-broth + 20% glucose. This 
was incubated at 37°C for 1 hour to allow expression of the antibiotic resistance and 
then 0.2 ml aliquots were plated out on L-broth agar plates containing the appropriate 
antibiotics. Plates were incubated at a suitable temperature until colonies appeared. 
2.5 Protein Techniques 
2.5.1 Polyacrylamide gel electrophoresis ofproteins 
E. coil proteins were routinely separated using SDS-polyacrylamide gel 
electrophoresis with a discontinuous buffer system (Laemmli, 1970). In most cases a 
10% resolving gel and a 4% stacking gel were employed. For the rapid analysis of 
proteins a 'Mighty-Small' mini-gel apparatus (SE 250) manufactured by Hoefer 
Scientific instruments was used. This used 10 x 5 cm gels, which could be 
electrophoresed in about 45 minutes. For better quality gels a larger apparatus (SE 
600) made by the same company was used; in this case the gels measured 16 x 18 
cm. The composition of typical gel solutions used were as follows: 
10% resolving gel 	acrylamide solution (40%) 	 2.5 ml 
4 x resolving gel buffer 2.5 ml 
10% SDS 	 0.1 ml 
10% ammonium persulphate 	 0.1 ml 
distilled water 	 4.8 ml 
TEMED 	 10 p1 
4% stacking gel 	acrylamide solution (40%) 	 0.5 ml 
4 x stacking gel buffer 	 1.25 ml 
10% SDS 	 0.05 ml 
10% ammonium persulphate 	 0.05 ml 
distilled water 	 3.15 ml 
TEMED 	 5 p1 
These solutions were made up immediately prior to use, with the ammonium 
persulphate solution and TEMED being added last. The resolving gel solution was 
pipetted between the glass plates separated by 0.75 mm spacers, enough room being 
left for the stacking gel. For the mini-gel apparatus the depth of the stacking gel 
between the bottom of the comb and the resolving gel was about 1 cm, and for the 
larger gel, was about 2.5 cm. Once the resolving gel had been poured it was layered 
with isobutanol saturated with lx resolving-gel buffer and allowed to polymerise for 
20 minutes. The isobutanol was then discarded and the top of the gel was washed 
with distilled water. The stacking-gel solution was poured on top of the resolving gel, 
the comb inserted and polymerisation allowed to occur. The comb was then removed 
and the wells washed out with lx reservoir buffer, which was also used to fill up the 
buffer chambers of the apparatus. The sample could be loaded onto the gel at this 
stage. 
Samples were mixed 1:1 with 2x PAGE-loading buffer, boiled for 3 minutes, 
and briefly spun in a microcentrifuge prior to loading. About 5-10 jil of sample per 
lane could be loaded onto the mini-gel and 10-30 p1 on the larger apparatus. Gels 
were typically electrophoresed at a constant current of 15 mA per gel for the mini-
gels and 30 mA per gel for the larger format gels, until the bromophenol blue dye 
front had reached the bottom of the gel. Once electrophoresis was complete the glass 
plates were removed from the apparatus, separated carefully using a plastic wedge 
and the gel placed in staining solution for 1 hour with gentle agitation. Gels were 
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transferred into destaining solution and left for between 2-24 hours, or until the 
bands of interest could be seen clearly. For preservation, the stained/destained gel 
was soaked in destaining solution plus 5% glycerol for 30 minutes and dried onto 
blotting paper using a vacuum gel drier at 80°C for about 1 hour. 
Solutions used in SDS-PAGE: 
Stock acrylamide 	acrylamide 	 37 g 
NN' methyl bis-acrylamide 	 1 g 
Made up to 100 ml with distilled water 
Filtered and stored at 4°C 
4x stacking-gel buffer 	Tris base 	 15.25 g 
made up to 250 ml with distilled water 
pH adjusted to 6.8, autoclaved 
4x resolving-gel buffer 	Tris base 	 45.5 g 
made up to 250 ml with distilled water 
pH adjusted to 8.8, autoclaved 
lOx reservoir buffer 	Tris base 	 30.2 g 
Glycine 144g 
Made up to 11 with distilled water 
0.1% S D S was added to the lx buffer 
before use 
2x PAGE loading buffer 4x stacking-gel buffer 	 125 .il 
10%SDS 	 300tl 
50% glycerol 200 pd 
2-mercaptoethanol 	 50 p1 
0.1% bromophenol blue 	 200 .tl 
Distilled water 	 125 p1 
Staining solution 	9% (v:v) acetic acid 
45% (v:v) methanol 
0.1% (w:v) Coomassie brilliant blue 
Destaining solution 	7% (v:v) acetic acid 
5% (v:v) methanol 
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Native (non-denaturing) polyacrylamide gels could be made by omitting the 
SDS from the stacking and resolving gel solutions and also from the running buffer. 
Also, during sample preparation, the cells are resuspended 1:1 in Native loading 
buffer and rather than being boiled for 3 minutes, are lysed by sonication. 
5x Native loading buffer 1 M Tris-HC1 (pH 6.8) 	 3.1 ml 
Glycerol 	 5 ml 
1% Bromophenol Blue 	 0.5 ml 
Distilled water 	 1.4 ml 
2.5.2 Two dimensional polyacrylamide gel electrophoresis 
Complex protein mixtures extracted from E. coli cells were separated by two-
dimensional electrophoresis (2-D electrophoresis) (O'Farrell, 1975) using the 
IPGphor isoelectric focusing system (Amersham Pharmacia biotech). This technique 
sorts proteins according to two independent properties in two discrete steps: the first-
dimension step, isoelectric focusing (IEF), separates proteins according to their 
isoelectric points (p1); the second dimension step, SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE), separates proteins according to their molecular size. 
Each spot on the resulting two-dimensional array corresponds to a single protein 
species in the sample. Thousands of different proteins can thus be separated, and 
information such as the protein p1, the apparent molecular size, and the amount of 
each protein is obtained. 
1 ml of culture (0D600 	0.2) was placed into an Eppendorf tube and 
centrifuged to pellet the cells, the supernatant was removed and the cells resuspended 
in 50 jil of lysis solution. The cells were then lysed by freeze thaw lysis (Lenstra et 
al, 1983) and centrifuged again to pellet any insoluble material. 45 .tl of the protein 
solution was then mixed with 205 tl of rehydration solution and the entire volume 
pipetted carefully into a 13 cm ceramic strip holder. The protective cover of the IPG 
strip (usually pH 3-10NL, 13 cm) was removed and the strip lowered, gel side down, 
into the ceramic holder. The strip was positioned so that the anodic end of the strip 
was directed towards the pointed end of the strip holder and gel contacted the strip 
holder electrodes at each end. IPG cover fluid (neutral mineral oil) was then applied 
to prevent evaporation and urea crystallisation. The cover was placed onto the 
ceramic holder and the holder was then placed onto the IPGphor. The IPGphor was 
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set at 20°C, 50 VtA per IPG strip and the following isoelectric focusing program was 
always used: 
Step Voltage (V) Duration (hr:min) Gradient type 
rehydration 20 12:00 Step-n-hold 
1 500 1:00 Step-n-hold 
2 1000 1:00 Step-n-hold 
3 8000 2:00 Step-n-hold 
A low voltage was applied during the rehydration step as it was found to give 
sharper focusing and also prevented protease activity during this period. 
After isoelectric focusing the strips were removed from the ceramic holders 
and placed into individual tubes, 10 ml of equilibration solution 1 was added, the 
tube was capped, placed on a rocker and allowed to equilibrate with gentle agitation 
for 15 minutes at room temperature. The strip was then removed to a new tube, 10 ml 
of equilibration solution 2 was added, and the tube was capped, placed on a rocker 
and again allowed to equilibrate for 15 minutes at room temperature with gentle 
agitation. 
A 10% SDS-PAGE gel was poured using the Hoefer SE600 apparatus as per 
the protocol for polyacrylamide gel electrophoresis, except the stacking gel was 
omitted and 1.5mm spacers were used. After the gel had polymerised, the focused 
IPG strip was dipped into 1 x reservoir buffer to lubricate it. The strip was then 
positioned between the plates on the surface of the second-dimension gel with the 
plastic backing against one of the glass plates. The strip was then pressed down with 
a thin ruler so that the entire lower edge of the IPG strip is in contact with the top 
surface of the slab gel, ensuring that no air bubbles were trapped between the IPG 
strip and the surface of the slab gel. Molecular weight markers were applied to a 
paper IEF sample application piece in a volume of 15 to 20 d and applied to the top 
surface of the gel next to one end of the IPG strip. 
1.5 ml of molten agarose sealing solution (no hotter than 50'C) was pipetted 
onto the top of the gel to hold the strip in place. The gel was then electrophoresed 
using the conditions given in polyacrylamide gel electrophoresis. 
Lysis solution 	Urea 19.2 g 
CHAPS 1.6g 
Tris Base 0.194 g 
Water to 40 ml 
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Rehydration solution 	Urea 12 g 
CHAPS 0.5g 
IPG buffer (same pH range as IPG strip) 125 1.11 
Bromophenol blue a few grains 
Water to 25 ml 
Equilibration solution 1 	Tris-Cl pH 8.8 (1.5M) 6.7 ml 
Urea 72.07 g 
Glycerol (87% v:v) 69 ml 
SDS 4g 
Water to 200 ml 
Just prior to use add 100 mg DTT to 1 Omi of buffer 
Equilibration solution 2 As per equilibration solution 1, except replace DTT with 
250 mg iodoacetamide 
Agarose sealing 	Agarose 	 0.5 g 
Solution 	 Bromophenol blue 	 a few grains 
1 x reservoir buffer to 100 ml 
Heat all ingredients until agarose completely dissolves. 
Dispense 2 ml aliquots and allow to cool. 
2.5.3 Western blotting procedures 
Western blotting (the transfer of proteins from an acrylamide gel to a 
membrane) was performed using a BioRad electrophoretic transfer cell. The 
previously run gel had the stacking gel removed and was placed on top of several 
sheets of blotting paper saturated in lx reservoir buffer without SDS (see section 
2.5.1). A sheet of Hybond PVDF membrane saturated in the same buffer was placed 
on top of the gel followed by several more sheets of saturated blotting paper. The 
whole 'sandwich' was secured in the transfer apparatus and transfer was allowed to 
proceed at 1 amp for 1 hour. After this the PVDF was removed from the apparatus 
and placed in blocking solution for 1 hour at room temperature or overnight at 4°C. 
The membrane was briefly rinsed twice with PBS-T (PBS + 0.1% (v:v) Tween-20) 
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and then washed with an excess volume of PBS-T for 5 minutes. The membrane was 
now ready for the application of the primary antibody. The primary antibody was 
diluted in 15 ml of PBS-T to give optimal results, and the membrane incubated in 
this solution, with constant agitation, at room temperature for 1 hour. The membrane 
was then washed for 2 x 10 minutes in PBS-T and incubated with 15 ml of the 
appropriate dilution of the secondary antibody (mouse/rabbit HRP-linked anti 
primary IGg from sheep/donkey, Amersham Pharmacia) at room temperature, with 
constant agitation, for 1 hour. The membrane was finally washed for 3 x 10 minutes 
with PBS-T and was now ready for the chemi luminescent detection of the protein of 
interest using the ECL Plus kit (Amersham Pharmacia). 
PBS: 	 Di-Sodium hydrogen orthophosphate 	11.5 g 
Sodium dihydrogen orthophosphate 2.96 g 
NaCl 	 5.84g 
Distilled water to 1L 
2.5.4 Determination ofprotein concentration 
Protein concentration was determined using the Bio-Rad Protein Assay kit. 
The Bio-Rad protein assay is a dye-binding assay based on the differential colour 
change of a dye in response to various concentrations of proteins (Bradford, 1976). A 
protein standard (bovine gamma globulin) was diluted to give samples of 0.2-1.4 
mg/ml and 100 il of these standards were added to 5 ml of lx dye reagent and mixed 
by inversion several times. An amount of the protein solution of unknown 
concentration was also added to 5 ml of lx dye reagent and mixed by inversion. The 
tubes were left for 10 minutes and then the 0D595 was measured using lx dye reagent 
as a blank. The 0D595 was plotted versus concentration of the standards, and the 
unknown concentration determined from the standard curve. 
2.5.5 Purification of His-tagged proteins 
His-tagged proteins were purified using His- Bind Kits (Novagen). For small 
amounts of protein (:~ 2.0 mg ) His- Bind Quick 900 cartridges were used and for 
larger amounts of protein His- Bind resin was used (His- Bind resin can purify 20 mg 
of protein per 2.5 ml of resin). 
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His-Bind resin allows rapid one step purification of proteins containing a His-
tag sequence by metal chelation chromatography. The His-tag sequence binds to Ni24 
cations, which are immobilised on the His-Bind resin using the charge buffer 
supplied in the His-Bind buffer kit. After unbound proteins are washed away, the 
target protein is recovered by elution with imidazole or EDTA. The His-Bind resin 
can be regenerated and reused many times. 
His-Bind Quick 900 cartridges are based on a large diameter cellulose matrix 
that has flow rates 5-50 times faster than agarose resins, and yet maintains similar 
binding capacity. His-Bind Quick 900 cartridges are packed with pre-charged resin 
(N i2+)and are designed for operation with a syringe. 
2.5.6 /3-Galactosidase assays 
The method used to determine the 3-galactosidase activity from a promoter-
lacZ clone, was as described by Miller (Miller, 1972). 1 ml of culture was taken and 
the 0D600 measured; from this 0.5 ml of culture was added to 0.5 ml of Z buffer. If 
the promoter activity was known to be high then 0.1 ml of culture was added to 0.9 
ml of Z buffer. The cells were permeabilised by the addition of 50 j.tl of chloroform 
and the samples vortexed for 30 seconds. The samples were stored at 4°C until all 
sampling had been performed. 
To assay, 200 t1 of 4mg/ml ONPG (o-nitrophenyl-f3-D-galactosidase) in 
0.1M sodium phosphate buffer (ph 7.5) was added to each sample and vortexed. A 
control was prepared from 0.5 ml of the culture medium used and 0.5 ml of Z buffer. 
The samples were then incubated at 30°C until sufficient yellow colour (o-
nitrophenol) had appeared such that when 0.5 ml of 1M Na2CO3 was added to stop 
the reaction, the absorbance at 420 nm was between 0.1 and 2.0. Standard curves 
constructed in this laboratory by T. Paterson had demonstrated that the absorbance 
measurements are linear within this range. Samples were then measured at both 420 
nm (o-nitrophenol) and 550 nm (to correct for light scattering by cell debris), using 
the control tube as a blank. 
The specific J3-galactosidase activity of the sample was calculated by the 
following equation and was expressed as Miller Units (MU): 
(OD420 —1.75 x OD550) xl000 
OD600xVxT 
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Where T represents the incubation time at 30°C in minutes and V represents 
the volume of the sample in millilitres. 
Z Buffer (per litre): 	Na2HPO4 7H20 0.06 M 
NaH2PO4 H2O 0.04 M 
3-mercaptoethanol 0.05 M 
KC1 0.O1M 
MgS04 7H2O 0.001 M 
SDS 0.005% 
2.5. 7 Synthesis of aspartic semialdehyde 
L-aspartic-I3-semialdehyde was prepared as described by Black and Wright 
(Black et al, 1955). Briefly; 2.3 g (20 mmoles) of L-allylglycine were dissolved in 20 
ml of 1 M Rd. Ozone was passed through a fitted glass plug into this solution, held 
at 0°C for 100 minutes. Before use the solution (which was 95% L-aspartic--
semialdehyde) must be neutralised with an equal volume of 1 M KHCO3. 
2.5.8 DHDPS activity assays 
To determine DapA activity in E. coli two methods were used. The first assay 
utilises an absorption change at 270 nm and is not suitable for complex mixtures and 
was therefore only used when assaying purified DapA protein. The second assay 
utilises a colour change when o-aminobenzaldehyde is present, the advantage of this 
assay is its specificity, which makes it possible to employ it for the analysis of crude 
extracts (both assays are described in Yugari et al, 1965). A typical assay solution 
might contain: 
270 tm assay 	DapA solution 1 	l 
Imidazole pH 7.4 (1M) 100 tl 
L-aspartic semialdehyde (IM) 5 	tl 
KHCO3 (1M) 5 il 
Sodium pyruvate (50 mM) 100 .il 
Water 789 j.tl 
Measure absorbance change at 270 nm. 
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o-aminobenzaldehydc 	Crude cell extract 100 j.d 
assay 	 Tris-CI pH 7.4 (1M) 100 	tl 
L-aspartic semialdehyde (1M) 5 .t! 
KHCO3 (1M) 5 p1 
Sodium pryuvate (50mM) 200 .il 
o-aminobenzaldehyde solution 2 p1 
(0.25 mg m1) 
Water 588 iii 
Measure absorbance change at 540 nm. 
In both assays, the rate of absorbance change is proportional to the activity of 
the enzyme. With the o-aminobenzaldehyde assay there is a lag before the reaction 
shows a uniform increase in colour with time, however the rate of the linear portion 

















Fig. 2.5.1 Standard curves for both the 270 p.m and o-aminobenzaldehyde assays. 
The amount of protein used is indicated next to each experimental curve. In both 
assays the gradient of the linear portion of the curve is directly proportional to the 
amount of protein added. 
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Chapter III 
Effects of GroE depletion on DapA 
011 
3.1 Growth rates of MGM100 
In the strain MGM 100 the cy 70  and 32  promoters of GroE have been replaced 
with the araC gene and araBAD promoter from pBAD-18 (McLennan et a!, 1998). 
This effectively puts GroE synthesis under the control of arabinose. Upon the 
addition of glucose to the growth medium, GroE production ceases and GroE levels 
halve with each generation. 
To measure the growth rates of MGM 100 the following protocol was used: 
MGM 100 was grown overnight in 5m1 LB + 0.2% ara and Kan. The following day 
the overnight culture was diluted 1/50 into lOml LB + 0.2% ara and the culture was 
grown at 37°C with shaking until the 0D600 reached 0.2. lml of the culture was 
then removed, placed into an Eppendorf tube and centrifuged to pellet the cells. The 
supernatant was removed and the cells resuspended in either lOml prewarmed LB + 
0.2% ara or 0.2% glu. The cells were then returned to the 37°C water bath and the 
first sample (T=0) was taken. The cells were grown with constant agitation, taking 
samples as necessary (for a standard growth curve samples were taken every 30 
minutes). If the 0D600 of the cells went above 0.2 the cells were diluted 1/10 into 
fresh prewarmed medium. 
Figure 3.1 shows typical growth curves of MGM 100 grown under different 
conditions. The sample with arabinose present has a normal cellular complement of 
GroE and hence will continue to grow exponentially as long as the 0D600 is kept 
below 0.2. The sample with glucose present has less GroE the longer it grows. For 
approximately the first 1.5 hours growth remains exponential (by the end of 2 hours, 
GroE levels will be reduced to 2-3% of normal levels), and then continues at a 
decreasing rate for another hour (at this time GroE levels would be reduced to 
0.25% of normal) before abruptly lysing, due to the absence of DAP in the 
peptidoglycan cell wall (McLennan et al, 1998). In the glucose sample + DAP, the 
growth rate is the same as the glucose sample, except the cells do not lyse at 2.5 
hours. This is because exogenous DAP is being incorporated into the peptidoglycan, 
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Figure 3.1 Growth rates of MGM 100 in LB + ara (GroE), glu (GroE) or glu DAP 
(GroE, no lysis). For clarity, when cells have been diluted 1/10, the OD has been 
multiplied by 10 and plotted on the graph. 1/10 dilutions were performed at 60 
minutes for all samples, at 120 minutes for the arabinose and glucose DAP samples 
and at 180 minutes for the arabinose sample. 
3.2 DapA activity in GroE depleted cells 
Previous work by McLennan (McLennan et al, 1998) suggested that DapA 
was affected by GroE depletion, causing GroE depleted cells to lyse. Therefore 
initial experiments were to determine if DapA activity was affected in GroE depleted 
cells. MGM 100 was grown using the method given in 3.1 and at various times 5ml of 
cells (0D600 = 0.1) were removed, the cells were centrifuged at 1500 x g and the 
supernatant removed. The cells were resuspended in 250 jfl of water and lysed by 
freeze-thaw lysis (Lenstra et al, 1983). The suspension was then centrifuged briefly 
to pellet any insoluble material and 100 tl of the cell extract was used in the o-
aminobenzaldehyde assay, as described in materials and methods. A further 50 il of 
the cell suspension was used to determine the protein concentration of the solution, 
again using the protocol described in materials and methods, so that DapA activity 
could be normalised for all samples. 
Figures 3.2.1, 3.2.2 and 3.2.3 show typical results from o-aminobenzaldehyde 
assays on protein samples removed at different times from cells grown in arabinose 
(GroE), glucose (GroE) and glucose plus DAP (GroE, no lysis) respectively. In the 
GroE sample the lines of the graph are, on the whole, parallel to each other (any 
deviations in gradient are due to more or less sample being loaded, and when the 
gradient/protein concentration is determined all samples have the same activity per 
unit protein). Since the gradient of the curve (after the initial lag period) is 
proportional to DapA activity, this shows that in GroE MUM 100, DapA activity is 
constant. But in the GroE samples, in the presence or absence of DAP, the later the 
samples are taken, the less DapA activity is recorded. This suggests that in 
MGM100, as the cells GroE deplete, DapA activity decreases, also the presence of 
DAP does not affect DapA activity. A tabulated form of these results is shown in 
Table 3.2.1 
By normalising the gradients of the graphs against the protein concentrations 
of the respective samples, it is possible to plot the activity of DapA under various 
conditions. In figure 3.2.4 the average (gradient/protein concentration) was 
determined for all time points and then set as 100%. Using this it is possible to plot 
percentage DapA activity (relative to a GroE1 sample) against the time the sample 
was taken. It is quite clear that in the GroE sample DapA activity is constant, 
whereas DapA activity decreases markedly in GroE depleted cells, falling to --10% 
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Fig. 3.2.1 Results of o-aminobenzaldehyde assay of DapA from MGM 100 + 
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Fig. 3.2.3 Results of o-aminobenzaldehyde assay of DapA from MGM 100 + glucose 
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Fig. 3.2.4 DapA specific activity from MGM 100 plotted against time of sampling. 
Samples taken from MGM 100 grown in Ara (GroE ), Glu (GroE) and GLU, DAP 
(GroE, no lysis). 
Sample Activity Protein Activity per Percentage 
(gradient of concentration mg of protein activity [100% 
slope) of sample (mg sample = average of 
mF) AraO to Ara 
225 (0.592)] 
Ara 0 0.473 0.81 0.584 98.7% 
Ara 45 0.435 0.72 0.604 102% 
Ara 90 0.435 0.72 0.604 102% 
Ara 135 0.489 0.8 0.611 103.2% 
Ara 180 0.5 0.89 0.562 94.9% 
Ara 225 0.79 1.35 0.585 98.8% 
Glu 0 0.473 0.81 0.584 98.7% 
Glu 45 0.286 0.825 0.347 58.6% 
Glu 90 0.167 0.865 0.193 32.6% 
Glu 135 0.1 0.95 0.105 17.7% 
Glu 180 0.05 0.8 0.063 10.6% 
Glu DAP 0 0.473 0.81 0.584 98.7% 
Glu DAP 45 0.29 0.79 0.367 62% 
Glu DAP 90 0.167 0.825 0.202 34.1% 
Glu DAP 135 0.113 0.96 0.118 19.9% 
Glu DAP 180 0.05 0.77 0.065 10.9% 
Glu DAP 225 .055 1.04 0.053 8.9% 
Table 3.2.1 DapA activity in MGM 100 growing under various conditions: LB + 
Arabinose (Ara), LB + Glucose (Glu) and LB + Glucose DAP (Glu DAP). The 
numbers next to these letters represents the time in minutes at which the sample was 
taken. The activity of the sample is determined by the gradient of the linear portion 
of the graphs shown in figures 3.2.1-3.2.3. The protein concentration of the sample 
was determined, and the activity per mg of protein calculated. The percentage 
activity was determined with 100% being set at 0.592 (the average activity per mg of 
protein for all the arabinose samples).  
3.3 DapA is an in vitro GroE substrate 
The results in the previous section show that DapA activity is affected by 
GroE depletion. This result could be explained if DapA is a protein that requires 
GroE to reach its native conformation. Before determining if DapA interacts with 
GroE in vivo it was decided to perform refolding experiments of DapA in vitro. 
0.3 p.m DapA was denatured in the presence of guanidinium thiocyanate 
(GdmT) buffer [6.OM GdmT, 0.1M Tris-Cl pH 7.4 and 20mM dithioerythritol 
(DTE)] for 1.5 hours at 25°C (Buchner et al, 1991). This was found to denature 
DapA completely, so that it exhibited no activity when removed from the denaturant. 
The denatured protein was then diluted 100 fold into a refolding buffer (0.1M Tris-Cl 
pH 7.4, 10mM MgC12, 10mM KC1 and 10 mM DTE, 2mM ATP) in the presence or 
absence of GroELS (2.5 p.M) at 37°C. GroEL is a weak, potassium dependant 
ATPase (Viitanen et al, 1990), hence the presence of KCI and ATP in the refolding 
buffer. 
After the denatured protein had been added to the refolding buffer, samples 
were taken out at various times and assayed for DapA activity. The samples were 
assayed using the o-aminobenzaldehyde assay in materials and methods, with one 
modification: 2 units of hexokinase and lOmIVI glucose were added to the assay mix. 
Hexokinase catalyses the transfer of a phosphoryl group from ATP to glucose to 
form glucose-6-phosphate (Anderson et a!, 1975), thereby quenching ATP in the 
assay mix and preventing GroELS from folding DapA during the assay reaction. 
The results of the refolding assay can be seen in figure 3.3.1. Undenatured 
DapA was used as a positive control, and for a negative control, denatured DapA was 
put into refolding buffer without GroELS. The graph shows quite clearly that DapA 
does not refold spontaneously to an active form when denatured, but can refold to an 
active form when GroELS (Sigma Aldrich) is present. Also we can determine from 
the graph that most DapA is refolded within the first 15 minutes of incubation with 
GroELS and then with a decreasing rate as the unfolded form becomes more dilute. 
Even if DapA is refolded in the presence of a greater concentration of GroELS the 
shape of the graph does not alter, this indicates that DapA and not GroELS is the 
limiting factor in this reaction. Once 50% of DapA has been refolded to an active 
form the rate of refolding decreases dramatically, this may be because denatured 
DapA is now only 50% of the DapA population and therefore the possibility that it 
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Fig. 3:3.1 Activity of denatured DapA that has been incubated with GroELS + ATP 
for various amounts of time.  
This experiment was also repeated using only GroEL or GroES for refolding 
denatured DapA, but in both cases, no DapA activity was determined at any time 
point, suggesting that DapA requires both GroEL and ES for refolding in vitro. 
3.3.1 Delayed lysis in cells over-expressing GroEL 
Denatured DapA requires both GroEL and GroES to fold in vitro to a 
functional form; to determine if DapA also required GroELS to function in vivo 
MGM 100 was transformed with a plasmid so that it could be depleted only of 
GroES. The plasmid pGroEL (Goloubinoff et al, 1989) contains a frame shift 
(inactivated) groES gene followed by a wild-type groEL gene cloned under the 
control of a Piac  promoter. Even in the absence of IPTG this plasmid causes the 
intracellular level of GroEL to increase 10 fold. The plasmid was transformed into 
MGM 100, so that when the cells were grown in the presence of glucose, the 
chromosomal production of GroELS was repressed (being under the control of the 
promoter PBAD)  but the plasmid-based production of GroEL was unaffected (i.e. the 
cells were only depleted of GroES). 
MGM100 pGroEL was grown, as per the protocol in section 3.1; 
chloramphenicol was also present to select for cells containing the plasmid pGroEL. 
The results of the growth curve are given in figure 3.3.2. 
These results show that an increased level of GroEL only prevents MGM 100 
from lysing. Since lysis in GroELS depleted cells is caused by a deficiency in DapA 
activity, and since cells depleted of GroES alone do not lyse, it is possible that DapA 
is functional in GroES depleted cells. This then would suggest that DapA only 
requires GroEL to fold correctly in vivo. 
To verify that pGroEL was not producing any GroES, the plasmid was 
transformed into the strain AG3 1 (groES). The plasmid did not complement the 
mutation at the non-permissive temperature of 43°C. 
Finally, DapA activity was measured in MGM 100 depleted of either GroELS 
or GroES. The results (Table 3.3. 1) show that while DapA activity does decrease in 
GroES depleted cells, it is not at the same rate as in GroELS depleted cells. The 
presence of more active DapA in GroES depleted cells may therefore be enough to 
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Fig. 3.3.2. Growth rates of MGM 100 in LB + ara (GroE), glu (GroE) or glu DAP 
(GroF, no lysis). Also MGM 100 pGroEL in LB + glu (Gr0ES-). For clarity, when 
cells have been diluted 1/10, the OD has been multiplied by 10 and plotted on the 
graph. 1/10 dilutions were performed at 60 minutes for all samples, at 120 and 180 
minutes for the arabinose, glucose DAP and pGroEL samples and at 240 minutes for 
the arabinose sample.  
NE 
Time after addition of glucose (hrs) 
0 	1 	2 	3 	4 
DapA 	activity 	in 
GroELS depleted cells 
(MGM 100) 
DapA activity in GroES 
depleted 	cells 
(MGM 100 pGroEL) 
100 50% 24% 
100% 85% 68% 
11% - 
53% 46% 
Table 3.3.1 DapA activity in MGM 100 or MGM 100 pGroEL at various times after 
the addition of glucose (i.e. start of GroE depletion).  
3.4 Pulse-chase experiments on DapA in MGM100 
In previous studies of DapA by McLennan (McLennan et a!, 1998) it was 
suggested that during GroE depletion in MGM 100 the amount of DapA in the cell 
decreases. Since dapA promoter activity does not decrease in GroE depleted cells (N. 
McLennan, pers. comm., also this work, chapter 5) it was suggested that the turnover 
rate of newly synthesised DapA in GroE depleted cells must increase, relative to that 
in a GroE cell. 
To determine if this were the case MGM 100 was grown as per the method in 
chapter 3.1 except the cells were grown in Spizizcn's minimal medium instead of 
LB. Samples were taken from both a culture with arabinose (GroE) and a culture 
with glucose and DAP (GroE), the GroE sample being taken at a time such that the 
intracellular level of GroE was less than 1% of the original cellular complement. 10-
j.tCi MI-1  of 355-methionine was then added to the samples and they were incubated at 
37°C for 5 minutes. During this time newly synthesised proteins would incorporate 
the radioactive methionine and would therefore become radioactively labelled, this 
would include DapA, which contains nine methionine residues. After the five minute 
labelling period a solution of non-radioactive methionine was added such that it was 
in great molar excess (..108)  compared to the radioactive methionine. This chase 
prevents any further labelling of the proteins with radioactive methionine. 
By taking samples at various times after the addition of the non-radioactive 
methionine and examining them by 2-D electrophoresis (following the protocol in 
materials and methods) it is possible to determine the turnover rate of proteins of 
interest. The location of DapA on a 2-D gel of E. coli proteins could be determined 
using the data provided by the Swiss-213 database (http://www.expasy.ch). If DapA 
did have an increased rate of turnover in GroE depleted cells, then the spot on the 2-
D gel corresponding to DapA should disappear faster in a GroE depleted sample that 
in a GroE sample. 
The results of the 2-D analysis are shown in figure 3.4.1. The gels were 
normalised by comparing the intensity of 5 spots (thereby reducing the possibility of 
error introduced by only comparing one spot), then the intensity of the DapA spot 
was determined at 0 minutes and 20 minutes after the addition of non-radioactive 
methionine. In a GroE cell, after 20 minutes, there is still 	88% of the original 
DapA still present, while in a GroE- cell, it is only slightly lower at 83%. It can be 
concluded that DapA does not appear to have an increased level of turnover in GroE 
depleted cells. 
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Fig. 3.4.1 2-D gel of proteins extracted from E. coli. In the upper picture the spot 
representing the protein DapA is circled. In the lower set of pictures is the DapA spot 
from cells grown in the presence of arabinose (GroE+) or glucose (GroE), which 
have been incubated with 10VtCi  mL' of 35S-methionine for 5 minutes, then had an 
excess of non-radioactive methionine added. Protein samples were taken at the stated 
time after the addition of the non-radioactive methionine and the intensity of the 
DapA spot was determined.  
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3.5 DapA turnover is not increased in GroE depleted cells 
The pulse-chase experiments with DapA had the disadvantage that the cells 
were growing in Spizizen's minimal medium rather than LB; the medium in which 
Dr. McLennan et at observed a decreased level of DapA in GroE depleted cells. To 
verify if the results observed in the pulse chase experiment were correct, MGM 100 
was again grown in LB, using the protocol given chapter 3.1 and samples were taken 
at different stages of growth from both GroE and GroE cells. These samples were 
analysed by Western blotting followed by detection with anti-DapA antibodies (a gift 
from Dr. Galili, Weizmann Institute of Science) and a subsequent chemiluminescent 
step. 
In the previous work by McLennan et at. to correct for possible loading 
differences in the SDS-PAGE step of the procedure, the level of FtsZ was also 
measured in the samples, using anti-FtsZ antibodies. It was assumed that FtsZ levels 
were not affected by GroE depletion, and therefore by normalising each sample so 
that it contained the same amount of FtsZ, DapA levels could be accurately 
measured. 
When the Western blotting procedure was repeated in this work, the protein 
concentrations of the samples were determined and appropriate amounts were loaded 
onto the SDS-PAGE gel accordingly. When the detection procedure was complete it 
was found that DapA levels did not decrease in GroE depleted cell, rather the levels 
of FtsZ increased as the cells became more GroE depleted (Fig. 3.5.1). Further 
evidence for this observation is that in MGMIOO grown in LB + glucose, in the 
absence of DAP, DapA levels are actually increased just before lysis, which agrees 
with the observation that dapA promoter activity increases just before lysis in this 
sample (chapter 5). 
For the analysis of FtsZ and DapA levels by Western blotting it was important 
to expose the samples long enough for them to be visible on X-ray film, but not long 
enough to saturate the film (i.e. working outside the linear range of the X-ray film). 
To overcome this problem, serial dilutions of the samples were used and also the 
samples were exposed to X-ray film for varying amounts of time. The films were 
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Fig. 3.5.1 Western blot of DapA from MGM 100 grown in LB + arabinose (GroE) or 
LB + glucose, DAP (GroE) for 3 hours. Total protein concentration was determined 
for each sample, and equivalent amounts loaded. The level of the protein DapA 
remains constant independent of cellular GroE levels, while levels of FtsZ increase in 
GroE depleted cells. The GroE sample has 2.3 x more FtsZ than the GroE sample, 
relative to DanA. 
FtsZ transcription is under the control of a g5 promoter, ftsQ]p (Vicente et al, 
1998). The sigma factor G5 encoded by the gene rpoS, is switched on during the 
stationary phase of growth in E. coli, such that rpoS is transcribed at a level 20 times 
higher than in logarithmic growth (Lowen et a!, 1994). In MGM 100 growth rate 
decreases as the cells become more GroE depleted (Fig. 3.1), this could plausibly 
cause an increased expression of rpoS and a corresponding increase in expression of 
ftsZ. Therefore by normalising FtsZ levels in GroE depleted cells, a decreased DapA 
level will be observed, but this is not actually representative of DapA levels in the 
cell, which, in fact, remains constant. 
After analysis of 44 different exposures (from three different experiments 
varying the time of exposure, and also using the results from a number of serial 
dilutions) it was determined that after 3 hours of GroE depletion, MGM 100 growing 
in LB had 1.3 ± 0.2 times more DapA and 4.08 ± 0.04 times more FtsZ than it did 
after 30 minutes of GroE depletion. 
Sample 30 mm. 
time  
180 mm. 
Sample 1/4 (A) 	1/8 (B) 1/4 (C) 	1/8 (D) 	(C)/(A) 	(D)/(B) 
dilution 
DapA 1874.7 	918.8 1933.6 	1029 	1.03 	1.12 
FtsZ 374.0 	206.6 1825.2 971.2 4.88 4.70 
Table 3.5.1 Results of a typical analysis of DapA and FtsZ levels by densitometry in 
GroE depleting cells. Samples were taken at an early (30 minutes) or late (180 
minutes) time during GroE depletion. The samples were diluted appropriately so that 
exposure to X-ray film would not cause saturation. The DapA and FtsZ levels were 
determined and also the ratio of the late time point to the early time point. In this 
example there is 1.08 times more DapA and 4.8 time more FtsZ at 180 minutes 
than at 30 minutes in GroE depleted cells. 
3.6 Gene replacement of dapA 
Since it had been shown that DapA protein was still present in GroE depleted 
cells, it was necessary to determine why DapA activity decreased as the intracellular 
levels of GroE decreased. Native DapA exists as a homotetramer with a molecular 
weight of 31,372 per monomer (Shedlarsky et al, 1970; Richaud et al, 1986). Since 
DapA was being transcribed and translated, yet showed no enzymatic activity in 
GroE depleted cells, it was possible then that the enzyme was not folding to its 
correct native state. Since previous Western analysis of DapA in MGM100 had been 
under denaturing conditions, it was unknown whether DapA forms a homotetramer 
in GroE depleted cells. It was hypothesised that if DapA were a GroE substrate, then 
in the absence of GroE newly synthesised DapA may not be able to fold correctly, 
and therefore may not reach its correct homotetrameric native state. 
To determine if DapA was indeed only present as either a monomeric species 
or in an aggregated form in GroE depleted cells, it was necessary to analyse the 
protein on a native gel. Unfortunately, the supply of antibodies that had been used 
previously to detect DapA had been exhausted, and it was not possible to obtain any 
more; therefore a new method to detect DapA had to be devised. A solution to this 
problem was to place a 'tag' onto the carboxy terminus of DapA, which would serve 
as an antigen for commercially available antibodies. 
The theoretic construction of a tagged version of DapA would be to construct 
the 'tagged' dapA gene on a plasmid and then use this to replace the wild type dapA 
gene on the chromosome of MGM 100. A number of gene replacement strategies 
exist but in this case a novel method developed by N. McLennan and M. Masters was 
employed. This gene replacement relies on the fact that high copy-number ColE I 
based plasmids, such as the pUC range of vectors, appear to recombine with the host 
chromosome via a single crossover and excise by the same mechanism. Regions of 
homology between the plasmid and the chromosome are required for the crossover to 
occur. The excision of the plasmid appears to be promoted by instability caused by 
the presence of a plasmid origin of replication on the E. coil chromosome. 
It is possible to direct the location of insertion of the plasmid onto the 
chromosome and interrupt or replace the gene of interest by cloning the gene, which 
has been inactivated by the insertion of a selectable marker such as an antibiotic 
resistance cassette, into the high copy-number plasmid. It is proposed that the 
plasmid can insert into the locus of interest via a single crossover between 
homologous DNA. The amount of flanking DNA required for efficient integration 
has not yet been determined, although 200 bp of homologous DNA upstream and 
downstream of the resistance marker has been shown to suffice (P. Stumpfle, pers. 
Comm.). Upon excision, one of two plasmids can be formed: a molecule identical to 
the plasmid that was initially introduced into the cells or a plasmid containing the 
wild-type locus, with the chromosomal ORF now interrupted by the resistance 
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Fig. 3.6.1 The single cross-over of plasmid DNA at a homologous region of 
chromosomal DNA. Excision of the plasmid can result either in the reformation of 
the original plasmid or the antibiotic marker can remain on the chromosome and the 





A P1 lysate is grown on the strain carrying the plasmid to be used for the 
replacement, the strain should also have an additional selectable marker within 
transducing range (<2 minutes) of the chromosomal gene being replaced. The 
transducing particles containing the region of interest will carry three possible 
arrangements of the chromosome: (i) the wild type locus, (ii) the locus with the entire 
plasmid inserted or (iii) the locus with the ORF of choice interrupted by the 
antibiotic marker. 
The P1 lysate is then used to transduce a wild-type strain, selecting for the 
insertion marker and the linked chromosomal marker. The resultant colonies must 
then be screened to ensure loss of the original plasmid. This is achieved by screening 
for the loss of the plasmid resistance marker, in the case of the pUC vectors, the loss 
of Amp resistance. 
3.6.1 Construction ofplasmidpUCDapHSV 
The HSV-Tag (Novagen) is a 36mer, which encodes a peptide of 11 amino 
acids derived from Herpes Simplex Virus glycoprotein D: 
GlnProGluLeuAlaProGluAspProGJ-uASPEND 
5' CAGCCTGAACTCGCTCCAGAGGATCCGGAAGATTAA 3' 
3' GTCGGACTTGAGCGAGGTCTCCTAGGCCTTCTAATT 5' 
There is a commercially available HSV-Tag mouse monoclonal IgG1 , that has high 
specificity and affinity for the peptide encoded by this sequence (Novagen). To 
determine if the HSV-Tag was suitable for use with MGM 100, a whole cell extract of 
MGM100 and a positive control extract containing a 31,102 Dalton protein that 
carries a C-terminal HSV-Tag was Western blotted and probed with anti-HSV 
antibody, as per the protocol described in materials and methods. The positive 
control gave one clear band, and there were no bands present in the MGM100 cell 
extract lane, indicating that the HSV antibody has no cross-reactivity with any 
endogenous MGM 100 proteins, and was therefore suitable for use. 
The HSV tagging of dapA is a three-step process. Firstly a pUC18 plasmid 
containing a 4 kb fragment of DNA (pUCDapA) containing the coding sequence of 
dapA and at least 1 kb of the upstream and downstream genes n/pB and gcvR, was 
subjected to a site directed mutagenesis. The purpose of this was to replace the dapA 
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stop codon TAA with a restriction site, so that the HSVTag sequence could be 
ligated in frame to produce the fusion gene dapAHSV. 
pUCDapA was analysed and found to contain no BglII restriction sites. Two 
primers, DAPBGLTOP and DAPBGLBOT, were designed which, when used with 
the site directed mutagenesis protocol described in materials and methods would 
mutate the dapA stop codon to a BglII restriction site. 
DAPBGLTOP: 5' ATCAAATCT000TAAAGATCTCAGCAAACCGGCATG 3' 
DAPBGLBOT: 5'CATGCCGGTTTGCTGAGATOTTTAGGGAGATTTGAT 3' 
dapA terminal sequence before mutagenesis: 
5' 	AAGCATGCCGGTTTGCTGTAAAGTTTAGGGAGATTTGATGGCT 	3' 
dapA. . LysHisAlaGlyLeuLeuEND 	 MetAla. . nlpB 
dapA terminal sequence after mutagenesis: 
5' 	AAGCATGCCGGTTTGCTGAGATCTTTAGGGAGATTTGATGGCT 	3' 
BglII 
When the point mutation was completed the plasmid pUCDapA, which 
previously had no BglII restriction sites was now linearised when cut with the 













Fig. 3.6.2 Restriction analysis of pUCDapA(mut). Lane 1; DNA markers, lane 2; 
pUCDapA, lane 3; pUCDapA incubated with BglII, lane 4; pUCDapA(mut) 
incubated with BglII. The plasmid pUCDapA has no BglII restriction sites, but after 
point mutation has 1 unique Bg[II site replacing the TAA stop codon of dapA. The 
bands in lanes 2 and 3 represent the supercoiled (small band) and open circle (large 
band) form of pUCDapA. 
The second stage in the tagging process was the construction of the HSVTag 
itself. In addition to the HSVTag being ligated in frame to dapA, an antibiotic 
resistance gene, cat, providing CmpR,  would also be inserted next to the tagged gene, 
providing an easy screening method for the gene when it was placed onto the 
chromosome. This was achieved by making a PCR product that contained BglII sites 
on its 3' and 5' ends, the HSVTag sequence and the sequence of the cat gene 
(including 955 bp of upstream sequence so that it would be under the control of its 
native promoter). 
The PCR required two primers, the first primer, HSVCATTOP contains a 
Bgill restriction enzyme recognition site, the coding sequence for the HSVTag and a 
region of DNA complementary to the DNA sequence 955 bp upstream of the start 








The second primer HCATBOT annealed 372 bp downstream of the TAA stop codon 
of the cat gene in pBR325 and introduced a BglII restriction enzyme recognition site. 
HCATBOT: 5' AGGCGCCGCCCTAGATCTTGTCTGCCTCCC. 3' 
BglII 
The two primers were used in a PCR with the plasmid pBR325 as the 
template DNA, according to the protocol given in materials and methods. The final 
product was 2064 bp long and was sub cloned into pGEM-T. 
The pGEM-T Easy Vector systems (Promega) are convenient systems for the 
cloning of PCR products. The vectors are prepared by cutting pGEM-T with the 
restriction enzyme EcoRV and adding a terminal 3' thymidine to both ends. These 3'-
T overhangs greatly improve the efficiency of ligation of a PCR product into the 
plasmid by preventing recircularisation of the vector and providing a compatible 
overhang for PCR products generated by thermostable polymerases which add a 
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Fig. 3.6.3 Restriction of pGEM-T HSVcat with BglII. Lane 1: DNA markers, lane 2: 
pGEM-T HSVcat restricted with BglII to give 2 fragments, pGEM-T (3.0kb) and 
HSVcat (' 2kb).  
The pGEM-T plasmid containing the 2064 bp insert was transformed into 
TOP- 10 and selected on plates containing Cmp and Amp and grown overnight at 
37°C. Transformed colonies were picked and the plasmid DNA extracted according 
to the protocol in materials and methods, the plasmid was then restricted with the 
enzyme BglII and run on an agarose gel (Fig. 3.6.3). The 	2kb fragment, 
corresponding to the HSV-cat cassette was extracted from the agarose gel using the 
J3-agarase protocol in material and methods, then the cleaned DNA was ligated to 
pUCDapA(mut) that had also been restricted with BglII and CIP treated, to prevent 
plasmid re-ligation. The ligation reaction was transformed into TOP-10 and 














5' .. . .- 	 .PGATCTCAGCCTGAACTCGCTCCAGAGGATCCG 
LysHisAlaGlyLeuLeuArgSerGlnProGluLeuAlaProGluASpPrO 
dapA 	 BglII 	 HSVTag 
GAAGATTAAGCAGGCATCGTGGTGTCACG.. . .3' 
G1uAspEND 
END 	Upstream cat 
Fig. 3.6.4. The plasmid pUCDapHSV (details of construction in text). The lower text 
shows the sequence of the plasmid at HSVTag region and shows that, when 
translated, DapA will have a HSVTag. 
As the plasmid pUCDapA(mut) was restricted with only one enzyme (BglII) it 
was possible that the HSVcat insert could ligate to the plasmid in either orientation. 
If the cassette ligated in the correct orientation (Fig. 3.6.4) then the HSVTag would 
be in frame with dapA and form a fusion protein, but if the cassette ligated in the 
opposite orientation there would be no tagged dapA. To determine the orientation of 
the cassette two primers were designed, one of which (DHCHKDAP) would anneal 
to DNA sequence in the dapA gene, and the other (TAGCHK) would anneal to DNA 
sequence in the upstream region of the cat gene. 
DHCHKDAP: 5' GAAGGGCATTTTGCCGAGGC 3' 
TAGCHK: 5' TOCGTGTCG000TTATT000 3' 
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Only if the HSVcat cassette had ligated in the correct orientation would it be possible 
to obtain a PCR product of 781 bp. 10 colonies were checked using this method and 
six were found that contained a plasmid (pUCDapHSV) which gave the correct size 
of fragment when checked by PCR. 
3.6.2 Construction ofplasmid p UCDapHis 
A 6 x His tagged form of dapA was also constructed, to aid in the purification 
of DapA from E. co/i. The construction of this plasmid, pUCDapHIS, was essentially 
the same as for pUCDapHSV, except instead of using the primer HSVCATTOP 
(which introduced the HSV sequence), the primer HISCATTOP was used. 
HISCATTOP: 
5' .. CAGTTAATAGATCTCATCACCATCACCATCACTAAGCAGGCA 
BglII HisHisHisHisHisHisEND 
TCGTGGTGTCACG. . .3' 
Complementary 
Region 
Because of the slightly smaller length of the primer compared to 
HSVCATTOP, when the plasmids pUCDapHIS were being screened using the 
primers TAGCHK and DHCHKDAP, the product would be 766 bp if the HIS-Tag 
cassette were ligated in the correct orientation. 
3.6.3 Construction ofp UCDapA:: CAT 
To determine if the tagging of DapA interfered with the activity of the 
protein, it was necessary to construct a dapA delete strain of E. coli, and determine if 
the plasmids carrying the tagged DapA could complement this deletion. 
The construction of the dapA deletion cassette used the crossover PCR 
technique (Link et al, 1997). Crossover PCR was originally used by Link et at. for 
the deletion of genes. Briefly, the protocol comprises three steps as illustrated in 
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figure 3.6.5. In the first step two different asymmetric PCRs were used to generate 
fragments to the left and right of the sequences targeted for deletion. The two inside 
primers, B and C, are complementary to the 5' and 3' ends of the gene to be deleted, 
but they also contain a 'tail' region, which is complementary over 21 nucleotides and 
may contain a restriction site. The outside primers, A and D were used to introduce 
restriction enzyme recognition sites into the flanking genes so that the entire final 
product could be easily cloned. Two PCR products were made using primer pairs AB 
and CD respectively, when these two PCR products are mixed the complementary 
regions anneal and prime at the 3' overlapping region for a 3' extension of the 
complementary strand. The fused molecule is then amplified using the outside 
primers A and D to give the final product with the gene deleted and restriction sites 
on either end. Since a restriction site was also introduced into the middle of the 
product, an antibiotic resistance gene could be inserted here for ease of selection 
when the deletion construct is moved onto the chromosome. 
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Fig. 3.6.5 Summary of cross-over PCR. x: upstream flanking gene, y: gene to be 
deleted, z: downstream flanking gene, A: outside primer, B: inside tailed primer, C: 
inside tailed primer, D: outside primer, 1: restriction site, 2: restriction site (not the 
same as either 1 or 3), 3: restriction site (may be the same as 1). i; PCRs of flanking 
genes using primer pair AB and CD to give products with complementary 3' ends. ii: 
PCR products mixed, 3' ends anneal and primer extension occurs, add outside 
primers A and D. iii: PCR with primers A and D to give final product with deleted 
gene y. Product can be restricted with enzymes 1 and 3 and ligated to an appropriate 
vector. Product may then be restricted with enzyme 2 and an antibiotic resistance 
cassette with complementary ends may be ligated in place. 
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To make the AdapA cassette four primers were designed, the two outside 
primers, End 5-3 and End 3-5 annealed to DNA located in the nlpB and gcvR genes 
respectively and introduced mutations so that the final PCR product would have a 5' 
BamHI and 3' EcoRI restriction enzyme recognition site. The two inside primers 
END 5-3 and END 3-5 contained a region of homology to the 5' and 3' ends of the 
dapA gene and also the complementary 'tails' containing a SmaI/XmaI recognition 
site (the sequence of the 'tail' region was taken directly from the paper by Link et al. 
which first described this method). 
END 5-3: 5' AATCGOGGGATCCTGCAGACGCAC 3' 
BamH I 
END 3-5: 5' CGCTGTCCOTGGAATTCGGTCAAA 3' 
EcoRI 
DAP 5-3: 5' CCCATCCCACAPAGCCCGGGACACCCGTGAACATGGGCCATCC 3' 
Tail 	SmaI/ 	Homology to dapA 
Region XmaI region 
DAP 3-5: 5' TGTCCCGGGCTTGTGGATGGGAAGCATGCCGGTTTGCTGTA 3' 
SmaI/ 	Tail 	Homology to dapA 
XmaI region region 
The primers END5-3 and DAP3-5 were used in a PCR reaction, as were the 
primers END3-5 and DAP 5-3, using chromosomal DNA extracted from MG1655 as 
the template. The two products were 1170 bp and 844 bp respectively. The PCR 
products were run on an agarose gel, and the DNA was extracted using the f3-agarase 
protocol as described in materials and methods. 10 ng of each product were then 
mixed together and used as the template in a new PCR using the primers END 5-3 
and END 3-5, their complementary 'tail' regions would anneal to each other to 
produce the AdapA cassette, a product of 2014 bp (Fig. 3.6.6). 












Fig. 3.6.6 Cross-over PCR products for the construction of AdapA cassette. Lanes 1 
and 3: DNA markers, lane 2: cross-over PRC product (2014 bp), lane 4: product of 
END5-3/DAP3-5 PCR (1170 bp), lane 5: product of END3-5/DAP5-3 PCR (844 bp). 
The AdapA cassette PCR product (2014 bp) was run on an agarose gel, 
extracted using the f3-agarase method, and sub cloned in pGEM-T. The construct was 
transformed into TOP-10 competent cells and plated on LB + Amp + X-gal, and 
screened for blue or white colonies. Since cloning a cassette into pGEM-T disrupts 
the lacZ gene, resultant colonies will be unable to hydrolyse X-gal, and will therefore 
produce white colonies. A number of white colonies were picked and the plasmid 
DNA was extracted and subjected to restriction analysis to determine if the construct 
was correct. When a plasmid bearing the correct construct was found, the cassette 
was released from the plasmid by digesting with the restriction enzymes EcoRI and 
BamHI. The 2 kb fragment was then ligated to the plasmid pUC 18 which had also 
been cut with EcoRI and BamHI, and the construct was again transformed into TOP-
10. Since the EcoRI and BamHI sites are located within the lacZ gene of pUC18, 
blue/white screening can again be used to determine if the cassette is ligated to the 
plasmid. Plasmid DNA from white colonies on LB + Amp + X-gal, was digested 
with the enzyme SmaI. Since there are no Smal sites in pUC18, this enzyme cuts 
only once in the unique site introduced by the 'tail' regions of the cross-over PCR. A 
blunt-ended piece of DNA containing the cat gene with its native promoter region 
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(from N. McLennan, the cat gene, along with its promoter was excised from 
pUCAT18 with Hindu and Ec113611) was ligated to this linearised plasmid. Since the 
cat fragment was blunt-ended, and the restriction of the vector with Smal resulted in 
a blunt-ended product, the cat fragment could be ligated to the vector in either 
orientation; colonies were selected in which the cat gene is transcribed in the same 
direction as dapA would have been (Fig. 3.6.7). 
3.6.4 construction of MGM100/idapA and MGM1OODapAHis /HSV 
The previous section dealt with the construction of the dapA::cat cassette. The 
following method was used to transfer this construct onto the chromosome of E. coli. 
In the first instance the plasmid of interest (pUCDapA::cat) was transformed 
into competent MG1655 and allowed to grow overnight at 37°C. During this time 
there was a crossover between the homologous regions n/pB and gcvR on the plasmid 
and chromosome. A P1 lysate was then made from the MG1655 and used to 
transduce NK6056, selecting for CmpR  and  TetS  colonies that could grow in the 
absence of adenine but required DAP (NK6056 contains purC::TnlO and in E. co/i 
purC is within 2 minutes of dapA, so any colonies which were both purC and CmpR 
after the P1 transduction and also required the presence of DAP, had the dapA::cat 
construct on the chromosome). By screening for Amps it was also possible to 
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Fig. 3.6.7 The plasmid pUCDapA::CAT, where cat has replaced dapA using the 
technique of cross-over PCR. 
Any of the transduced NK6056 colonies that were CmpR, TetS, Amps, purC 
and required the presence of DAP were used as the donor for a new P1 lysate, which 
was then used to transduce MGM1655 or MGM100, selecting now only for CmpR 
and screening for DAP dependence (also for MGM 100, the presence of arabinose for 
growth). 
Surprisingly the AdapA strain would not grow on LB + DAP, although it 
would grow on minimal media + DAP. Though the reason for this is still unclear, it 
was hypothesised that since MGM100/MG1655 have a much faster growth rate in 
LB (generation time 22 minutes) than they have in minimal media (generation time 
40 minutes) it was possible that the cells could not take up DAP at a sufficient rate 
to make new peptidoglycan when growing on LB. If this were the case then the cells 
would grow faster than they could make new cell wall, and would soon lyse; when 
on minimal media, the cells made new peptidoglycan less rapidly and could 
consequently match the supply of DAP with its demand. 
The strain MGM 1 OOAdapA showed no enzymatic activity for DapA using the 
o-aminobenzaldehyde assay as described in materials and methods. 
The plasmids pUCdapHIS and pUCDapHSV were able to complement 
MGM100AdapA, allowing the strain to grow in the absence of DAP. The presence of 
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either of the plasmids also allowed the strain to grow on LB + DAP as well as 
minimal media + DAP. 
The construction of MGM100DapAHis and MGM100DapAHSV was 
primarily the same as for the construction of MGMIOOAdapA except that the 
presence of DAP was not required when screening colonies. 
3.7 Native structure of DapA in GroE depleted cells 
Earlier in this work it had been shown that in GroE depleted cells, dapA is 
still transcribed and translated, but as the cells become more GroE depleted, the 
activity of the enzyme decreases. Since previous studies had only measured the 
amount of denatured protein in the cell, it was impossible to determine if the native 
structure of DapA was affected in GroE depleted cells. Since DapA is only active 
when it forms a homotetramer it was possible that DapA was affected by GroE 
depletion in such a way that it could not form a tetrameric structure. 
A HSV tagged form of DapA was constructed in MGM 100, which exhibited 
normal levels of DapA activity (i.e. an equivalent amount of protein from MGM100 
and MGM100DapAHSV gave the same level of DapA enzymatic activity). When 
protein extracted from this strain was run on a denaturing gel and probed using anti-
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Fig. 3.7.1 Chemiluminescent detection of DapAHSV probed using anti-HSV IgG. 
Lane 1: Protein molecular weight markers, lane 2: whole cell extract from 
MGM 1 OODapAHSV (DapA monomer = 31273 Da), lane 3: whole cell extract from 
MGM100, lane 4: positive control extract (HSV tagged protein of3l 102 Da). 
To determine the native structure of DapA in GroE depleted cells, 
MGM100DapAHSV was grown in either LB + ara (GroE) or glu (GroE-) and 
samples were taken at various times and analysed on an 8% (w:v) native gel with 
Western blotting and detection with anti-HSV IgG (as per the protocol in materials 
and methods). The results, shown in figure 3.7.2 show that as MGM100 becomes 
GroE depleted, DapA is still present in a tetrameric form, even though the samples 
show hardly any DapA activity. Also, the amount of the tetrameric form, rather than 
decreasing, actually increases (see lane 7 on figure 3.7.2). This is consistent with the 
fact that the level of transcription of DapA is regulated by the intracellular level of 
DAP, and therefore, as cells become GroE depleted, the amount of DapA increases 
(discussed in chapter 5). Results of the densitometry analysis of this Western blot can 
be seen in Table 3.7.1. 
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Fig. 3.7.2 Chemiluminescent detection of DapA tetramer from MGM 1 OODapAHSV. 
Lane 1: GroE sample at T = 0 minutes after dilution into LB + ara/glu, lane 2 GroE 
sample, T = 60 minutes, lane 3: GroE T = 135 minutes, lane 4: GroE sample, T = 
150 minutes, lane 5: GroE sample, T = 60 minutes, lane 6: GroE sample, T = 135 
minutes, lane 7: GroE sample, T = 150 minutes. Also, lane 1 had 2x more protein 
loaded than any other lane. 
That DapA is present in GroE depleted cells as a homotetramer, yet has no 
enzymatic activity could be caused by two possibilities. (i) DapA is a GroE substrate, 
and requires GroE to fold to a enzymatically active native state, yet in the absence of 
GroE DapA may still be able to fold to a near-native state such that it can form a 
homotetramer but has no enzymatic activity, (ii) In GroE depleted cells, DapA 
activity is inhibited through some unknown mechanism. 
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+ 	 + 	+ GroE GroE GroE GroE
+ 
 
Omins. 60 	135 150 
mins. mins. mins. 
GroE- GroE GroE GroE-
0 mins. 
roE
O ins. 60 	135 150 
mins. mins. mins. 
Densitometry 64992 36128 42370 41206 64992 34379 65932 108021 
reading 	(32469) 	 (32469) 
Table 3.7.1 Densitometry readings of the amount of native DapA in wild type and 
GroE depleting cells. The Western blot in figure 3.7.2 was analysed by densitometry, 
the analysis shows that in a GroE cell the level of native DapA remains 
approximately the same at all time points, while in a GroE depleting cell, the amount 
of native DapA increases as the cell becomes GroE depleted. (The 0 minute sample 
had two times more protein loaded than any other sample, the first densitometry 
reading is the actual value from the Western, while the figure in brackets is half of 
that value, i.e. the densitometry reading if only lx protein had been loaded). 
3.8 DapA is not inhibited in GroE depleted cells 
Since DapA has no enzymatic activity in GroE depleted cells it is possible 
that during GroE depletion, an inhibitor molecule for DapA is synthesised in 
MGM 100. There are many modes of inhibition in E. co/i, for example the inhibitor 
molecule could have a similar structure to aspartate semialdehyde (the substrate for 
DapA) to the extent that it specifically binds to the active binding site, yet differs 
from the true substrate in that it is unreactive. 
To determine if an inhibitor molecule for DapA was synthesised during GroE 
depletion a culture of MGM100 was grown in LB + ara/glu for 3 hours (in the 
glucose sample, the DapA activity was >25% of the arabinose sample) and then 20 
ml of 0D600  0.1 cells were removed. These cells were centrifuged at 1500 x g for 5 
minutes and the supernatant discarded. The cells were then resuspended in 500 iil of 
0.1 M Tris buffer (pH 7.4) and sonicated to lyse the cells. If there were an inhibitor 
present in the GroE depleted cells, then, in theory, it should be present in the GroE 
lysate. 100 nm of purified DapA was then mixed with 200 tl of either the GroE or 
GroE lysate, and allowed to incubate at 25°C for 15 minutes, then the DapA activity 
of the GroEr lysates (200 p1), the GroE7 lysates with 100 nm DapA (200 p1) and 
100 nm of DapA were measured. 
For the GroE lysate incubated with DapA, the final DapA activity should be 
the sum of the activity of the lysate and the purified DapA. For the GroE lysate 
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incubated with DapA, if DapA activity is inhibited, the final activity should be less 
than the sum of the activity of the lysate and the purified DapA. The results are 
shown in Table 3.8.1. 
The data suggests that incubating DapA with a GroE lysate does not result in 
any greater decreased DapA activity than incubating DapA with a GroE lysate. 
From this it can only be concluded that, under these circumstances, GroF cells do 
not seem to contain a diffusible molecule that is inhibitory to DapA activity. It is 
possible that any inhibitor molecule is covalently attached to DapA in the GroF 
lysate, and therefore was not present as a free compound in the soluble fraction. 
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Percentage 
activity of 100 
(ii) DapA nm DapA after 
(i) DapA 	activity of (iii) DapA 	incubation 
activity of lysate + activity of 100 with lysate 
lysate 	lOOnm DapA nm pure DapA 	(iii/iii)*  100 
GroE 	2 	 2.27 	 0.35 	 77% 
GroE 0.73 1 0.35 77% 
Table 3.8.1 Results of inhibition experiment of DapA. DapA activity is measured as 
arbitrary units. After incubation with lysates from both GroE and GroE cells, DapA 
activity is the same, suggesting that a GroE- lysate contains no more inhibitory 
material than a GroE lysate.  
3.9 Purification of DapA from GroE depleted cells 
Since DapA did not appear to be inhibited in GroE depleted cells, it was 
possible that the decrease in DapA activity was due to a structural problem. The 
native gel analysis shows that DapA can form a homotetramer in conditions where 
GroE is absent, but this method will only show gross structural changes and is not 
sensitive enough to show a slight structural change, for example in the catalytic site, 
that might cause the enzyme to lack activity. It was hypothesised therefore that DapA 
is a GroE substrate and requires the presence of GroE to fold correctly to its active 
form, yet in the absence of GroE may be able to fold to a near-native state, but will 
not fold one hundred percent correctly, and will consequently have no enzymatic 
activity. 
To determine if this were indeed the case it was necessary to purify DapA 
from GroE and GroE cells and determine the structure of the protein using a 
number of methods, including circular dichroism (van Stokkum et al, 1990), nuclear 
magnetic resonance spectroscopy (Ferentz et al, 2000), Fourier transform infrared 
spectroscopy (Surewicz et al, 1993) and microcalorimetry (Cooper, 1999). 
In an attempt to purify DapA from GroE/ cells, 1 litre of the strain 
MGM100DapAHIS was grown in LB + ara or glu for 135 minutes, the entire culture 
was centrifuged at 1500 x g for 10 minutes in a chilled rotor and the supernatant was 
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discarded. The cell pellet was then resuspended in 5 ml of His-Bind buffer and the 
protein was extracted using a His-Bind Quick 900 cartridge using the protocol given 
in materials and methods. While the protein that was extracted from the GroE cells 
had little activity (>25% of the GroE sample) there was very little protein in either 
sample, the GroE sample producing 0.37 mg of DapA and the GroE sample 
producing 0.2 mg. As 5-8 mg of DapA protein would be required to analyse the 
structure of the protein (requiring 25-40 litres of culture) it was decided that 
purification from a strain overproducing DapA would be more feasible. 
The next approach was to use the plasmid pUCDapHis in MGMIOOAdapA to 
overproduce DapA under the control of its native promoter. The strain 
MGM100AdapA was used as the presence of the plasmid complements the dapA::cat 
mutation, and therefore cell viability is an easy way of selecting for the presence of 
the plasmid. Unfortunately, when MGM 100AdapA pUCDapHis was grown in LB + 
glucose, the cells did not lyse (Fig. 3.9.1). As discussed in the introduction to this 
thesis, McLennan et al. found that the presence of dapA on a multicopy (pBR322) 
plasmid delayes lysis in GroE depleted cells. It was hypothesised that a 'pool' of 
DapA was present, folded correctly before the cell became GroE depleted, and this 
could delay the onset of lysis. Following this logic, a pUC based plasmid, having a 
higher copy number still would have an even larger 'pool' of correctly folded DapA. 
When MGM 100 becomes GroE depleted, the cells eventually stop growing, if this 
happens before the pool of correctly folded DapA has been depleted, the cells will 
never lyse. This, therefore, renders the plasmid pUCDapHis useless in the 
purification of DapA from GroE depleted cells, as it will not be possible to extract a 
homogenous form of DapA, there will always be a mixture of correctly and 
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Fig. 3.9.1 Growth curves of MGM100AdapA pUCDapHis in LB + ara (GroE), glu 
(GroE) or glu DAP (GroE, no lysis). For clarity, when cells have been diluted 1/10, 
the OD has been multiplied by 10 and plotted on the graph. A 1/10 dilution was 
performed on all samples at 90 minutes and on the ara sample at 210 minutes. 
3.9.1 Construction ofpT7-5DapAHis 
One of the over-expression systems that was used to try and purify DapA 
from GroE depleted cells was the T7 system. The pT7 range of vectors contain the 
17 RNA polymerase promoter 10 in front of a polylinker sequence (Tabor et al, 
1985). When the gene of interest (dapAHis) is cloned into the multiple cloning site 
of the vector, its expression is regulated by the amount of T7 RNA polymerase in the 
cell. The strain MGM1002DE3 [constructed using the 2cDE3 lysogenisation kit 
(Novagen)] has a chromosomal copy of the T7 RNA polymerase gene under the 
control of a lacUV5 promoter, thereby making the expression of DapAHis 
dependent on the addition of the gratuitous inducer IPTG. 
119 
Two primers were designed (UP-DAPA and DWN-DAPA) which, when used 
in a PCR with MGM100DapAHis chromosomal DNA as the template, would 
generate a product of l kb which would contain the coding sequence for the His 
tagged version of dapA, with its native ribosome binding site, but without its —10 and 
—35 region. The primers would also introduce engineered sites into the PCR product 
such that it would have an EcoRI site at its 5' end and a HindlIl site at its 3' end. 
UP-DAPA: 5' TGCTTGCTTTGAATTCCATACCAAAC 3' 
EcoRI 
DWN-DAPA: 5' GAGCTGAATGAAGCTTTACCAAACGA 3' 
Hindl II 
The PCR product was sub cloned into pGEM-T, and then released from the 
vector by cutting with the restriction enzymes EcoRI and Hindlil. The restriction was 
run on an agarose gel, the I kb band corresponding to dapAHis was excised and 
cleaned up using the -agarase protocol as described in materials and methods. The 
fragment was then ligated to the plasmid pT7-5, which had also been cut with EcoRI 
and Hindill. The final product, pT7-5DapA.His (Fig. 3.9.2) was then transformed 
into the strain MGM l002DE3. 
The strain was grown in LB + ara/glu and IPTG was added (0.4 mM) at 150 
minutes. After 30 minutes the samples were run on an SDS-PAGE gel according to 
the protocol given in materials and methods. In the GroE1 cells there was a clear 
increase of dapAHis, but in GroE cells there was no increase in dapAHis (Fig. 
3.9.3). 
This experiment was repeated a number of times, with both varying 
concentrations of inducer and adding the inducer at varying times (though no earlier 
than 120 minutes, as the GroE cells would not be sufficiently GroE depleted to 
produce misfolded DapA); in GroE-  cells there was consistently no induction of 
dapA His. 
Since the list of verified GroE substrates is far from complete, it was 
hypothesised that T7 RNA polymerase was affected by GroE depletion causing the 




Fig. 3.9.2 The plasmid pT7-5DapAHis. The His tagged version of the gene dapA is 
cloned into the multiple cloning site of the plasmid, putting it under the control of the 
4 10 promoter. 
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Fig. 3.9.3 Coomassie blue stained SDS-PAGE gel of protein from MGM 100XDE3 
pT7-5DapAHis. Lane 1: GroE before induction, lane 2: GroE 30 mm. after 
induction (0.4mM IPTG), lane 3: GroE before induction, lane 4: GroE 30 mm. after 
induction (0.4mM IPTU). The induced band corresponding to DapAHis (31.2 KDa) 
is clearly visible in lane 2.  
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3.9.2 Construction ofpJFDapAHis 
To overcome the problems of the T7 system the His tagged dapA gene was 
cut out of pT7-5DapAHis using the restriction enzymes EcoRI and HindIll and 
ligated to the plasmid pJFI 18(EH) (Furste et al, 1986) which had also been cut with 
EcoRI and HindIIl . The resulting plasmid, pJFDapAHis had the dapAHis gene 
under the direct control of a tac promoter (Fig. 3.9.4). The plasmid also carried the 
laclQ gene which prevents transcription from the tac promoter in the absence of the 
inducer IPTG and therefore tightly regulates transcription of dapAHis. 
The plasmid was transformed into competent MGMIOO and the cells were 
grown in LB + ara/glu as per the instructions in section 3.9.1. IPTG was added to a 
final concentration of 0.4 mM and the samples analysed on an SDS-PAGE gel 
according to the protocol in materials and methods. 
The results (Fig. 3.9.5) again show that while DapAHis is over-expressed in 
the GroE sample, it is not over-expressed in the GroE depleted sample. It was at this 
point that it was discovered that Lacl is affected by GroE depletion. In GroE depleted 
cells, Lacl does not release from LacO when IPTG is present (discussed in detail in 
chapter 4), therefore nothing is expressed from a lac or tac promoter in GroE 
depleted cells. This would also explain why the T7 vector failed to overproduce any 
protein. The T7 RNA polymerase required to transcribe the mRNA of the gene under 
the control of the 10 promoter, was itself under the control of a lacUV5 promoter, 




Fig. 3.9.4 The plasmid pJFDapAHis. The His tagged version of the dapA gene was 
cut out of the plasmid pT7-5DapAHis using the restriction enzymes EcoRI and 
Hindill and cloned into the EcoRI and Hindlil sites ofpJFl 18(EH). 
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Fig. 3.9.5 Coomassie blue stained SDS-PAGE gel of protein from MGM 100 
pJFDapAHis. Lane 1: GroE before induction, lane 2: GroE 60 mm. after induction 
(0.4mM IPTG), lane 3: GroE before induction, lane 4: GroE 60 mm. after induction 
(0.4mM IPTG). The induced band corresponding to DapAHis (31.2 KDa) is clearly 
visible in lane 2. 
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3.9.3 Construction ofpPROTet. El 32DapA His 
Since it was not possible to use a lac promoter based system to overproduce 
protein in GroE depleted cells, the PRO bacterial expression system was used instead 
(Clontech). The PROTet.E vectors utilise a novel tetracycline-regulated promoter, 
PLtet0-1 that takes advantage of the high expression levels from the PL promoter of 
phage ?. and the tight control provided by operator 2 of the TnlO tetracycline 
resistance operon (Lutz et al, 1997). Thus, PLtetO-1  is tightly repressed by the highly 
specific Tet repressor protein and induced in response to anhydrotetracylcine (aTc) 
allowing control of induction over a wide range. (Anhydrotetracycline is a derivative 
of tetracycline that acts as a more potent inducer of PROTet.E systems and is less 
toxic to E. coil than tetracycline). PLtet0-1  has been paired with the Col El high-copy 
replication origin (on) to deliver a 2500-fold range of inducibility. At full induction 
levels, the target protein can represent as much as 10% of total protein. The SpcR 
plasmid pPRO, used in conjunction with the PROTet.E plasmids, expresses defined 
amounts of the Tet repressor to ensure reliable intracellular conditions. 
The His tagged version of dapA was cloned into the vector pPROTet.E 132 in 
the following manner; the dapAHis gene was amplified using PCR on chromosomal 
DNA from MGM 1 00DapAHis, the primers used were DWN-DAPA (from section 
3.9.1) which introduced a 3' HindiJi restriction enzyme recognition site, and the 
primer UPDAPA-K, which introduced a KpnI recognition site into the 5' end. 
UPDAPA-K: 5' TGCACAGAGGGGTACCCATGTTCAOG 3' 
The important aspect of this primer was that it introduced the KpnI site one 
base before the ATG of dapAHis. Therefore when it was cloned into pPROTet.E 132 
the number of bases between the ribosome binding site and the ATG of the inserted 
gene would be conserved. 
pPROTet.E 132: 
5' 	......... ATTAAAGAGGAGAAAGGTACCCGGTGAA ......... 3' 
PLtetO-1 	 RBS 	KpnI Myc-Tag 	Hindlil 
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5' end of dapA His after PCR with DWN-DAPA and UPDAPA-K: 
5' 	......... TGOACAGAGGGGTACCCTTCACG ..........3' 
KpnI dapAHis 
Therefore when dapA His was cloned into the KpnI and Hindlil sites of 
pPROTet.E 132, the initiation codon of dapkHis would be in the same position as 
the initiation codon of the Myc Tag would have been, thereby assuring that both the 
PLtetOl promoter and ribosome binding site were used to give the best level of 
expression. 
The dapAHis fragment was amplified by PCR, run on an agarose gel and the 
1 kb fragment extracted using the 3-agarase protocol in materials and methods. The 
fragment was then sub cloned into pGEM-T, and then released by cutting with the 
restriction enzymes KpnI and Hindill. The fragment was then ligated to 
pPROTet.E132 which had also been cut with KpnI and HindIII. The resulting 
plasmid pPROTet.E132DapAHis (Fig. 3.9.6) now had dapAHis expression under 
the control of the promoter PLtetOl. 
The plasmid was then transformed into MGM 1 OOPRO (MGM 100 containing 
the SpcR  pPRO plasmid which carries the tetR gene) and transformants were selected 
on LB + Kan, Spc, Cmp and 0.2% ara. 
To test if DapAHis was produced in GroE depleted cells using the PLtetOl,  the 
cells were grown in LB + ara/glu using the method described in section 3.9.1 and the 
inducer, aTc, was added to a final concentration of 100 ng m1 1 , with samples being 
taken before and after induction for analysis on an SDS-PAGE gel. The results (Fig. 
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Fig. 3.9.6 The plasmid pPROTet.El32DapAHis. The dapAHis gene, being cloned 
into the KpnI and HindIII sites ofpPROTet.E132 is now under the control of the 
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Fig. 3.9.7 Coomassie blue stained SDS-PAGE gel of protein from MGM 100PRO 
pROTet.E 1 32DapAHis. Lane 1: GroE before induction, lane 2: GroE 60 mm. after 
induction (100 ng ml aTc), lane 3: GroE 60 mm. after induction (100 ng ml-1 aTc). 
The induced band corresponding to DapAHis (31.2 KDa) is clearly visible in both 
lanes 2 and 3. 
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3.10 Over-expressed DapA is insoluble in GroE depleted cells 
The plasmid pROTet.El32DapAHis was used to express DapA-His in GroE 
depleted MGM100PRO, the cells were then lysed and the protein extracted from the 
soluble fraction of the lysate using the protocol described in materials and methods. 
When the elution step was performed in the purification protocol it was found to 
contain no DapA-His, yet performing the same procedure on GroEt cells resulted in a 
high yield of DapA-His. Since DapA-His was being expressed in these cells (as 
determined by SDS-PAGE analysis) it is unclear why the protein cannot be purified. 
It was then observed that when expression of DapA-His was induced in 
MGM100PRO the cells formed large inclusion bodies (Fig. 3.10.1) suggesting the 
possibility that the over-expressed protein was aggregating. When a protein 
aggregates it is usually found in the insoluble fraction of an E. co/i cell lysate, this 
might explain why the protein could not be extracted from the soluble fraction of a 
GroE depleted cell lysate. 
To determine if DapA was becoming insoluble when over-expressed in GroE 
depleted cells, MGM 100PRO pROTet.El32DapAHis was grown in LB+ glu/ara and 
induced with aTc (100 ng ml-1) at 150 minutes after the dilution into LB glu or LB 
ara. Samples were taken after induction and one of two procedures was performed: 
either the cells were resuspended in 1 x PAGE loading buffer and lysed by boiling 
for 3 minutes (this would result in a sample which contained both soluble and 
insoluble proteins) or the samples were resuspended in 0.1 M Tris buffer and 
sonicated to lyse the cells. The samples were then centrifuged (10 minutes at 14000 x 
g) to pellet insoluble material and the soluble fraction mixed with 1 x PAGE loading 
buffer (resulting in a sample containing only soluble proteins). The samples were run 
on an SDS-PAGE gel and analysed. 
The results (Fig. 3.10.2) required careful analysis as the soluble fraction 
sample always contained less protein than the soluble + insoluble fraction sample. By 
choosing a control band (the upper band in the gel image) and normalising all lanes 
so that they had the same intensity for that band, the relative intensities of the band 
representing DapA-His could be determined. 
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Fig 3.10.1 Inclusion bodies in MGM100PRO over-expressing DapAHis under 
GroE conditions.  
To determine if the control band changed intensity in GroE depleted cells the 
intensity of the DapAHis band from the GroE sample (soluble + insoluble fraction) 
and GroE sample (soluble + insoluble fraction) were compared when the intensities 
had been normalised using the control band. If the control band was affected by 
GroE depletion (either increasing or decreasing in intensity) then the values for the 
DapAHis band from the two samples should be quite different. The value of the 
DapAHis band from the GroE sample was 1760 (arbitrary units) and the value from 
the GroE sample was 1648. This suggested that the control band was unaffected by 
GroE depletion and was therefore acceptable to normalise against. 
The GroE sample (soluble fraction) had a DapAHis value of 1101.5 when 
normalised, while the GroE sample (soluble fraction) had no band corresponding to 
DapAHis. This data suggests that even in a GroE sample, some fraction (in this 
instance, - 37%) of over-expressed DapAHis is insoluble, but in GroE depleted cells 
100% of DapAHis is the insoluble. 
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Fig. 3.10.2 Coomassie blue stained SDS-PAGE gel of proteins from MGM 100PRO 
pROTet.El32DapAHis induced with aTc (b Ong ml- 1). Lane 1: GroE soluble 
fraction, lane 2: GroE soluble + insoluble fraction, lane 3: GroE soluble fraction, 
lane 4: GroE soluble + insoluble fraction. The upper arrow in the image is pointing 
to the control (normalising) band and the lower arrow is pointing to the band 
representing DapA-His. 
It is not surprising that even in the GroE sample some of the over-expressed 
DapA-His is aggregating. If, as it is hypothesised, DapA is a GroE substrate, then 
when DapA is produced at a much higher level than is physiologically usual, the cell 
may not have enough GroE to fold all of it correctly. The incorrectly folded protein 
would then act like DapA from a GroE cell, and consequently form aggregate. 
To try and overcome the problems of aggregation of over-expressed 
DapA-His in GroE depleted cells, a range of aTc concentrations was used, with 
values from 0.1 ng ml' to 100 ng ml-1. The cells were also allowed to express at 
different temperatures; 4°C, 22°C, 30°C and 37°C (if expression is slowed down, i.e. 
by growing the cells at a lower temperature, then the proteins may not aggregate) but 
the DapA-His protein was always found in the insoluble fraction. 
The plasmid pPROTet.El32DapAHis has a copy number of 50-70 molecules 
per cell, yet the plasmid pBRA6 (dapA on pBR322) while having the same copy 
number does not produce inclusion bodies in MGM100. The major difference 
between these two plasmids is that pBRA6 contains the dapA gene under the control 
of its own promoter. 
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The His tagged version of dapA was amplified using the primers DWN-
DAPA (introducing a 3' HindIll site) and DAPANP (introducing a 5' EcoRl site), the 
PCR product was 1.1 kb and contained the coding region for dapA-His with the 
native dapA promoter. 
DAPANP: 5' TGGTGTTCAGAATTCCAGGGCGAT 3' 
EcoRI 
The 1.1 kb PCR product was sub cloned into pGEM-T, released by cutting 
with the restriction enzymes EcoRI and HindIII, and then cloned into pBR322 which 
had also been cut with EcoRI and Hindu!. 
pBR322 is Amp' and TetR  but when the PCR product was cloned into the 
EcoRI and Hindill sites of the plasmid it disrupted the gene responsible for TetR, 
therefore recombinant DNA could be selected for by finding transformants that were 
now AmpR  and  TetS. 
The plasmid was transformed into MGM 100 and the cells were grown in LB 
+ ara/glu DAP with samples being harvested after 5 hours. Since DapAHis was 
being constitutively expressed in this strain, it was necessary to harvest the cells at a 
later time to be sure that only misfolded DapAHis was present. While pBRA6 
delayed lysis in GroE depleted cells, it did not prevent it altogether, and even with 
pBRA6 present, GroE depleted cells lysed after 5 hours, this represented the time at 
which there was no longer any correctly folded DapA to prevent the cells from 
lysing. 
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Fig. 3.10.3 Levels of DapA, measured by Western blotting and chemi luminescent 
detection, from the soluble and insoluble fraction of MGM 100 pBRA6 at various 
times after the start of GroE depletion. 
The DapA-His protein was then extracted according to the protocol described 
in materials and methods, but there was no protein detected in the final elution, 
though when the same procedure was performed on GroE cells a large amount of 
active DapA-His was extracted. This data suggests that even though the dapA 
promoter may not be as strong as the PLtetOI  promoter, and consequently not as much 
DapA-His is produced (the absence of visible inclusion bodies indicates that less 
aggregate is being made), the amount of DapA-His that is produced is still going into 
the insoluble fraction of E. coli proteins. 
Figure 3.10.3 shows the results of a Western analysis of DapA levels in the 
soluble and insoluble fractions of MGM100 pBRA6 at various times after GroE 
depletion. The data clearly shows that, as the cells become more GroE depleted, less 
DapA protein is found in the soluble fraction. 
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3.11 Summary and discussion 
Previous work on DapA in E. co/i had suggested that levels of the DapA 
polypeptide were greatly decreased in GroE depleted cells (McLennan et al, 1998). It 
was hypothesised that in the absence of the chaperone GroELS, DapA was misfolded 
and therefore became a target for proteolysis; while DapA was being actively 
translated in GroE depleted cells the protein had a rapid turnover rate. 
In this work pulse chase experiments were performed on DapA: newly 
synthesised protein were labelled by incorporating radioactive methionine residues 
into the protein and then an excess of non-radioactive methionine was added. The 
addition of an excess of non-radioactive methionine effectively quenched the 
incorporation of any more radioactive methionine. The rate of decay of the 
radioactive proteins could then be measured to determine their stability. The proteins 
of both GroE and GroE E. co/i were separated using 2-D electrophoresis and the 
intensity of the spot representing DapA was measured. Using this method it was 
shown that DapA from both GroE and GroE cells had a similar turnover rate, 
suggesting that DapA levels do not decrease in GroE depleted cells. 
One of the major limitations of this work is that the substrates of GroE in E. 
coil are still largely unknown, therefore the choice of a 'control' protein to compare 
turnover rate against is crucial. If the 'control' protein is itself affected by GroE 
depletion then the data from such experiments will be incorrect. In the comparison of 
turnover rates of DapA a number of 'control' proteins were therefore chosen to 
minimise the possibility of this occurrence. 
When the levels of DapA were measured directly in GroE depleted cells using 
immunodetection they were not found to decrease as had been previously reported. 
In the past DapA levels had been measured relative to a control protein FtsZ, but in 
this work it was shown that FtsZ levels increase in GroE depleted cells. FtsZ is under 
the control of a as  promoter (Vicente et al, 1998). When cells become GroE depleted 
growth slows and the cells eventually stop growing. This causes an increased level of 
transcription from the us promoter thus producing higher levels of FtsZ. Therefore 
by normalising FtsZ levels, rather than observing a stable level of DapA and an 
increased level of FtsZ the reverse is observed: a stable level of FtsZ and a decreased 
level of DapA. 
While it had now been shown that DapA levels were constant in GroE 
depleted cells, the activity of the protein did decrease markedly with GroE depletion. 
Since the native structure of DapA is a homotetramer (Shedlarsky et al, 1970; 
Richaud et al, 1986) and previous measurements of DapA levels had been of the 
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denatured protein (i.e. it was only measuring the amount of monomeric protein) it 
was possible that DapA was not forming a tetramer in GroE depleted cells, which 
would explain the lack of activity. By extracting DapA under non-denaturing 
conditions and running on a non-denaturing polyacrylamide gel, the native structure 
of DapA could be observed. It was found that DapA from GroE depleted cells ran at 
the correct size for a homotetramer, much like DapA from a GroE cell. This then 
suggested that in GroE depleted cells DapA can either fold well enough to form a 
homotetramer, but not completely correctly (having no enzymatic activity) or in 
GroE depleted cells DapA activity is somehow inhibited. 
The ability of chaperone requiring proteins to fold to a near native state is not 
unheard of. The E. co/i chaperone SecB will not bind to either the native or unfolded 
state of the protein barstar, but rather, binds to a late near-native intermediate along 
the folding pathway (Panse et al, 1998). 
To determine if DapA were being inhibited in GroE depleted cells, pure DapA 
was mixed with a lysate containing the soluble fraction of GroE depleted E. co/i. If 
there were an inhibitor molecule in the GroE lysate then it may cause decreased 
activity of added purified DapA. While a small decrease in DapA activity was noted 
after it was incubated with a GroE- lysate, it was also noticed when the protein was 
incubated with a GroE lysate. This may have been due to the presence of proteolytic 
enzymes in the lysates, but does not indicate the presence of an inhibitor of DapA 
specific to the GroE- lysate. It must also be noted that this experiment does not 
preclude the possibility of an inhibitor for DapA being present in a GroE depleted 
cell, only that inhibition of DapA was not observed under these circumstances 
(which are obviously quite different from in vivo conditions). There is also the 
possibility that the inhibitor binds irreversibly to DapA, and therefore in the GroE-
lysate, l t , all the inhibitor may already be bound to DapA, therefore the inhibitor would 
not be available to inhibit the DapA which was added during the assay. 
As it did not seem that DapA had lost activity due to inhibition, an attempt 
was made to purify DapA to determine if there were indeed minor structural 
differences between DapA from GroE and GroE cells. To achieve this a His or 
HSV tagged form of DapA was constructed and used to replace the wild-type DapA 
of MGM 100. The tags were not found to cause any change in the activity of the 
protein (and therefore did not affect the correct folding of the protein) yet they 
provided a way to either detect the protein using anti-His or anti-HSV antibodies or 
to purify the protein by affinity chromatography. Unfortunately the purification 
strategy of DapA from GroE depleted cells met with a number of obstacles. Firstly, it 
was found that lac based over-expression vectors did not work in GroE depleted cells 
133 
(this phenomena is described in greater detail in chapter 4). This again further 
illustrates one of the major problems with the search for GroE substrates; as the 
substrates for GroE in E. coil are largely unknown, it is almost impossible to predict 
what will be affected by GroE depletion, as in this case where a promoter used to 
over-express a putative GroE substrate was itself affected by GroE depletion! 
The second obstacle in the purification of DapA in GroE depleted cells was 
that the slightly misfolded DapA was highly prone to aggregation when the gene was 
present in more than one (chromosomal) copy. While the reasons for this behaviour 
remain unknown there are a number of possibilities that could explain it. When 
DapA was under the control of the PLtto.i promoter (Lutz et al, 1997) it was 
expressed at a very high rate, much higher than when it was under the control of its 
native promoter. And when DapA was present on a multicopy plasmid (pBR or pUC) 
there were many more copies of the dapA gene being transcribed than if only the 
chromosomal copy were present. It may also be hypothesised that in the absence of 
GroE, DapA, while being able to fold almost correctly, would have a different 
folding kinetic. 
Hen lysozyme does not require GroEL for folding in vitro, yet in the presence 
of GroEL an early intermediate is bound and the slow kinetic phase that reflects the 
reversal of non-native interactions is accelerated (Coyle et al, 1999). This 
observation suggests a mechanism for GroEL-assisted folding in which the 
reorganisation of non-native tertiary interactions is facilitated but domain folding is 
unperturbed. If this were the case with DapA then in the absence of GroE the newly 
synthesised protein may fold more slowly to its near-native state than DapA would 
fold to its native state in the presence of GroE. Also if there were many more copies 
of the slowly folding protein present in the cell (such as would be the case when 
dapA was on pBR or pUC) then there is an increased risk that exposed hydrophobic 
regions would interact leading to aggregation. It may therefore only be possible to 
purify DapA from GroE depleted cells using a His-tagged form on the chromosome 
and extracting the protein from large batches of culture. 
Although DapA seems to have a requirement for both GroEL and GroES to 
refold in vitro, the data from the experiment described in section 3.3.1 suggests that 
only GroEL is required for folding in vivo. There is the possibility that enough 
GroES was still being made from the chromosome to allow the GroELS reaction 
cycle to occur, but the levels would be very low at 5 hours after the start of depletion 
(0.25%) and therefore this does not seem likely. 
The plasmid pGroEL has the gene groEL under the control of a lac promoter 
(the plasmid was used before it was discovered that expression from lac promoters 
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decreases in GroE depleted cells) on a multicopy plasmid. Theoretically when this 
plasmid was transformed into MGMIOO and the cells grown in the presence of 
glucose, transcription from the chromosomal groELS genes would cease and 
transcription from the plasmid groEL gene would continue. Though what was 
probably happening was that upon addition of glucose transcription from the 
chromosomal groELS genes would cease (as expected) but as the cells became more 
GroE depleted, transcription from the plasmid groEL gene would also cease. This 
may explain why DapA activity did decrease (albeit at a slower rate than cells 
without the plasmid pGroEL) in these cells eventually. While the cells had a higher 
initial level of GroEL (allowing newly synthesised DapA to fold correctly and thus 
delaying the production of inactive tetramer) this eventually decreased so that all 
newly synthesised DapA was folded in the absence of both GroEL and GroES. To 
overcome this problem, GroEL synthesis could be put under the control of a 
promoter unaffected by GroE depletion (i.e. PLtetOl) and the experiment repeated to 
determine if DapA only requires GroEL to fold in vivo. Again the hen lysozyme 
experiments of Coyle et al. demonstrate the folding of protein by GroEL in the 
absence of GroES. Other examples are reviewed by Wang and Weissman (Wang et 
al, 1999). 
In conclusion, DapA has proved a most interesting potential GroE substrate, 
one that may be able to reach a near-native conformation in GroE depleted cells yet 
requires GroE to attain an enzymatically active state; a protein that may only require 
GroEL and not the GroELS complex for folding; a protein that is highly susceptible 
to aggregation when over-expressed in the absence of GroE, yet does not aggregate 
when present in only a single copy. To further understand this complex protein, 
attempts should be made to purify DapA from GroE depleted cells and compare it 
structurally to DapA from GroE cells. 
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Chapter IV 
Effects of GroE depletion on Lad 
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4.1 The lac operon 
During the course of this work it was discovered that it is not possible to 
produce DapA from Lac based promoters in GroE depleted cells. This chapter 
describes the analysis of the Lac promoter in MGM 100 during GroE depletion, and 
shows that Lacl behaves differently in wild type and GroE depleted cells. 
More than 30 years ago, Jacob and Monod (Jacob et al, 1961a) introduced the 
E. coli lactose operon as a model for gene regulation. The model persists as a cogent 
depiction of how a set of structural genes may be co-ordinately transcribed or 
repressed depending upon the concentration of metabolites in the growth medium. 
The expression of the lac enzymes is regulated by three basic components: the 
promoter-operator sequence, a transcriptional inhibitor [lac repressor protein (Lad)], 
and a transcriptional activator (cyclic AMP-dependent catabolite gene activator 
protein: CAP) (Kolb et al, 1993). Cyclic AMP (cAMP) levels are inversely related to 
the availability of glucose via effects on adenyl cyclase activity (Kolb et al, 1993), at 
high concentrations of cAMP (i.e. low concentrations of glucose) a complex of the 
CAP protein with cAMP raises the amount of transcription by binding a recognition 
site on the DNA adjacent to RNA polymerase and thereby the affinity of RNA 
polymerase for the promoter is increased (Zubay et al, 1970). This arrangement 
ensures the most direct metabolic route to energy production through preferential 
utilisation of glucose under conditions where lactose is also available. The partially 
twofold symmetrical operator DNA target sequence for Lacl overlaps the promoter 
sequence (Gilbert et al, 1973). RNA polymerase binding (Schlax et al, 1995), 
initiation (Straney et al, 1987), and/or elongation (Lee et al, 1991) are inhibited when 
Lacl occupies this site, precluding production of the mRNA encoding the lac 
enzymes (Fig. 4.1.1). In the absence of lactose, the high affinity of Lacl for the 
lactose operator sequence (LacO) allows production of only small quantities of lac 
mRNA 
When lactose is available in the environment, the low constitutive amounts of 
lac permease transport this sugar into the cell, and the correspondingly low levels of 
-ga1actosidase result in production of the in vivo inducer f3-1 ,6-allolactose (Jobe et 
al, 1972). Binding of this natural inducer to the repressor elicits a conformational 
change that diminishes its affinity for the operator sequence without effect on 
binding to non-specific DNA (Riggs et al, 1970; Lin et al, 1975a). Excess non-
operator DNA in the cell thereby effectively competes for binding to the protein and 
sequesters the repressor-inducer complex (Lin et al, 1975b; von Hippel et al, 1974; 
Kao-Huang et al, 1977), allowing transcription of lac mRNA to proceed so long as 
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lactose is available in the medium. When lactose levels are decreased, the 
intracellular store of inducer is depleted by f3-galactosidase hydrolysis. Under these 
conditions, 13-1,6-allolactose dissociates from the repressor protein, which resumes 
its conformation with high affinity for operator DNA, associates with LacO, and 
shuts down further synthesis of lac mRNA. The lactose regulatory cycle therefore 
involves association with both specific and non-specific DNA sequences, binding of 
sugar molecules and conformational shifts in response to these ligands. 
The gratuitous inducer, isopropyl-f3-D-thiogalactoside (IPTG) can be used to 
turn on transcription of the lactose operon (Jacob et al, 1961b) using the same set of 
events as 13-1 ,6-allolactose, but IPTG is not a substrate for f3-galactosidase and 
therefore it is not metabolised. 
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Fig. 4.1.1 Schematic of lactose operon. P1, promoter for i gene; i, gene encoding 
lactose repressor (Lad); P, promoter for lac enzymes; 0, lactose operator sequence 
(LacO); z, gene encoding 3-galactosidase; y, gene encoding lac permease; a, gene 
encoding thiogalactoside transacetylase; I, inducer; RNA p01, RNA polymerase 
holoenzyme. The i gene product, lactose repressor, binds to operator to preclude 
transcription by RNA polymerase. In the presence of inducer sugars, Lacl undergoes 
a conformational change that diminishes affinity for LacO but does not affect 
binding to non-specific DNA sites, which then compete for binding Lad-Inducer. 
When inducer levels are depleted, Lacl resumes its state with high affinity for LacO 
and inhibits transcription of mRNA. 
4.2 Evaluating the effect of GroE depletion on PL,,, 
Previous observations of LacZ expression in GroE depleted cells [LacZ under 
the control of the dapA promoter, PDapA (section 5.2)] has shown that LacZ folding 
and function is GroE independent, and therefore J3-galactosidase assays can provide 
an accurate analysis of promoter function in GroE depleted cells. MGM 100, being an 
MG 1655 derivative, is a lack strain, with LacZ under the control of the lac promoter 
on the chromosome. 
Initial experiments were to grow MGM 100 in buffered LB [(LB - NaCI) + (1 
x VB salts)] + ara or glu + DAP (it was found that the inclusion of 1 x VB salts gave 
a more consistent result when performing 3-galactosidase assays), and induce LacZ 
expression by adding IPTG at a concentration of 1mM at various stages of GroE 
depletion. 
The results (Fig. 4.2.1) show that in GroE depleted cells LacZ expression is 
dramatically reduced when induced with IPTG at 1mM concentration. The two 
graphs show Miller Units plotted against either time or log 0D600. By plotting Miller 
Units against time it is easier to compare induction levels of samples that had 
different optical densities, but by plotting Miller Units against log OD it is possible 
to determine the amount of induction of LacZ per amount of cell growth. 
Since decreased LacZ expression is not due to a failure of LacZ to fold or 
function or of lacZ InRNA to be translated, it must be due to a decrease in the level 
of expression of the lac promoter. Two possible explanations for this result are that 
IPTG was not entering the cell and thus was unable to promote induction, or that 
Lacl activity had been affected either directly or indirectly by GroE depletion and 
was unresponsive to IPTG. An example of a direct effect on Lacl by GroE depletion 
could be that Lacl protein structure changes, which causes it to become unresponsive 
to IPTG, whereas an example of an indirect effect on Lacl by GroE depletion might 
be that DNA topology could be affected and consequently Lacl may remain bound to 
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Fig. 4:2.1 Graphs showing J3-galactosidase activity in MGM 100 growing in buffered 
LB + Arabinose or Glucose DAP. An overnight culture was diluted 1:100 into 
buffered LB containing ara, the cells were grown to 0D600 0.2, 1 ml of culture was 
centrifuged, the supernatant was removed and the cell pellet was resuspended in 10 
ml buffered LB + ara or glu and DAP (this was time=0). The cultures were induced 
with 1mM IPTG at 120 minutes. For clarity, when cells have been diluted 1/10, the 
OD has been multiplied by 10 and plotted on the graph.  
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4.3 Experiments to test if IPTG enters GroE depleted cells 
The gratuitous inducer IPTG can diffuse across the E. co/i membrane to reach 
equilibrium with the extracellular concentration. But IPTG is also actively 
transported across the membrane by the product of the lacY gene, lac permease, at a 
rate such that the intracellular to extracellular ratio is 50:1 (Miller, 1972). If LacY 
were a GroE substrate, and consequently was inactive in GroE depleted cells, then 
IPTG may be at 50 x higher concentration in GroE cells as compared to GroE cells. 
This could explain why LacZ expression is lower in GroE depleted cells compared to 
GroE normal cells. If this were so, then adding IPTG at an extracellular 
concentration of 50mM to GroE-  cells should give the same level of LacZ expression 
as IPTG added at an extracellular concentration of 1mM to GroE cells. The results 
of the f3-galactosidase assays are shown in figure 4.3.1. IPTG was added at 1mM and 
50mM to both GroE and GroE cells at 120 minutes. There is no significant 
difference in LacZ expression in GroE depleted cells at either IPTG concentration. 
There is also no significant difference in LacZ expression in GroE cells at either 
IPTG concentration, suggesting that 1mM IPTG is enough to cause full induction of 
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Fig. 4.3.1 J3-galactosidase activity in MGM 100 growing in buffered LB + Arabinose 
or Glucose DAP. An overnight culture was diluted 1:100 in to buffered LB 
containing ara, the cells were grown to 0D600 0.2, 1 ml of culture was centrifuged, 
the supernatant was removed and the cell pellet was resuspended in 10 ml buffered 
LB + ara or glu and DAP (this was time=0). The cultures were induced with 1mM or 
50 mM IPTG at 120 minutes. For clarity, when cells have been diluted 1/10, the OD 
has been multiplied by 10 and plotted on the graph. 
4.4 Construction of MGM100 lacI::TnlO 
Since IPTG appears able to enter GroE depleted cells normally, the decreased 
expression of LacZ upon induction must be due to some other failure in the lac 
regulatory mechanism. As Lacl inhibits the transcription of lac mRNA, it is possible 
that Lacl was affected by GroE depletion so that it did not dissociate from LacO. To 
determine whether Lacl was involved in causing decreased LacZ expression in GroE 
depleted cells, a IacI mutant of MGM100 was needed. CAG18439, a lacZ ochre 
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mutant is also a lacI::Tn]O. P1 transduction using P1 grown on CAG 18439 was used 
to transduce MG1655 to LacF, LacZt The transduction mix was plated on VB 
minimal agar plates in the presence of lactose and tetracycline to select tact and 
lacI::TnIO recombinants (lac constitutive mutants). One of the MG 1655 lacI::TnIO 
colonies was then used as the donor to make a new P1 lysate, which was 
subsequently used to transduce MGM 100. Transductants were selected on LB agar in 
the presence of ara, Kan and tetracycline. 
MGM 100 lacI::TnlO has a lac promoter that is no longer repressed by Lad; 
consequently lacZ mRNA is constitutively expressed. This strain was grown at 37°C 
overnight in buffered LB + ara, Kan and tetracycline. The following day the culture 
was diluted 1/100 into 10 ml fresh buffered LB + ara, and grown at 37°C, with 
constant shaking until an 0D600 of 0.2 was reached. 1 ml of culture was then 
removed, placed into an Eppendorf tube and spun briefly to pellet the cells. The 
supernatant was removed and the pellet resuspended in 10 ml of either buffered LB + 
glu, DAP or buffered LB + ara, DAP. The culture was grown for 3 hours with 
shaking at 37°C, diluting as necessary to keep the 0D600 below 0.2. Samples were 
taken every 30 minutes and assayed for 3-galactosidase. The results of the assay are 
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Fig. 4.4.1 3-ga1actosidase results activity in MGM 100 lacI::TnlO grown in buffered 
LB + ara, DAP (GroE) or buffered LB + glucose, DAP (GroE). An overnight 
culture was diluted 1:100 in to buffered LB containing ara and Tet, the cells were 
grown to 0D600 0.2, 1 ml of culture was centrifuged, the supernatant was removed 
and the cell pellet was resuspended in 10 ml buffered LB + ara and Tet or glu, DAP 
and Tet (this was time=0). Samples were taken every 30 minutes during growth and 
3-galactosidase activity determined. For clarity, when cells have been diluted 1/10, 
the OD has been multiplied by 10 and plotted on the graph. 
4.5 Constant induction of PLaC with IPTG in GroE depleted cells 
The previous experiment had shown that MGM 100 lacI::TnlO did not show a 
decrease in IacZ expression as the intracellular levels of GroE decreased. To 
determine conclusively that this result was due to the absence of Lacl a similar 
experiment was conducted in a lacT strain. By growing MGM100 in the constant 
presence of I mM IPTG, the lac operon should always be induced, and then the level 
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Fig. 4.5:1 3-galactosidase activity in MGM 100 grown in buffered LB + glucose, 
DAP (GroE) and iniM IPTG or ara, DAP (GroE) and 1mM IPTG. An overnight 
culture was diluted 1: 100 in to buffered LB containing ara and IPTG (0.1 mM), the 
cells were grown to 0D600  0.2, 1 ml of culture was centrifuged, the supernatant was 
removed and the cell pellet was resuspended in 10 ml buffered LB + ara and IPTG 
(0.1mM) or glu, DAP and IPTG (0.1mM).This was time=0. Samples were taken 
every 30 minutes during growth and 3-galactosidase activity determined. 
MGM 100 was grown as described in section 4.4 except that tetracycline was 
omitted and 1 mM IPTG was added to the buffered LB (including the overnight 
culture). The results of this experiment are shown in figure 4.5.1. The 3-
galactosidase results clearly show that as GroE levels decreased, so did LacZ 
expression. By comparing the results of this experiment to the result obtained in the 
previous experiment, it is observed that in a LacI strain, as GroE depletes, so does 
lacZ expression; but in a LacY strain, lacZ expression is unaffected by GroE 
depletion. Therefore it can be concluded that Lacl is affected by GroE depletion such 
that it remains bound to LacO in the presence of IPTG. 
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4.6 Footprint analysis of Lacl in GroE depleted cells 
To prove conclusively that Lacl remained bound to LacO when inducer was 
present it was necessary to 'footprint' the protein DNA complex in vivo. The 
technique of primer extension footprinting analysis (Gralla, 1985) has been used for 
examining protein-DNA interactions in vivo on both plasmid (Sasse-Dwight et al, 
1989) and genomic DNA (Sasse-Dwight et al, 1990) in different bacteria (Morett et 
al, 1988). 
The protocol involves three major steps. First, the DNA is covalently 
modified with an attacking reagent [in this case dimethyl sulfate (DMS)]. Next, the 
modified DNA is isolated and broken at the sites of modification. Third, the break 
points are detected by primer extension procedures. in the primer extension a specific 
32  end-labelled synthetic oligonucleotide is hybridised to the modified template 
DNA and extended with a DNA polymerase. The resulting extension products, which 
all have the same 32P end-labelled 5' end and a 3' end that varies according to the 
position of the template modification at which the primer extension is inhibited, are 
analysed on a DNA sequencing gel. 
If the original modification took place on protein-bound DNA, the attacking 
reagent may have had altered access to the DNA. in the simplest case this results in a 
'protected' band on the gel autoradiograph compared to a lane in which the protein 
was not present. The interpretation is just as in conventional footprinting techniques 
that involve using end-labelled template DNA rather than end-labelled primer 
(Church et al, 1984; Galas et al, 1978). 
4.7 Construction of pJF118LacZ 
While in vivo footprinting can be carried out on either chromosomal or 
plasmid DNA in E. coli, plasmid DNA was chosen for ease of extraction, handling 
and because the sequence of interest to be footprinted is enriched relative to other 
sequences. The plasmid pJF 11 8(EH) which contains a tac promoter also has lacIQ on 
the plasmid, this would provide a higher LacI:LacO ratio than a plasmid binding 
Lacl originating from the chromosome, and should therefore increase the sensitivity 
of the footprint. 
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While pJF 11 8(EH) contains a tac rather than lac promoter, it still contains the 
LacO operator region and is therefore suitable for use in footprinting the Lad 
binding site. Also, since the tac promoter is a fusion of the —10 region of the lacUV5 
promoter and the —35 region of the trp promoter (Amann et al, 1983), it no longer 
contained the CAP-cAMP binding site, so this could be excluded from affecting 
promoter expression in GroE depleted cells. To determine if the tac promoter was 
affected by GroE depletion in a similar manner to the lac promoter, lacZ was inserted 
into the multiple cloning site of pJFll8(EH). A 4.0kb lacZ fragment had been cut 
from pRS55 I using the Smal and SnaBI restriction enzyme sites; it had then been 
ligated into the unique Smal site of pBAD18. The Smal site of pBAD18 is in the 
multiple cloning site between an upstream EcoRI site and a downstream HindIII site. 
To construct pJF 11 8LacZ, the 4kb lacZ fragment was cut out of pBAD 18 using the 
EcoRI and HindJII sites and cloned into the EcoRI and HindIII sites of pJF 11 8(EH) 
(Fig 4.7.1.). The ligated DNA was transformed into TP8503, a AlacZ strain, and 
colonies were screened on LB plates containing X-gal, IPTG and Amp. Plasmid 
DNA was extracted from blue colonies, those containing lacZ under the Ptac 
promoter, and used to transform MGM 100, and the transformed colonies being 




Fig. 4.7.1 pJF118LacZ. The 4kb fragment of lacZ from pBADLacZ was cloned into 
the EcoRI and HindIII sites of pJF 11 8(EH). 
MGM 100 pJF1 l8LacZ was grown as per the conditions in section 4.4 except 
tetracycline was replaced by Amp. Also IPTG, 1mM, was added at 5.5 hours after 
the initial 1/10 dilution, with samples being taken before and after IPTG addition to 
use in a 3-galactosidase assay. The results of the assay are shown in figure 4.7.2. 
This data shows that the tac promoter behaves similarly to the lac promoter when 
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Fig. 4.7.2. 3-galactosidase results of MGM 100 pJF118LacZ grown in buffered LB + 
ara, ampicillin, DAP or glucose, ampicillin, DAP. An overnight culture was diluted 
1:100 in to buffered LB containing ara and amp, the cells were grown to 0D600 0.2, 1 
ml of culture was centrifuged, the supernatant was removed and the cell pellet was 
resuspended in 10 ml buffered LB + ara, amp and DAP or glu, amp and DAP (this 
was time=rO). The IPTG+ cultures were induced with 1mM of IPTG at 5.5 hours. 
4.7.1 The lac operon is not affected by stationaiy phase growth 
As MGM 100 becomes GroE depleted, the generation time of the cells 
increase; consequently when the lac operon is induced with IPTG, the cells at that 
time have a different growth rate than GroE cells (chapter 3.1). While the lac operon 
is not known to be affected by growth rate, there was the possibility that this may be 
what was causing the observed differences in induction of lacZ. 
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Fig. 4.7.3 MGM100 grown in LB + ara (GroE) had 1mM IPTG added when the 
cells were either in logarithmic growth or stationary phase, and the level of LacZ was 
determined. The X-axis of the graph represents time before and after IPTG addition. 
Both samples have a similar level of induction, showing that the lac operon is 
unaffected by growth rate.  
To determine if the lac operon of cells entering stationary phase growth had a 
different response to IPTG than cells in logarithmic growth, MGM 100 was grown in 
LB + ara (GroE) to either mid-log (0D600  - 0.2) or early stationary phase (0D600 
1.5) and then imIVI IPTG was added. Samples were taken for 30 minutes before and 
after the addition of IPTG for use in a 3-galactosidase assay. Figure 4.7.3 shows the 
results of the 3-galactosidase assay. These results show that the lac operon is 
unaffected by growth rate, and therefore the decreased levels of expression from the 
lac promoter observed in GroE depleted cells must be caused by GroE depletion. 
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Fig. 4.8.1 LacO DNA sequence with summary of footprint information. The 
sequence is numbered relative to the position of the transcription start site (+I). Bold 
lettering delineates DNA methylation protection in the presence of Lad. 
4.8 Footprint analysis of LacO 
The operator of the lac operon was originally identified from cis-acting 
constitutive (o) mutants (Jacob et a!, 1961a). A 27 bp DNA fragment, which 
encompasses these 0'  mutants and is protected from deoxyribonuclease digestion by 
bound lac repressor, is centred 11 bp downstream from the start of transcription of 
the lacZ gene (Gilbert et al, 1973). This operator has an axis of approximate dyad 
symmetry, a feature common to many transcriptional regulatory sites (fig. 4.8.1). 
Sites within the operator DNA sequence affected by or influencing Lacl binding 
have been identified by a variety of studies using methylation, ethylation, nuclease 
digestion, photochemical cross-linking, and base substitution (Wick et al, 1991; 
Barbier et a!, 1984; Shalloway et a!, 1980). In addition to the principal operator 
LacO, the lac operon has two auxiliary operators 02 and 03, which were discovered 
after the lac repressor was isolated and its operator DNA was sequenced (Gilbert, 
1975). The centre of the second operator, 02, is located 401 bp downstream from the 
primary operator in the lacZ gene. The third operator, 03, overlaps the COOH-
terminal coding sequence for the lacl gene and is centred 91 bp upstream from LacO 
(Table 4.8.1). All three operators are required for maximum repression in vivo 
(Oehler et al, 1990). 
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Operator 	 Sequence (5'-3') 	 Location 
LacO AATTGTGAGCGGATAACAATT 	+1 
02 	 AAATGTGAGCGAGTAACAACC 	-93 PI, -250 
pJF 118 
03 	 GGCAGTGAGCGCAACGCAATT +401 P,,,, +401 
pJF 118 
Table 4.8.1. Sequences of the lac operator, LacO and the pseudo operators 02 and 
03 aligned with the centre of each operator in the lac operon in bold type. Bases 
listed with capital letters are identical to the bases in the primary operator LacO. 
Locations are given relative to LacO in either the chromosomal lac operon; PI, or in 
the plasmid pJF1 18LacZ; pJF 1 18.  
To determine if Lacl remained bound to LacO in the presence of inducer in 
GroE depleted cells, methylation protection footprinting was performed on the 
plasmid pJFl l8LacZ in MGM100. A synthetic oligonucleotide, JFI l8Lac 
('GCGCCGACATCATAACGGTT3 ), was designed which was located 59 bp 
upstream of the +1 site in the LacO sequence and was complementary to the 
'bottom' strand. The oligonucleotide was labelled with [y-32P] ATP using the T4 
polynucleotide kinase reaction as described in materials and methods. 
The MGM100 pJF118LacZ samples used to produce the -galactosidase 
results in figure 4.7.2 had DMS added to a concentration of 10 1iiM after the 15 
minutes incubation with IPTG. A DMS concentration of 10mM for 3 minutes at 
37°C had been show to result in the methylation of less than 1 purine per DNA 
strand (Ogata et al, 1979). The culture was left with constant agitation at 37°C for 3 
minutes, and then transferred to a chilled universal tube and centrifuged for 5 
minutes in a chilled rotor at 1500 x g The supernatant was discarded and the DMS 
modified plasmid DNA extracted according to the protocol given in material and 
methods. 
DMS is capable of penetrating the bacterial cell and modifies the DNA is such 
a way that the modifications can be made to serve as blocking sites for extension by 
a DNA copying enzyme. Specifically, DMS modifies, among other sites, the N-7 
position of guanine residues. When treated appropriately with piperidine, the DNA 
strand becomes susceptible to cleavage at these modified guanine residues and this 
break serves as a block to the DNA copying enzyme during primer extension. 
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The plasmid DNA was resuspended in 100 i1 of 1.OM piperidine and cleaved 
at 90°C for 30 minutes as described by Maxam and Gilbert (Maxam et al, 1977). The 
I M piperidine was evaporated in a DNA speed vac 110 (Savant) and the cleaved 
DNA fragments washed twice with 50 l of water, before being suspended in a final 
volume of 50 1 of water. 
4.9 Primer extension on the PL, promoter 
The primer extension footprinting technique used was a modification of the 
polymerase chain reaction. This technique amplifies band signal by allowing 
multiple rounds of extension and permits the extension to occur at a higher 
temperature, thereby minimising non-specific hybridisation. It is equivalent to PCR 
except that only one primer is added to the reaction mix. The primer, JF1 18Lac, 
since it is complementary to the 'bottom' strand of the plasmid pJF118LacZ would 
reveal extension termination events in the bottom strand of the LacO operator DNA. 
The primer extension reaction was performed as per the PCR protocol given in 
materials and methods. 1.5 tl of the primer JFI l8Lac (10 pmol p1') was added and 
the reaction was then cycled for 20 rounds of 94°C for 10 seconds, 59°C for 30 
seconds and extension temperature of 68°C for 30 seconds, before a final single 
round of extension for 10 minutes. The PCR mix was then passed through a 
Sephadex G-25 column (Amersham Pharmacia) and evaporated in a speed vac. The 
DNA pellet was resuspended vigorously in 5 l of Sequenase stop solution and 2 p1 
was loaded onto a 6% sequencing gel (following the protocol in material and 
methods). The gel was run at 50 Watts until the bromophenol blue dye front reached 
the bottom of the gel. The gel was then dried and exposed to X-ray film overnight. A 
manual sequencing reaction of the plasmid pJF 11 8LacZ using unlabelled primer 
JF 11 8Lac was also run on the same gel so that the appropriate bands could be 
identified. The results of the primer extension are shown in figure 4.9.1. The lettering 
down the right hand side of figure 4.9.1 corresponds to the bottom strand of figure 
4.8.1 and indicates bases where an extension termination reaction has occurred, i.e. 
where a base has been modified by DMS. The bold G represents the guanine residue 
in the bottom strand of the LacO region, which is protected from methylation when 
Lacl is bound. Lanes I and 3, corresponding to GroE and GroF cells without IPTG 
added, show full protection of the guanine at +17 bp. This protection makes the 
residue unavailable for modification by DMS, consequently there is no cleavage by 
piperidine and no extension terminating reaction occurs, so a band is not present on 
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the gel. This shows that in the absence of IPTG, Lacl is bound to LacO in both 
GroE and GroE cells. Lane 2 is from GroE cells with IPTG added, here Lacl is no 
longer occupying LacO and so the guanine at +17 bp can be modified by DMS, 
cleaved by piperidine and an extension termination reaction will occur causing a 
band to appear on the gel. Lane 4 corresponds to GroF cells with IPTG added, in 
this sample there is a small deprotection of the guanine residue at +17 bp, but it is 
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Fig. 4.9.1 Result of the primer extension reaction on pJF118LacZ in MGM 100. Lane 
1 is GroE IPTG-, lane 2 is GroE IPTG+, lane 3 is GroE IPTG- and lane 4 is GroE 
IPTG+. The lettering down the right hand side of the picture corresponds to the base 
where the termination reaction has occurred and also corresponds to the bottom 
strand of figure 4.8.1. 
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To resolve any errors that may have been caused by loading differences on the 
gel or different amounts of template DNA used in the primer extension reaction, a 
control band was chosen, the DMS modification of which is not affected by Lad, in 
this case the guanine at +23 bp, and the ratio of the intensity of guanine 17 to 
guanine 23 determined for both the GroE and GroE samples (the bases GlO and 
T24 are both affected by Lacl binding (Matthews et a!, 1998) and were therefore not 
suitable for use as control bands). 
The results of this area integration are shown in figure 4.9.2. The baseline for 
these graphs can be determined in one of two ways, using either a baseline of best fit 
(solid line) or a lowest value baseline (dotted line). Though using either baseline 
gives approximately the same peak-to-peak ratio. For the purposes of this analysis, 
the lowest point baseline was used. For the GroE sample with IPTG present, the 
area of peak G 23 is 4928 (arbitrary units) and the area of peak G 17 is 3619, giving 
a ratio of G17:G23 of 0.73. For The GroE sample with IPTG present, the area of 
peak G 23 is 4819 and the area of peak G 17 is 856, giving a Gl7:G23 ratio of 0.18. 
Therefore the percentage deprotection of the guanine 17 for the GroE compared to 
the GroE sample is 24.7%. (Using a best-fit baseline this value is 23%). From this 
data it can be concluded that in a GroE cell, in the presence of 1mM IPTG, only 






















Fig. 4.9.2 Intensities of bands in figure 4.4.4 in GroE and GroE samples incubated 
with 1mM IPTG for 15 minutes. G 23 and G 17 represent the intensity of the bands 
on figure 4.4.4 representing guanines at 23 bp and 17 bp respectively 
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4.10 Summary and Discussion 
Initial experiments in the study of the lac promoter showed that lacZ was not 
expressed at the same level in GroE depleted cells as in GroE cells in the presence 
of the gratuitous inducer IPTG. Previous studies in this work had eliminated LacZ 
folding or function from being the cause of this problem as LacZ can be expressed 
from other, non-lac promoters in GroE depleted cells to the same level as in GroE 
cells. Therefore, the decreased level of expression of lacZ must have resulted from a 
decreased level of activity in the lac promoter. 
lac permease, encoded by the lacY gene is responsible for the transport of 
lactose across the E. coil membrane. IPTG can diffuse across the bacterial membrane 
to reach equilibrium with the external concentration, but LacY can also transport 
IPTG such that the internal concentration is 50 times higher than the external 
concentration. If LacY were affected by GroE depletion, for example not folding 
correctly and therefore being unable to transport IPTG across the membrane, then 
there may have been a reduced internal concentration of IPTG in GroE cells. If 
LacY was not transporting IPTG across the membrane then increasing the 
extracellular IPTG concentration to 50mM should have produced the same level of 
lacZ expression in a GroE cell as 1mM IPTG would produce in a GroE cell. 
Adding IPTG at 50 fold higher concentration did not affect lacZ expression in GroE 
depleted cells, and from this it was concluded that LacY did not seem to be the factor 
limiting expression. This could also be tested by measuring the uptake of 
radioactively labelled IPTG in a GroE strain. 
The other obvious protein, which might affect expression from the lac 
promoter, is the lac repressor protein: Lad. This protein binds to the lac operator 
sequence, LacO, preventing RNA polymerase from binding to the DNA and 
transcribing lac mRNA. In the presence of either 3-1 ,6-allolactose or IPTG, Lad 
undergoes a conformational change that causes it to have decreased affinity for 
LacO, such that RNA polymerase can now bind and transcription of lac mRNA 
proceed. If Lacl were affected by GroE depletion so that it did not have reduced 
affinity for LacO in the presence of IPTG, this might account for the reduced level of 
expression from a lac based promoter in GroE depleted cells. 
In MGM 100 a lacI::TnlO strain was constructed. This strain, regardless of the 
amount of GroE, constitutively expressed lacZ mRNA. In contrast LacZ expression 
decreased markedly in MGM 100 (lac[) depleted of GroE in the continual presence 
of IPTG. From these two experiments it was possible to deduce that Lacl was being 
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affected by GroE depletion and that it did not have reduced affinity for LacO when 
the inducer IPTG was present. 
To determine conclusively that Lacl remained bound to LacO in the presence 
of inducer, methylation protection footprinting was performed on the LacI-LacO 
complex. In this procedure a DNA methylating agent, DMS, is added to GroE7 cells 
in the presence/absence of IPTG. If Lacl is bound to LacO it will protect certain 
bases from methylation that would otherwise be methylated, these bases having been 
well characterised in previous works. The methylating agent is added at a 
concentration such that less than 1 purine per DNA molecule is modified. The 
modified DNA is then cleaved at the methylated bases and used as the template in a 
primer extension reaction. The resulting footprint, seen on the sequencing gel, 
represents bases that have been modified by DMS. If Lacl was bound to LacO then 
certain bases should have been protected from methylation and should be absent 
when compared to a sample where Lacl is disassociated from LacO. From the 
footprint we can clearly see that in a GroE depleted cell greater than 75% of Lad 
remains bound to LacO in the presence of IPTG. 
The main reason that DMS was used as the DNA modification reagent in this 
work is that the interaction between Lacl and LacO had been previously 
characterised using DMS footprinting, and thus the data on bases protected by Lad 
was readily available. The use of other DNA modification reagents to give a more 
detailed picture of bases affected by Lacl binding should not be ignored. For 
example, DMS modifies the N-7 position of guanine residues and potassium 
permanganate (KMn04) modifies primarily thymine and to a lesser extent cytosine 
residues (Hayatsu et al, 1967). In addition to these two chemicals, several enzymes 
have been used in primer extension footprinting. These include DNaseI (Buchanan et 
al, 1987; Zhang et al, 1990) and micrococcal nuclease (Zhang et al, 1989), which 
have different modes of cleavage and thus give complimentary information. They are 
not suitable for use in bacteria since they do not penetrate the cells, but have been 
used in primer extension protocols in vitro and in permeabilised mammalian cells 
(Zhang et al, 1989). 
A major limitation in this work has been the inability to perform the primer 
extension reaction on the top stand of LacO. While one base on the bottom strand of 
LacO is affected by the presence or absence of Lad, the top strand would have been 
preferable to use as the methylation states of 4 bases are affected (Fig. 4.8.1). 
Unfortunately the primer extension reaction failed to work on the top strand. 
Multiple primers were used with a variety of different binding sites and different 
T 1's, different polymerases were used as well as different primer extension 
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conditions, but none of these were able to overcome the problem. The primer used in 
this work, JF 11 8Lac, was complementary to a region of DNA upstream of LacO, but 
the primers complementary to the top strand of LacO bound downstream of it. In the 
plasmid pJF118LacZ there is a multiple cloning site just downstream of LacO and 
since most restriction enzyme sites display twofold symmetry it is possible that areas 
of secondary structure may have formed (DNA hairpins) in the multiple cloning site. 
If this were the case then it could explain why primer extension could not proceed on 
the top strand; the polymerase, upon reaching the area of secondary structure, would 
stall and extension would terminate. This hypothesis is consistent with the results 
observed upon probing the top strand, the sequencing gel showing primer extension 
products a short distance away from the primer, but then the absence of any more 
bands before the LacO site is reached. 
Further work on this subject would be to determine how Lacl is affected by 
GroE depletion, whether it is an indirect effect, i.e. is DNA structure altered in GroE 
depleted cells causing the 'off rate of Lael in the presence of IPTG to decrease, or is 
it a more direct effect, such as misfolding of Lacl protein. 
It is interesting to note that when Lacl was overproduced (plasmid 
pJF 11 8LacZ also has lac] on it, this carries a mutation in the lacl promoter region 
which causes an increased level of expression of lad) the expression of LacZ was 
not affected until much later into GroE depletion than when Lacl was present in 
single copy on the chromosome. In figure 4.2.1 IPTG is added to cells containing the 
chromosomal lac promoter at 120 minutes and there is a noticeable difference 
between LacZ expression in GroE and GroE cells. When this experiment is 
performed using the plasmid pJF1I8LacZ (Fig. 4.7.2) the IPTG is added at 330 
minutes to observe the same result, adding IPTG much before this time results in 
similar levels of LacZ expression in both GroE and GroE cells. There seem to be 
some parallels with the overproduction of Lacl prolonging the Lacl response to IPTG 
in GroE depleted cells and of DapA delaying lysis in GroE depleted cells (McLennan 
eta!, 1998). It may be possible that, like DapA, as an excess of Lacl is made when 
GroE is still present, it takes longer to reduce this intracellular pool of Lacl which 
has not been affected by GroE depletion, consequently the tad promoter would not be 
affected by GroE depletion until much later. 
The Lacl monomer has four functional units, an NI-12-terminal headpiece 
which binds specifically to the DNA, the hinge region, a sugar binding domain and a 
COOH-terminal helix, which is responsible for Lacl tetramer formation (Lewis et al, 
1996). Lacl binds to LacO as a dimer, with each NH2-terminal headpiece binding to 
one half of the palindromic LacO sequence, yet the fully functional lac repressor is a 
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tetramer. To achieve maximal repression of the lac operon requires three operators 
suggesting that the tetrameric form of the repressor is required for maintaining the 
physiology of the system. Removing LacO, 02 or 03 (Table 4.8.1) reduces the 
repression ratios by varying degrees (Oehler et al, 1990). A single lac repressor 
tetramer binds two operators that are separated by 401 bp or 93 bp in a lac promoter 
(401 bp and 250 bp in the plasmid pJF1 18 LacZ). Since the repressor tetramer 
binds two independent pieces of operator DNA, a continuous DNA must bend to 
form repression loops (Eismann et al, 1990; Flashner et al, 1988) (Fig. 4.10.1). 
The results observed when lac or tac promoters are induced in GroE depleted 
cells do not show a decreased level of repression, but rather an increased level of 
repression. This suggests Lacl is probably still present as a tetramer, is still forming a 
repression loop and that any possible misfolding is not affecting the COOH-terminal 
helix. 
DNA supercoiling is affected in groE strains (Murayama et al, 1996). It has 
also been reported that expression from the lac promoter is decreased in strains 
where DNA gyrase is inactive (Yung et al, 1979; Borowiec et al, 1979). While this 
may be a possible explanation for the decreased expression from PLac  in a GroE 
depleted cell it seems unlikely. DNA supercoiling affects expression from PL,,  by 
decreasing the affinity between RNA polymerase and the lac promoter, not by 
increasing the affinity of Lacl for the operator region. Also while changes in 
supercoiling may render certain bases in the lac promoter region more or less 
susceptible to modification by DMS, the base G17 has not been reported to be 
affected by supercoiling. This suggests that the change in methylation sensitivity of 
G 1 is due solely to the presence or absence of Lacl and thereby further suggests that 
the presence of Lacl and not the absence of RNA polymerase is responsible for the 
decreased expression from PL,,  in a GroE depleted cell plus IPTG. 
The three most plausible areas of Lacl which, if misfolded could cause the 
protein to become unresponsive to IPTG would be, (i) the DNA binding domain; a 
mutation in this domain might cause Lacl to remain irreversibly bound to LacO, (ii) 
the sugar binding domain; a mutation in this domain could cause Lacl to not interact 
with IPTG and consequently no conformational change would come about to cause 
Lacl to have reduced affinity for LacO or (iii) the hinge region; even if the sugar 
binding domain and the DNA binding domain were functional, without the hinge 
region there would be no 'communication' between either domain and thus Lacl may 
not respond to the presence of IPTG. 
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Fig. 4.5.1. Representation of Lacl tetramer bound to LacO and one pseudo operator. 
Lacl monomers are coloured red, light blue, green and bronze, with the COOH-
terminal helices, responsible for tetramer formation at the bottom of the picture. 
To determine if the Lacl DNA binding domain were misfolded in GroE 
depleted cells causing it to remain irreversibly bound to LacO, DNA footprinting 
could be performed. If Lacl was bound to the operator DNA in an altered 
conformation then it may also exhibit an altered DNA footprint. To confirm this a 
number of reagents would have to be used to probe the DNA. One advantage to 
using a variety of reagents is that each attacks the DNA differently and their joint use 
can give a very detailed picture of the DNA bound by the protein. For example, 
DNaseI cleavage occurs by attack through the DNA minor groove, DMS attacks 
guanines in the DNA major groove, micrococcal nuclease attacks exposed positions 
on the DNA backbone, and permanganate attacks melted DNA preferentially 
(Borowiec et a!, 1987; Zhang et al, 1990; Zhang et al, 1989). Therefore by 
comparing the footprint of LacO from GroE compared to GroE cells it may be 
possible to determine if the Lacl DNA binding domain is affected by GroE depletion. 
In conclusion, the isolation of Lacl from GroE depleted cells and the 
determination of its structure may extend our knowledge of potential GroE substrates 
in vivo, and further our understanding of the mechanisms involved in the regulation 
of the lac operon. 
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Chapter V 
Regulation of dapA expression 
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5.1 Introduction 
The dapA gene encodes dihydropicolinate synthetase (DHDPS, E.C. 
4.2.1.52), the first enzyme of the diaminopimelate and lysine pathway (Shedlarsky et 
al, 1970). It has been mapped to 55.8 minutes on the E. coli chromosome 
(Bachmann, 1983). DHDPS activity is sensitive to lysine inhibition (Yugari et al, 
1965) as is aspartokinase III, encoded by the lysC gene (Stadtman et a!, 1961), the 
first enzyme on the biosynthetic pathway leading from aspartate to diaminopimelate, 
lysine, methionine, threonine and isoleucine (Fig 5.1.1). The regulation of expression 
of several genes of the lysine regulon (Patte, 1983), including lysC (Stadtman et al, 
1961), asd (Boy et al, 1972), dapB (Losick et al, 1966), dapD (Richaud et al, 1984), 
dapE (Cohen et al, 1965), and lysA (Patte et al, 1962), has been studied either by 
directly measuring their gene products or by the use of lacZ or galK fusions. In 
contrast to all these genes, whose level of expression respond to lysine pool size, the 
synthesis of DHDPS has not been reported to be subject to any regulatory control 
(Butour et al, 1974; Bouvier et a!, 1984). 
The native DHDPS enzyme forms a homotetramer with a molecular weight of 
31,372 Da per monomer (Richaud et al, 1986; Shedlarsky et al, 1970). The amino 
acid sequence has been derived both from the nucleotide sequence and protein 
analysis (Laber et al, 1992). Also amino acid sequences of DHDPS of 
Corynebacterium glutamicum (Bonnassie et al, 1990), wheat (Kaneko et al, 1990) 
and maize (Frisch et al, 1991) have been published. In all of these cases, DHDPS is a 
homotetramer as well. In plants, the enzyme is competitively inhibited by low 
concentrations of the endproduct of the pathway, lysine, with 10.5  values ranging from 
0.01 to 0.05 mM (Perl et al, 1992; Shaul et al, 1993; Cheshire et al, 1975; Ghislain et 
al, 1990; Frisch et al, 1991; Dereppe et al, 1992; Kumpaisal et al, 1987). Bacterial 
DHDPS is inhibited to a much lesser extent with an 105 value of 1.0 mM (Laber et al, 
1992). 
In this chapter, work is described which suggests that the gene dapA is 
regulated at the level of transcription or translation and that the expression of dapA is 
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Fig. 5.1.1 The biosynthetic pathway from oxaloacetate to lysine, threonine, 
methionine and isoleucine. The product of the lysC gene is aspartokinase III; asd: 
aspartate semialdehyde dehydrogenase; dapA: dihydropicolinate synthetase; dapB: 
dihydropicolinate reductase; dapD: tetrahydropicolinate succinylase; dapC: succinyl 
diaminopimelate aminotransferase; dapE: succinyl diaminopimelate desuccinylase; 
dapF diaminopimelate epimerase; lysA: diaminopimelate decarboxylase; murE: 
UDP-N-acetyl-muramoylalnyl-D-glutamate-2,6-diaminopimelate ligase; thrA: 
homoserine dehydrogenase I; metL: homoserine dehydrogenase II. 
5.2 Increased dapA expression in GroE depleted E. coli 
Using the strain MGMl002PdapA-1acZ it was previously observed that, just 
before lysis caused by GroE depletion, expression of LacZ under the control of the 
dapA promoter increased in cells growing in LB (N. McLennan, pers. comm.). The 
level of expression of LacZ from the dapA promoter in a GroE strain is 300 Miller 
units, while from a GroE- strain just before lysis it is 	650 Miller units. This 
suggests that, contrary to previous observation, dapA is regulated at the level of 
expression and that there is increased transcription or translation of DapA in GroE 
depleted cells. 
Since it was known that in GroE depleted cells, the enzyme DapA had little 
activity, the first step was to determine if dapA expression was autoregulated. 
A P1 lysate was made using MGM100AdapA as the donor. This lysate was 
then used to transduce MGM100XPdapAIacZ. Transductants were selected on 
minimal media plates + Cmp and DAP. Those colonies which were Kan 
R,  Cmp' and 
required both ara and DAP for growth on minimal medium (MGM100AdapAXPdaPA-
lacZ) were then re-streaked on suitable plates or frozen for later use. 
The strain MGM 100AdapA?PdapA-lacZ was grown in minimal medium, 
casamino acids (CAA), ara and DAP; these conditions resulted in a GroE, dapA 
strain. MGM 100?PdapA /acZ was grown both under these conditions and also in the 
absence of DAP. The strains were grown overnight at 37°C with constant agitation 
and then diluted 1:100 into fresh medium the next day. The cells were grown in a 
37°C water bath with shaking until the 0D600 reached 0.2, samples were then taken 
and used to determine the j3-galactosidase activity. The results of five repeats of this 
experiment are shown in Table 5.2.1. 
The results show that in all cases 3-galactosidase activity and hence dapA 
promoter activity remains approximately the same. This would indicate that dapA 
expression is not autoregulatory, as a dapA strain has the same level of expression 
from PdapA as a dapA strain. 
In the following experiments, MG1655 could have been used instead of 
MGM 100, but since the initial observations regarding dapA expression were made in 
MGM 100, this strain was used. 
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Miller Miller Miller Miller Miller Average 
Units Units Units Units Units Miller 
#1 	#2 	#3 	#4 	#5 	Units 




MGM100AdapA dapA Yes 
2PdapA-IaCZ 
MGM 100 dapA Yes 
?PdapA-laCZ 
MGM 100 dapA No 
&Pda pAlacZ 
388 	361 	379 	365 	378 
	
374.2 
385 	345 	360 	366 	379 
	
367 
382 424 386 404 388 1396.8 
Table 5.2.1 Miller units representing the level of -ga1actosidase activity from 
2PdapAlacZ in either a dapA or dapA strain of MGM 100 grown under various 
conditions. The strains were grown in minimal medium until 0D600 - 0.2 and 
samples were taken to determine 3-galactosidase activity. The experiment was 
repeated 5 times. Since all samples have a similar level of expression from PdapA  this 
suggests that dapA expression is not autoregulatory. 
5.3 dapA expression is regulated by a downstream product 
The data above shows that dapA is not autoregulated, but it was possible that 
dapA expression may be regulated by a downstream product. Since lysine levels 
were known not to affect dapA expression (Bouvier et al, 1984) the next compound 
to check was rneso-diaminopimelate (DAP). DAP is at the branch-point of the lysine 
biosynthetic pathway which leads either to lysine or to incorporation into the cell 
wall by MurE, and therefore would be a possible regulatory compound. In the 
previous experiments all the cells contained DAP, either from an extracellular source 
or because they could synthesise it (MGM 100AdapAXPdapA-lacZ requires the 
presence of DAP to grow and MGM 1 0OkPdapAlacZ is a dapA strain and therefore 
will produce DAP). Therefore if DAP does regulate dapA expression it is not 
surprising that the previous samples had a similar level of expression from PdapA. 
To test this hypothesis it was necessary to grow a dapA mutant without DAP. 
This is problematic as cells grown under these conditions will lyse as they cannot 
make peptidoglycan (the result observed in GroE depleted cells). To overcome this 
problem the cells were grown in osmotically protected medium (medium containing 
10 MM M9SO4), which prevents the cells from lysing (Heijenoort, 1996). 
The strain MGM 100AdapA2PdapA-/acZ was grown as described in section 5.2, 
except that when the cells reached an 0D600 of 0.2, 1 ml of culture was removed, 
centrifuged and the supernatant removed. The cell pellet was then resuspended in 10 
ml of minimal medium, CAA, with 10 MM MgSO4, ara and DAP or just 10 mM 
MgSO4  and ara (this was time=0). Samples were then taken every 10 minutes and 13-
galactosidase activity determined. 
The results (Fig. 5.3. 1) show that expression of LacZ from PdapA increases in 
the strain MGM100AdapA2PdapA-lacZ when extracellular DAP is removed, while 
expression from PdapA  remains unaffected when extracellular DAP is present. These 
results were explained by the hypothesis that DAP regulates expression from the 
promoter PdapA.  In MGM100AdapAXPdapA-lacZ, intracellular DAP levels decrease 
when DAP is removed from the medium. As the strain is dapA and cannot synthesise 
DAP, the intracellular 'pool' of DAP is exhausted as it is incorporated into the 
peptidoglycan cell wall; the decreasing levels of DAP therefore lead to an increase in 
the level of expression from the promoter PdapA.  If DAP is supplied in the medium it 
is transported inside the cell and therefore intracellular DAP levels do not decrease 















Fig. 5.3.1 -galactosidase activity in MGM IOOAdapAXPdapA-lacZ growing in 
osmotically protected minimal medium, CAA, ara with (DAP+) or without (DAP-) 
DAP. The strain was grown in minimal medium, CAA, ara and DAP and then 
centrifuged, the supernatant removed and the cells resuspended in osmotically 
protected minimal medium + ara and DAP or just ara (this was time=0). As the 
intracellular levels of DAP fall in the strain grown without DAP, expression from 
increases. 
5.4 Lysine levels also affect expression from PdapA 
The previous data suggests that the intracellular levels of the lysine precursor 
DAP regulates expression from PdapA. The reason therefore that expression from 
PdapA increases in GroE depleted cells was that as DapA was not functional (see 
chapter 3), DAP was not synthesised, and consequently intracellular levels of free 
DAP decreased as it was incorporated into peptidoglycan (if DAP was supplied in 
170 
the medium, increased expression from PdapA was not observed during GroE 
depletion). 
In all the experiments up until this point lysine has also been present in the 
medium, and therefore intracellular DAP was only needed for peptidoglycan 
synthesis. If lysine were missing from the medium, then intracellular DAP levels 
would be reduced more quickly as it would be both incorporated into peptidoglycan 
and used to synthesise lysine. 
The strain MGM 100AdapA ?PdapA lacZ was grown as described in section 5.3, 
except that instead of minimal medium and CAA, the cells were grown in minimal 
medium and SCAA —Lys (see chapter 6). This is a synthetic medium that contains 
the same levels of each amino acid as would be supplied using casamino acids except 
that it has no lysine. 
When the cells were grown in this medium in the absence of DAP, there was 
a great increase in the level of LacZ, thereby showing a great increase in the level of 
expression from PdapA (Fig 5.4.1). In the graph, 3-galactosidase results from 
MGM 1 OOtxdapA?PdapA-lacZ grown in osmotically protected minimal medium, CAA 
and ara have been included so that a comparison can be made between the - 
galactosidase levels in a strain with either low intracellular DAP levels or low 
intracellular DAP and lysine levels. The results show quite clearly that when 
extracellular lysine and DAP are removed, there is a much greater level of expression 
from PdapA.  This can be explained by the fact that the intracellular pool of DAP is 
required for both the synthesis of lysine and incorporation into peptidoglycan, 
therefore intracellular DAP levels fall more quickly than when it is required for 
peptidoglycan synthesis alone and consequently PdapA is more rapidly affected. 
To show that lysine itself does not affect expression from PdapA  a version of 
MGM 1OO?PdapA JacZ was constructed which had a mutation in lysA. A P1 lysate was 
made using the strain ET505 (lysA::TnlO) as a donor. The P1 lysate was then used to 
transduce MGM 1 OOXPdapA lacZ. Transductants were selected on appropriate plates 
containing Tet. 
The strain MGM 1001ysA&PciapAlacZ is dapA but lysA. If the strain is grown 
in medium without lysine it will be able to synthesise DAP but not lysine (and as the 
internal reserve of lysine is depleted, intracellular lysine levels will decrease). If 
lysine levels are affecting expression from PdapA  then the strain should produce 
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Fig. 5.4.1 J3-galactosidase activity in MGM 100/\dapA?PdapA-lacZ growing in 
osmotically protected minimal medium, CAA and ara (DAP-, Lys+) or osmotically 
protected minimal medium, SCAA —Lys, ara with (DAP+, Lys-) or without (DAP-, 
Lys-) DAP. The strain was grown in minimal medium, CAA, ara and DAP and then 
centrifuged, the supernatant removed and the cells resuspended in the above media 
(this was time=0). When intracellular levels of both lysine and DAP are decreased 
there is a large increase in expression from PdapA.  
MGM 100lySA?PdapAlaCZ was grown overnight in minimal medium, CAA, 
ara, Kan and Tet at 37°C with constant agitation. The following day the culture was 
diluted 1:100 into 10 ml of fresh medium and grown at 37°C with constant agitation 
until the 0D600 was 	0.2. 1 ml of culture was removed, centrifuged and the 
supernatant was removed. The cell pellet was then resuspended in either 10 ml of 








Fig. 5.4.2 f3-galactosidase activity in MGM 1001ySA&PdapAlaCZ growing in 
osmotically protected minimal medium, ara and either CAA (Lys+) or SCAA —Lys 
(Lys-). The strain was grown in minimal medium, CAA and ara and then 
centrifuged, the supernatant removed and the cells resuspended in the above media 
(this was time=O). When intracellular levels of lysine are depleted there is no 
increased expression from PdapA,  confirming that lysine does not affect PdapA 
The results (Fig. 5.4.2) show that when lysine is removed there is no 
increased expression from PdapA.  This result confirms prior observations that 
intracellular levels of lysine do not regulate expression from PdapA. 
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5.5 Growth rate does not affect PdapA 
During the course of the previous experiments, it was observed that growth 
rate during the different growth conditions varied greatly. When 
MGMlOOAdapA?PdapA-/acZ was grown in the presence of DAP it had a similar 
growth rate as MGM 100 2Pda pA-lacZ and it also displayed a similar level of 
expression from PdipA.  But when MGM10OAdapA2PdapA-lacZ was grown in the 
absence of DAP, it had a much slower growth rate (eventually the cells formed 
spheroplasts and stopped growing) and a higher level of expression from PdapA (this 
is summarised in Table 5.5.1). Since MGM 100 depleted of GroE slows down just 
before lysis (see chapter 3.1), it was necessary to determine if growth rate affected 
expression from PdapA. 
A P1 lysate was made using the strain CAG18442 (thrA::TnlO) as a donor. 
The P1 lysate was then used to transduce MGM1OOkPdapA1acZ. Transductants 
(MGM 10OthrA?PdapA-lacZ) were selected on appropriate plates containing Tet. 
When MGM 1 00thrA2PdapA-lacZ is grown in minimal medium SCAA —Thr 
(see chapter 6) it hardly grows at all (any growth is probably due to intracellular 
stores of threonine), without affecting intracellular levels of DAP. If growth rate, and 
not DAP, were actually regulating expression from PdapA  then there should be an 
increase in -galactosidase levels under these conditions. 
MGM 100thrA2Pda pA-lacZ was grown under the conditions described in 
section 5.4 (except using SCAA —Thr not SCAA —Lys). The growth curves of 
MGM 100AthrAXPdapA-/acZ in the presence and absence of threonine can be seen in 
figure 5.5.1 and the results of the 3-galactosidase assay can be seen in figure 5.5.2. 
Growth Conditions 	I 	Growth Rate 
	
Expression from Pd, 
DapA, DAP+ + 	 + 
DapA, DAP+ 	 + + 
DapA, DAP- 	 + 	 + 
DapA, DAP- - ++ 
DapA, DAP-, Lys-  
Table 5.5.1 Summary of growth rates and expression from PdapA under the various 
conditions used. A + sign represents a 'normal' level of growth or expression, 
multiple + signs represent increased levels and - signs represent decreased levels. 
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.-v- SCAA -Thr 
Fig. 5.5.1 Growth rates of MGM 100thrAXPdapA-lacZ growing in osmotically 
protected minimal medium, ara and either CAA or SCAA —Thr. The strain was 
grown in minimal medium, CAA and ara and then centrifuged, the supernatant 
removed and the cells resuspended in the above media (this was time0). For clarity, 
when the cells have been diluted 1:10 (delineated by the arrow) the OD has been 
multiplied by 10 and plotted on the graph. 
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Fig. 5.5.2 -gaIactosidase activity in MGM100thrAXPdapA-lacZ growing in 
osmotically protected minimal medium, ara and either CAA or SCAA —Thr. The 
strain was grown in minimal medium, CAA and ara and then centrifuged, the 
supernatant removed and the cells resuspended in the above media (this was time=O). 
When growth rate decreases (SCAA —Thr) there is no increased expression from 
PdaDA, confirming that growth rate does not affect PdapA  expression. 
These results clearly show that even when growth rate is dramatically 
decreased, there is no increase in the level of expression from PdapA,  thereby showing 
that PdapA  is not regulated by growth rate, and is indeed regulated by intracellular 
levels of DAP. 
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5.6 Construction of MGM10OMapA?RSPD72 
Since it had now been determined that DAP regulates expression from PdapA it 
was necessary to determine the method of regulation. The construct MGM lOOXPdapA 
lacZ was constructed using 1 kb of DNA upstream of dapA ATG (this DNA 
included the entire coding sequence for the upstream gene gcvR). It was hypothesised 
that PdapA  was being regulated by a transcription factor (either an activator or 
repressor) which was itself affected either directly or indirectly by the intracellular 
levels of DAP. To determine the binding site for this hypothetical transcription factor 
it was necessary to construct a new ?PdapA lacZ reporter in MGM 100 using much 
less upstream DNA. By steadily decreasing the amount of upstream DNA, and then 
observing the point at which expression of lacZ is unaffected by DAP levels, a 
putative binding site could be found. 
It was decided that the first construct should contain the least amount of 
upstream DNA that still included the ribosome-binding site and polymerase-binding 
sites. Two primers were designed, AP  and AP3, which would produce a 79 bp piece 
of DNA upstream of the dapA ATG. These primers would also introduce a 5' EcoRI 
and a 3' BamHI site into the DNA fragment. 
AP 1: 
5' GGGGATCCTCTGTGCAAACA 3' 
BamH I 
AP3: 
5' ATOAGAAGAATTCTGTCTGC 3' 
EcoRI 
When these primers were used in a PCR using chromosomal DNA as a 
template, the final product was an 81 bp fragment of DNA which had the following 
sequence: 
5' ATCAGAAGAATTCTGTCTGCTTGCTTTTAATGCCATACCAAACGTACCATTGAGA 
EcoRI 	 —35 	 —10 
CACTTGTTTGCACAGAGGATCCCC 3' 
mRNA 	RBS BamFil 
start site 
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The PCR was performed using an extension time of 30 seconds with MG1655 
chromosomal DNA as the template. The PCR product (79 bp) was run on a 1.5% 
agarose gel, extracted using the 3-agarase method and sub-cloned into pGEM-T. The 
construct was transformed into TOP-10 competent cells and plated on LB + Amp + 
X-gal, and screened for blue or white colonies. In theory, since the cloning into 
pGEM-T disrupts the lacZ gene, constructs containing the 79 bp fragment should not 
be able to hydrolyse X-gal and should produce white colonies. In this case it was 
found that the small insert did not disrupt the lacZ gene, and correct constructs 
resulted in blue colonies. 
Three blue colonies were obtained, the plasmid DNA was extracted and 
subjected to restriction analysis to determine if the construct was correct. One 
plasmid bearing the correct construct was found (the others lacked inserts). The 
fragment was released from the plasmid by digesting with the restriction enzymes 
EcoRI and BamHI. The fragment was then ligated to pRS55I, which had also been 
cut with EcoRl and BamHI. This produced the plasmid pRS551-PD72 (Fig. 5.6.1). 
This plasmid now has lacZ expression under the control of 70 bp of dapA promoter 
DNA. 
pRS551-PD72 was transformed into NM6212RS45. The ?RS45 contains the 
genes lacA, lacY, lacZ and the 5' terminal half of bla (Simons et a!, 1987). This 
allows homologous recombination to occur with the plasmid pRS55I between bla 
and lacA. If a double crossover occurs between bla and lacZ-lacA then the 2 will 
now carry both the KanR  cassette and lacZ under the control of 70 bp of dapA 
promoter DNA. 
The strain NM629RS45 pRS551-PD72 was grown overnight in LB + Kan 
(to allow recombination to occur) at 37°C with constant agitation. The following day 
a X lysate was made (by UV induction) using the protocol described in materials and 
methods. 
The ? lysate was then used to lysogenise MG 1655. Lysogens were selected on 
LB plates containing Kan, and were later screened for Amps. Any colonies that were 
KanR and Amps  were then transduced with a P1 lysate made from MGM 100. Since 
the PBA DgI0ESL in MGM 100 is linked to a KanR  cassette it could not be selected 
with antibiotic resistance; therefore transductants were selected for their ability to 
grow on LB containing arabinose but not glucose. 
The resultant strain (MGM1002cRSPD72) was then transduced with a P1 
lysate made from MG1655AdapA. Transductants were selected on plates containing 
Kan, Cmp and ara. 
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EcoRl 
Fig. 5.6.1 The plasmid pRS551-PD72. A 70 bp fragment of DNA upstream of the 
dapA initiation codon (PD70) was cloned into the EcoRI and BamHI sites of the 
plasmid pRS551. 
The final strain (MGM10OAdapA2RSPD72) was tested to see if lacZ 
expression was affected by intracellular levels of DAP. The strain was grown as 
described in section 5.3. The results (Fig. 5.6.2) show that when intracellular levels 
of DAP decrease, expression of lacZ from PdapA increases. This then indicates that 
the putative transcription factor-binding site is within this 70 bp region of dapA 
promoter DNA (PdapA70). 
A computer analysis was run on the 70 bp DNA sequence to determine if any 
common transcription factor binding sequences were present. None were found. Nor 











Fig. 5.6.2 J3-galactosidase activity in MGM100AdapAXRSPD72 growing in 
osmotically protected minimal medium, CAA, ara with (DAP+) or without (DAP-) 
DAP. The strain was grown in minimal medium, CAA, ara and DAP and then 
centrifuged, the supernatant removed and the cells resuspended in osmotically 
protected minimal medium + ara and DAP or just ara (this was timeO). As the 
intracellular levels of DAP fall in the strain grown without DAP, expression from 
PdanA70 increases.  
5.7 Attempts to characterise hypothetical transcription factor 
It was important to discover if the hypothetical transcription factor regulating 
PdapA was a repressor or inhibitor. It was known that when intracellular levels of 
DAP decreased, expression from PdapA increased, but when excess DAP was present 
expression did not decrease past a basal level; a dapA strain grown with or without 
extracellular DAP has the same level of lacZ expression (see Table 5.2.1). 
The strain MGMI00AdapAARSPD72 was grown as described in section 5.3, 
and after 60 minutes, DAP was added to the DAP- medium. The results (Fig 5.7.1) 
show that as intracellular levels of DAP begin to increase again, expression from 
PdapA70 decreases. This suggests that expression from PdapA70 increases when 
intracellular levels of DAP decrease, and decreases as intracellular levels of DAP 
increase (but only to a basal level, and then no further regardless of the amount of 
DAP). 
To try and determine if the hypothetical transcription factor were an activator 
or inhibitor, the strain MGM100AdapAARSPD72 was transformed with the plasmid 
TOP-10 PD79 (the plasmid TOP-10 with the 79 bp PCR product formed using 
primers API and AP3). It was hypothesised that this plasmid would titrate any 
transcription factor present. If, during DAP depletion, the transcription factor bound 
to PdapA7O  and increased transcription of lacZ (an activator) then it would also bind to 
the plasmid TOP-10 PD79, and hence lacZ transcription levels would increase less 
during DAP depletion. If, on the other hand, the transcription factor acted like a 
repressor, binding to PdapA70  in the presence of DAP and prevent transcription of lacZ 
(much like Lad), then the plasmid TOP-10 PD79 should also bind this protein and 
hence lacZ transcription levels would increase more during DAP depletion (also 
basal transcription in the presence of DAP would be higher). 
The strain MGMl00AdapA?RSPD72 transformed with the plasmid TOP-10  
PD79 or just TOP- 10 was grown overnight in minimal medium, CAA, ara and DAP 
at 37°C with constant agitation. The following day the culture was diluted 1:100 into 
fresh medium and allowed to grow at 37°C with constant agitation until 0D600 was 
0.2. Samples were then taken every 10 minutes for 30 minutes and the 3-
galactosidase activity determined. The results of this experiment are shown in Table 
5.7.1. The results indicate that the basal level of lacZ expression from PdapA70 is 
unaffected by the presence of extra PdapA70 DNA. This would indicate that the 
hypothetical transcription factor does not act like an inhibitor (if it did, there should 
have been an increase in basal lacZ expression from PdapA70 when extra copies of 
PdapA70 DNA were present). 
Next the aforementioned strains were grown as described in section 5.3 and 
the -galactosidase activity measured in the presence and absence of extracellular 
DAP. The results (Fig. 5.7.2) show that in the strain containing multiple copies of 
PdapA7O DNA (TOP- 10 PD72), when intracellular levels of DAP decrease there is less 
expression of lacZ from PdapA70 than in the control strain (TOP- 10). This observation 


















Fig. 5.7.1 -galactosidase activity in MGM100AdapA?RSPD72 growing in 
osmotically protected minimal medium, CAA, ara with (DAP+) or without (DAP-) 
DAP. The strain was grown in minimal medium, CAA, ara and DAP and then 
centrifuged, the supernatant removed and the cells resuspended in osmotically 
protected minimal medium + ara and DAP or just ara (this was time0). At 60 
minutes, DAP was added to the DAP- sample. As the intracellular levels of DAP 
increase again in the strain grown without DAP, expression from PdapA70 decreases. 
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Strain 	 I f3-gal #1 	-gal #2 	-gal #3 	3-gal #4 1 Ave 	- 
MGM100AdapA?RSPD72 289.7 
	
300.7 	298 	303.3 	1297.9 
TOP- 10 PD72 
MGMI 00AdapA2RSPD72 287.6 
	
286.6 	304.3 	297.7 	1294.08 
TOP- 10 
Table 5.7.1 The strain MGM100AdapA2RSPD72 containing either the plasmid 
TOP-10 PD72 or TOP-10 was grown in minima! medium, CAA, ara and DAP. 
Samples were taken every 10 minutes for 30 minutes and the f3-galactosidase activity 
determined; this was repeated for four different cultures. The average of these three 
readings are recorded as 3-gal #1-4. The final average of cultures 1-4 (a final average 
of 12 readings, over 4 cultures) is recorded as Ave 3-gal. The results indicate that 
basal expression of lacZ from PdapA70 is unaffected by the presence of extra copies of 
PdaDA70 DNA.  
When the cells have a high level of intracellular DAP, the hypothetical 
transcription factor may not bind to PdapA70 and therefore there is only a basal level of 
expression of lacZ. Under these circumstances, adding excess DAP would not cause 
a decrease in expression from PdapA70. When the intracellular levels of DAP decrease, 
the transcription factor might then bind to PdapA70  and cause an increased expression 
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Fig. 5.7.2 3-ga1actosidase activity in MGM1OOAdapA2RSPD72 containing either the 
plasmid TOP-10 or TOP-10 PD72, growing in osmotically protected minimal 
medium, CAA, ara with (DAP+) or without (DAP-) DAP. The strains were grown in 
minimal medium, CAA, ara and DAP and then centrifuged, the supernatant removed 
and the cells resuspended in osmotically protected minimal medium + ara and DAP 
or just ara (this was timeO). As the intracellular levels of DAP fall in the strain 
grown without DAP, but containing multiple copies of PdapA70 DNA (TOP- 10 PD72 
DAP-), expression from PdapA7O does not increase at the same rate as it does in the 
strain containing only 1 copy of PdapA70  (TOP-10 DAP-). This indicates that the 
transcrrntion factor acts like an activator. 
5.8 Gel retardation assays on PdapA70 
In an attempt to identify the hypothetical transcription factor, a gel retardation 
assay was performed using the PdapA70 fragment and lysates from MGM100AdapA 
grown in the presence or absence of DAP. 
Gel retardation is a powerful approach for both qualitative and quantitative 
analysis of protein-nucleic acid interactions. The method is based on the observation 
that the electrophoretic mobility of a nucleic acid through a polyacrylamide gel can 
be altered when a protein is bound to it (Garner et al, 1981; Fried et al, 1981). The 
gel method is ideal for purifying new proteins that bind to a defined target DNA. 
Two approaches can be taken: the gel method can be used to assay classical 
biochemical purification steps, or the protein can be purified directly from the 
complex in the gel. 
In crude cell extracts, detection of binding activity toward a specific target 
DNA is complicated by the presence of other binding proteins. It is possible to detect 
a specific binding protein against this background of non-specific binding activities 
because the specific and non-specific proteins are competing for binding to the target 
DNA, but the specific complex has a higher affinity under most conditions. The 
addition of non-specific DNA (poly dIdC) and in this instance, non-specific promoter 
DNA (pUC 18) should cause a decrease in non-specific binding to the DNA fragment 
of interest. 
The PdapA70  DNA fragment (generated by PCR using primers API and AP3) 
was labelled with [y-32P] ATP using the T4 polynucleotide kinase reaction as 
described in materials and methods. 
The strain MGM I OOAdapA was grown in osmotically protected minimal 
medium, CAA, ara and either the presence or absence of DAP. 100 ml of the culture 
was grown at 37°C with constant agitation until the 0D600 was 0.5. The culture was 
then centrifuged for 5 minutes at 1500 x g and the supernatant was discarded. The 
cell pellet was then resuspended in 1 ml of 0.1M Tris-Cl (pH 7.4) and the cells lysed 
by sonication. The lysates were then subjected to a further centrifugation of 14000 x 
g for 5 minutes, and the supernatant (soluble cell lysate) removed for future use. 
For the band shift experiment, 10 pmol of 32P-PdapA70 was incubated with 400 
ng ofpUCi8, 5 ig of poly dIdC, lx band shift buffer (20mM Tris-Cl (pH 7.9), 1 m 
EDTA, 50mM, NaC1) and varying amounts of either DAP+ or DAP- lysates. The 
incubations were carried out at 37°C for 15 minutes. The mixtures then had glycerol 
added at a final concentration of 5% (v:v) and were loaded onto a 6% (w:v) 







Fig. 5.8.1 Gel retardation assay on PdapA70. PdapA7O DNA was incubated with 0. ipi, 
1 .i1 or 1 Ojil of either DAP+ lysate (lanes 2-4 respectively) or DAP- lysate (lanes 5-7 
respectively) under the conditions described in the text. Lane 1 is a control lane 
which has neither lysate added. There is no band shift in the presence of either lysate 
at any concentration.  
The results (Fig. 5.8. 1) show that there was no band shift using either a DAP+ 
or DAP- lysate at varying concentrations. Though this experiment was repeated 
many times, using widely-ranging concentrations of both 32PPdapA70 DNA and 
lysates, no band shift was ever observed. There are a number of possible 
explanations as to why this might have been: the protein may have been inactive, too 
little protein may have been present or the gel pH may have been too high. 
5.9 Yeast one hybrid system 
In a further attempt to isolate the hypothetical transcription factor responsible 
for the regulation of the dapA promoter, a yeast one-hybrid system was used (Grow 
'n' Glow, MoBiTec GmbH). 
The yeast one-hybrid system (Wang et al, 1993), a modified version of the 
two-hybrid system, rapidly identifies DNA binding proteins from either cDNA 
libraries or known gene sequences. The one—hybrid system exploits the bimodular 
structure of eukaryotic transcriptional activators. A DNA binding element of interest 
is cloned into the promoter region controlling expression of the green fluorescent 
protein (GFP) reporter in the GFP reporter vector. The particular GFP variant 
expressed by the GFP reporter plasmid, GFPuv, has the same excitation and emission 
maxima as wild-type GFP, but is 18 times brighter than the wild-type variant 
(Crameri et al, 1996). A gene encoding a potential DNA binding protein is cloned in 
the prey plasmid so that it is expressed as a fusion to a B42 activator peptide. 
Interaction of the DNA binding protein with the DNA element brings the B42 
activator peptide into a position that initiates transcription of the GFP reporter gene. 
Thus, colonies with DNA binding proteins that interact with the DNA element of 
interest glow bright green, which is easily seen by eye under UV illumination (300 
nm) (Fig. 5.9.1). 
Expression of fusion proteins by the prey plasmid is controlled by the GALl 
upstream activation sequence. In yeast with an intact galactose regulatory system, the 
GALl activation sequence is induced by galactose and repressed by glucose. This 
regulation provides a mean to prevent expression of library/activation domain 
fusions until the actual screening, which avoids any potentially toxic library proteins 
affecting growth of the yeast. 
Yeast is a suitable organism for this work as the lysine biosynthetic pathway 
in yeast is very different from the lysine biosynthetic pathway in bacteria. The 
commonly known pathway for the biosynthesis of lysine in bacteria is initiated by 
the condensation of pyruvate and aspartic semialdehyde to form dihydropicolininc 
acid and involves diaminopimelic acid as a key intermediate (Davis, 1952). The 
second pathway for the biosynthesis of lysine present in fungi and blue-green algae 
(cyanobacteria) begins with a condensation of acetate and a-ketogluterate to form 
homocitric acid and involves a-aminoadipic acid as a key intermediate (Gilvarg et al, 
1951). Since yeast does not utilise DAP there is little chance that it might produce 
any DAP regulated transcription factors that would bind to the introduced E. coli 
DNA 'bait' sequence. 
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Fig. 5.9.1 Overview of the yeast one-hybrid system. A fusion protein (DNA binding 
protein-B42 activator peptide) that binds to the DNA region of interest (target 
element) will activate expression of GFPuv, resulting in bright green colonies when 
expose to light of a wavelength of 300 nm. 
5.9.1 Construction of a DNA library 
The plasmid pJG4-5 was cut with the restriction enzyme EcoRI and treated 
with calf intestinal phosphatase (CIP) to prevent religation. 20 Vg of chromosomal 
DNA from MG1655 was cut with 20 units of the restriction enzyme ApoI for 10 
minutes at 37°C (these conditions gave the greatest number of fragments with sizes 
between 1.5 and 4 kb). The partially digested chromosomal DNA was then ligated to 
pJG4-5 using the protocol described in materials and methods. The ligated 
plasmid/chromosomal DNA was then transformed into TOP-10 and selected on 
plates containing Amp. All AmpR  colonies were pooled together and their plasmid 
DNA extracted using the protocol outlined in materials and methods. 
5.9.2 Construction ofpGNG-72 
The plasmid pGNG-2 was extracted from the strain LNV1 10, cut with the 
restriction enzyme NruI and treated with CIP to prevent religation. The DNA bait 
region (PciapA70) was generated by PCR using primers API and AP3, but using Vent 
DNA polymerase, to give a blunt ended product. The PCR product was run on an 
agarose gel, the correct size band extracted using the -agarase method, and ligated 
to Nrul cut pGNG-2. Ligated plasmid/DNA was transformed into TOP-10 and 
colonies selected on LB plates containing Amp. A number of colonies were picked, 
the plasmid DNA extracted using the protocol described in materials and methods, 
and the plasmid DNA sequenced to determine if any had the bait sequence ligated to 
the plasmid. A correct plasmid was found and called pGNG-72. 
5.9.3 Screening of one-hybrid system 
The plasmid pGNG-72 was transformed into the yeast strain EGY48 (using 
the Glow 'n' Grow high efficiency yeast transformation kit, MoBiTec) and 
transformants were selected for their ability to grow on DOBA —Ura (Glucose) 
(EGY48 has a mutation in the URA3 gene while the plasmid pGNG-72 carries an 
intact copy of the URA3 gene, and can therefore complement the mutation, allowing 
growth in the absence of uracil). 
EGY48 pGNG-72 was then transformed with a large amount of the plasmid 
pJG4-5 containing the chromosomal DNA library. This time transformants were 
selected for their ability to grow on DOBA —Ura —Trp (Galactose) (EGY48 also has 
a mutation in the TRP1 gene, while pJG4-5 carries an intact version of the TRP1 
gene). Since the plates contained galactose, expression of the fusion library was now 
active, and colonies were screened for any positives (glowed bright green when 
exposed to UV light of 300 nm). 
Although this experiment was repeated many times, as was the construction 
of the chromosomal DNA library, no positives were ever found. 
5.10 Summary and discussion 
In this chapter work has been described that suggest the possibility of a novel 
transcription factor for dapA in E. co/i. 
The original observation that led to this discovery was that during GroE 
depletion the expression of dapA increased. Until this time it had been thought that 
expression of dapA was not regulated (Butour et a!, 1974; Bouvier et al, 1984). 
During the course of the work it was discovered that this regulation was not by the 
peptide DapA (a AdapA strain grown in the presence of DAP had the same level of 
expression from the dapA promoter as a dapA strain) but by one of its downstream 
products: DAP. 
In E. co/i the lysine biosynthetic pathway is not reversible except at the step 
catalysed by DapF (the racemisation of LL-diaminopimelate to meso-
diaminopimelate), therefore when DAP is added to a AdapA strain, only the level of 
those metabolites that are downstream of the DapE catalysed step are affected, i.e. 
the addition of meso-DAP will only change the levels of LL-DAP, meso-DAP and 
lysine. Therefore when DAP was added to DAP depleted cells and observed to 
change the level of expression from the dapA promoter, only one of the 
aforementioned compounds could have been responsible. 
When E. co/i were depleted of their intracellular stores of lysine in a AdapA 
strain, expression from PdapA  was observed to increase dramatically, though when 
this experiment was repeated in a lysA mutant strain, the effect was not observed at 
all. This observation could be explained by the fact that in the first instance DAP was 
being exhausted as it was required for both the synthesis of lysine and peptidoglycan, 
but in the second instance (the lysA mutant) DAP could not be converted into lysine, 
and therefore DAP levels were unaffected in this experiment. As expression from 
PdapA only changed when intracellular DAP levels changed, this was good evidence 
that DAP was actually regulating expression from PdapA. 
To make sure that changes in the intracellular levels of DAP were only 
affecting expression from the dapA promoter and did not affect lacZ, experiments 
were conducted in which the chromosomal levels of lacZ (under its native promoter) 
were measured during DAP depletion (MGM 1 OOAdapA was grown under conditions 
which caused DAP depletion). In these experiments chromosomal lacZ expression 
was unaffected by changes in the intracellular levels of DAP. This showed that DAP 
levels do not affect lacZ expression unless it is under the control of the dapA 
promoter. 
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In later work the region in which the transcription factor could bind was 
narrowed down greatly from 1 kb of DNA to 70 bp of DNA. The PdapA7O  reporter 
construct acted in the same way as the previous reporter construct. Unfortunately the 
binding region could not be narrowed down any further using the truncation method 
as to do so would incur the loss of the RNA polymerase binding sites. It was hoped 
that if a transcription factor had been discovered, its exact binding region could have 
been determined using in vitro DNA footprinting. 
Two methods were used to try and discover the identity of the transcription 
factor, band shift and yeast one-hybrid. The band shift proved inconclusive, as the 
mobility of the 70 bp DNA strand was not affected by the presence of a cell lysate 
made from E. co/i either with or without normal intracellular levels of DAP. But, if 
the transcription factor was present only at very low amounts (as may be expected) 
then it is possible that a mobility shift may not have been observed. Also, if the 
conditions were not correct for the binding of the transcription factor to the DNA 
fragment, again no mobility shift would be observed. There is also the possibility that 
in the DAP depleted cell lysate, the transcription factor is tightly bound to the 
chromosomal dapA promoter region and none is actually present in the lysate at all! 
The gel retardation assay might be better employed to verify that purified protein 
does actually bind to the DNA region of interest. 
The yeast one-hybrid system is an elegant approach to discovering the identity 
of proteins that interact with a DNA region of interest. Unfortunately in this case a 
pre-made E. co/i chromosomal library in the plasmid pJG4-5 was not available. This 
would have made the entire process much easier, as the library construction was 
probably the limiting step in this experiment. If the fusion library does not give 
representative coverage of the chromosome then it may be unlikely that any DNA 
binding proteins of interest would be found. 
Another approach to purifying the transcription factor could be to use DAP to 
purify the protein. If DAP were immobilised to an appropriate resin (sephadex for 
example), then cell lysates could be passed over this resin to see what binds to the 
DAP. Of course the problems with this approach are numerous, how tight is the 
interaction between DAP and the protein? Under what conditions do they interact? 
Under what conditions do they dissociate? And most importantly, does DAP interact 
directly with the transcription factor, or does it do so via a second protein (i.e. DAP 
binds to a protein, which in turn modifies the transcription factor, causing it to 
change expression of the dapA promoter)? 
There is of course the possibility that dapA is not regulated at the level of 
transcription, but at the level of translation. In the Pda pAlacZ reporter constructs, the 
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first 21 bases of the fusion mRNA is dapA mRNA. It is possible that this small 
region of mRNA may contain some sequence, which allows for the regulation of its 
translation (though this sequence did not contain any hairpin-loop forming regions, 
which tend to characterise regions controlling regulation of translation). Probably the 
easiest way to determine if dapA is being regulated at the level of translation is to 
measure the amount of dapA-IacZ fusion mRNA during DAP starvation. If the level 
of mRNA does not increase, but LacZ activity does increase, then this is good 
evidence that expression from the dapA promoter is being regulated at the 
translational level. 
In conclusion, in this chapter it has been proposed that the expression of dapA 
is regulated in a hitherto unknown manner by the metabolite, DAP. Though this work 
is still incomplete, the identification of a dapA DNA binding protein, or a protein that 
regulates translation of dapA mRNA in response to fluctuating DAP levels, may help 
in our further understanding of the regulation of genes in E. coli. 
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Chapter VI 




In initial studies of DapA it was thought that the protein had an increased rate 
of turnover in GroE depleted cells. To determine if this were true, newly synthesised 
DapA was labelled with 35S-methionine in either GroE or GroE cells, an excess of 
unlabelled methionine was added, and samples were taken at various times to 
determine how much radiolabelled DapA remained. 
Unfortunately, uptake of 35S-methionine in LB is very low (due to the 
presence of methionine in the medium), and while the cells could be labelled in 
minimal medium, they exhibited a much slower growth rate in this medium. 
Therefore it became necessary to formulate a new medium; one in which cells would 
have a similar growth rate as in LB but which also allowed sufficient uptake of 
35S_ 
methionine to allow efficient labelling of newly synthesised proteins. 
6.2 Radiolabelling of MGM 100 
In earlier experiments (see chapter 3) it was necessary to radiolabel newly 
synthesised proteins using 35S-methionine. Until this time MGMIOO had been 
consistently grown in LB, but 35S-methionine uptake in this medium is very low (due 
to the presence of methionine in the medium, see figure 6.2.1). Therefore it was 
necessary to perform radiolabelling of MGM 100 in a medium that lacked 
methionine. One approach was to grow MGM 100 in Spizizen's minimal medium 
(MM); while growth in this medium allowed the highest uptake of 35S-methionine 
(Fig. 6.2. 1) the medium was rejected as the cells had a vastly different generation 
time to those grown in LB (generation time in LB and ara is 22 minutes, while in 
MM and ara it is 60 minutes). Another approach was to grow MGM 100 in LB and 
then rapidly filter the cells and resuspend them in MM just before the labelling 
process. While this method gave better 35S-methionine uptake than did LB (Fig. 
6.2. 1) the uptake was still much less than when the cells were grown in MM alone. In 
all of the above experiments the cells were grown in the appropriate medium 
overnight at 37°C with constant agitation, the following day the cells were diluted 
1:100 into fresh medium and grown at 37°C with constant agitation until the 0D600 
was 0.2. The culture was then diluted 1:10 into fresh prewarrned medium and 
grown for 60 minutes. After 60 minutes 35S-methionine was added at a final activity 
of 100 iCi m1', this was time 0 (for the sample that was shifted from LB into MM, 
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the cells were vacuum filtered through 0.45 pm Whatman filters and resuspended in 
prewarmed MM just before the radiolabel was added). 10 ml of culture at 0D600 0.2 
was removed at various times, the cells were vacuum filtered through 0.45 jim 
Whatman filters, washed with an ice cold solution of 5% trichloroacetic acid (to 
remove surface macromolecules) and the filters were dried. The filters were then put 
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Fig. 6.2.1 Scintillation counts of MGM100 labelled with 100 j.tCi ml' 35S-
methionine in various media. Cells were grown in LB (LB), Spizizen's minimal 
medium (Spiz) or LB and then shifted to Spizizen's minimal medium just before 
adding the radiolabel (Spiz into LB). Growth conditions are described in the text. In 
both the LB and LB into Spiz samples, uptake of 35S-methionine is very low 
compared to the Spiz sample. The plateau In the Spiz sample is not caused by a 
limiting amount of radiolabel (there was a total of 1.4x107 CPM available). 
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6.3 Composition of SCAA 
It was noted that the generation time of MGM100 growing in MM 
supplemented with casamino acid (CAA) was 30 minutes. This was much closer to 
the generation time in LB and it was therefore decided to try and create a supplement 
which had the same composition as CAA but lacked methionine. 
Casamino acid is formed by the acid hydrolysis of casein. Before a 
supplement that had the same composition as CAA but lacked methionine could be 
created, it was necessary to determine the composition of CAA. 
Casein (from Bovine milk) is composed of four different types of casein, 
a2, 3 and K, which account for 39.7%, 10.3%, 36.9% and 13.1% of the total casein 
respectively (Swaisgood, 1992). The amino acid composition of the different forms 
of casein was determined (Swaisgood, 1992) and can be seen in Table 6.3.1. Using 
this information the approximate composition of CAA (at a concentration of 100 mg 
ml') could be determined (Table 6.3.2). 
Growth curves were plotted to determine if MM supplemented with the 
synthetic casamino acid (SCAA) solution gave the same generation time as MM 
supplemented with CAA. MGM 100 was grown at 37°C in MM  [MM supplemented 
with thymidine, adenine, uracil, tryptophan, vitamin BI and either CAA (5 mg m1 1 ) 
or SCAA (5 mg ml')]. The 0D600  was measured at various times and plotted. The 
results (Fig. 6.3. 1) show that MGM 100 grown in MM  SCAA and ara has the same 
generation time as MGM 100 grown in MM  CAA and ara. 
Since MM SCAA appeared to supply the same nutrients as MM CAA, a new 
version was made from which methionine was omitted (SCAA —Met). When 
MGM 100 was grown in MM  SCAA —Met and ara it was found to have a generation 
time of 33 minutes, but it also allowed for a much greater uptake of 35S-methionine 
(Fig. 6.3.2). This demonstrated that MM1 SCAA —Met was a suitable medium for 
use in radiolabelling experiments with 35S-methionine. 
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Casein US as2 J3 K 
Amino No. % Cone. No. % Cone. No. % Cone. No. % Cone. 
Acid  
Ala 9 4.7 1.87 8 4.1 0.42 14 9 3.31 5 2.5 0.32 
Arg 6 3.1 1.24 6 3.1 0.31 5 3 1.10 4 2 0.26 
Asn 8 4.2 1.66 14 7.1 0.73 8 4.8 1.76 5 2.5 0.32 
Asp 7 3.7 1.45 4 2 0.21 3 1.8 0.66 4 2 0.26 
Cys 0 0 0 2 1 0.10 2 1.2 0.44 0 0 0 
Gin 14 7.3 2.90 16 8.2 0.84 14 8.4 3.09 20 9.8 1.28 
Glu 25 13 5.19 24 12.2 1.26 12 7.2 2.65 19 9.3 1.22 
Gly 9 4.7 1.87 2 1 0.10 2 1.2 0.44 5 2.5 0.32 
His 5 2.6 1.03 3 1.5 0.15 3 1.8 0.66 5 2.5 0.32 
Ile 11 5.8 2.28 11 5.6 0.57 13 7.8 2.87 10 4.9 0.64 
Leu 17 8.9 3.53 13 6.6 0.68 8 4.8 1.76 22 10.8 1.41 
Lys 14 7.3 2.90 24 12.2 1.26 9 5.4 1.98 11 5.4 0.71 
Met 5 2.6 1.03 4 2 0.21 2 1.2 0.44 6 2.9 0.38 
Phe 8 4.2 1.66 6 3.1 0.31 4 2.4 0.88 9 4.4 0.58 
Pro 17 8.9 3.53 10 5.1 0.52 20 12 4.41 35 17.2 2.25 
Ser 8 4.2 1.66 6 3.1 0.31 12 7.2 2.65 11 5.3 0.71 
Thr 5 2.6 1.03 15 7.7 0.78 14 8.4 3.09 9 4.4 0.58 
Trp 2 1 0.41 2 1 0.10 1 0.6 0.22 1 0.5 0.06 
Tyr 10 5.2 2.07 12 6.1 0.63 9 5.4 1.98 4 2 0.26 
Val 11 5.8 2.28 14 7.1 0.73 11 6.6 2.43 19 9.3 1.22 
Total 191 100 39.7 196 100 10.3 167 100 36.9 204 100 13.1 
Table 6.3.1 The amino acid composition of the four types of casein. The number of 
residues of each amino acid is shown (No.) as well as the percentage of the casein 
that they represent (%). To make a 100 mg ml-1 solution of SCAA with the same 
amount of each amino acid as CAA, ci casein must be added at 39.7 mg mF1 , as2 
casein must be added at 10.3 mg m1 1 , 13 casein must be added at 36.9 mg ml-1 and K 
casein must be added at 13.1 mg m1 1 . The columns marked Cone. show how much 
of each amino acid must be present (in mg m1) to make up the appropriate amounts 
of the individual caseins.  
Amino Acid mg/ 100 ml Amino Acid mg/ 100 ml 
Ala 592.65 Leu 739.71 
Arg 292.41 Lys 686.62 
Asn 448.73 Met 207.67 
Asp 258.49 Phe 343.99 
Cys 54.70 Pro 1072.57 
Gin 812.85 Ser 533.60 
Giu 1032.92 Thr 549.89 
Gly 273.88 Trp 80.60 
His 218.09 Tyr 495.46 
Ile 637.91 Val 667.27 
Table 6.3.2 The composition of SCAA. The Cone. values from Table 6.3.1 were 
totalled and multiplied by 100 for each amino acid. By adding the amino acids above 
at the noted concentrations a 100 ml solution of SCAA (at a concentration of 100 mg 
ml- ') will be obtained which will have the same amino acid composition as CAA at a 
concentration of 100 mg m1'. 
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Fig. 6.3.1 Growth curves of MGM100 grown in MMI supplemented with either 
CAA (5 mg ml') and ara or SCAA (5 mg ml) and ara. MGM100 was grown 
overnight in 5 ml of the appropriate medium at 37°C with constant agitation. The 
following day the culture was diluted 1:100 into fresh medium and grown at 37°C 
with constant agitation until the 0D600 was 0.2. The culture was then diluted 1:10 
into fresh, prewarmed medium (this was time = 0) and grown at 37°C with constant 
agitation. The 0D600  was measured every 30 minutes. For clarity, where the culture 
has been diluted 1:10, the OD has been multiplied by 10 and plotted on this graph. 
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Fig. 6.3.2 Scintillation counts of MGMIOO labelled with 100 j.iCi m1' 35S-
methionine in various media. Cells were grown in MM  or MM  supplemented with 
SCAA —Met (5 mg m1 1 ) at 37°C with constant agitation. 100 tCi m1' 35S-
methionine was added (this was time = 0) and samples were taken at various times to 
determine the uptake of the radiolabel. MGM 100 grown in MM  supplemented with 
SCAA —Met has a similar uptake level as MGM100 grown in un-supplemented 
medium.  
When newly synthesised proteins in GroE cells were labelled with S-
methionine in MM1 SCAA —Met, very good results were obtained (Fig. 6.3.3); but 
when labelling was attempted in GroE depleted cells, the radiolabelling was much 
less efficient (Fig. 6.3.3). To explain this observation it was suggested that 
methionine uptake might be affected by GroE depletion. To visualise radiolabelled 
proteins in GroE depleted cells, a 2D gel was used to separate proteins; the proteins 
were then transferred to a PVDF membrane using the Western blotting technique 
(described in materials and methods) and the membrane was covered with a thin 
layer of EA wax (EA Biotech Ltd.). EA wax contains a scintillant, which amplifies 
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the signal from 35S. When the membrane is exposed to X-ray film, a much clearer 
image can be obtained than if the wax were not used (using EA wax it was possible 
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Fig. 6.3.3 2D gels of soluble proteins from MGM 100 labelled with S-methionine. 
MGM 100 was grown in the presence of ara (A) or glu (B) and labelled with 35S-
methionine, the soluble protein fraction was then separated by 2D electrophoresis. 
These images show that the efficiency of labelling of newly synthesised proteins was 
greatly reduced in GroE depleted (B) cells. 
6.4 Growth of GroE depleted cells in SCAA 
SCAA —Met was formulated so that radiolabelling experiments in GroE 
depleted MGM 100 could be performed; it was therefore necessary to determine if 
GroE depleted MGM100 acted in the same way in this medium as it did in LB. 
MGM100 was grown in appropriate medium containing arabinose until 0D600 0.2 
and then diluted 1: 10 into fresh medium containing glucose. The results (Fig. 6.4. 1) 
show that GroE depleted MGM100 grown in MM1 SCAA behaves like GroE 
depleted MGM 100 growing in LB; the cells grow at a decreasing rate and eventually 
lyse. But GroE depleted MGM 100 growing in MM  SCAA —Met behave differently; 
the cells grow at a decreasing rate, but do not lyse (acting like MGM 100 grown in 
LB, glu and DAP). This was an unexpected result, which meant that MM  SCAA - 
Met was not suitable for use in radiolabelling of proteins in GroE depleted cells. 
Since MGM 100 did not lyse in this medium there was the possibility that the results 
obtained from this medium would be different from results obtained from MGM100 
grown in LB + glucose. 
To determine if other amino acid deficient media caused unusual growth in 
GroE depleted MGM100, multiple versions of SCAA were made each of which 
lacked one amino acid. The growth curves of GroE depleted MGM 100 growing in 
these media can be seen in figures 6.4.2 and 6.4.3. While growth rates and lysis times 
of MGMIOO varied in these different media, lysis eventually occurred in all but 
three: SCAA —Leu, SCAA —Lys and SCAA —Met. 
MGM 100 had a very slow growth rate in the medium lacking isoleucine. In E. 
co/i, K-12 strain, the isoleucine and valine biosynthetic pathways are parallel, with 
one enzyme catalysing both parallel reactions (Umbarger, 1996). One of the enzymes 
on the biosynthetic pathways (acetohydroxy acid synthase) is only derepressed when 
valine is limiting [the isozyme of acetohydroxy acid synthase that is insensitive to 
valine inhibition contains a frameshift mutation, and is therefore not active (Lawther 
et al, 1981)]. Therefore when isoleucine levels are low, but valine levels are high, the 
strain cannot synthesise isoleucine, and therefore grows at a very slow rate (if at all). 
It is important to stress that this is not a result of GroE depletion. 
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Fig. 6.4.1 Growth of MGM 100 in various media. MGM 100 was grown overnight in 
an appropriate medium, LB and ara, MM 1 SCAA and ara or MM 1 SCAA —Met and 
ara, at 37°C with constant agitation. The following day the culture was diluted 1:100 
into fresh medium and grown at 37°C with constant agitation until the 0D600 was 
0.2. 1 ml of culture was removed, centrifuged and the supernatant discarded. The cell 
pellet was then resuspended in 10 ml of prewarmed medium and glucose (this was 
time = 0). The cells were grown at 37°C with constant agitation and the 0D600 was 
determined every 30 minutes. The cultures were diluted 1:10 when the 0D600 
reached - 0.2. For clarity, where the cultures have been diluted 1:10, the OD has 
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Fig. 6.4.2 Growth of MGM 100 in various media. MGM 100 was grown overnight in 
an appropriate medium (MM1 SCAA —various amino acids) and ara at 37°C with 
constant agitation. The following day the culture was diluted 1:100 into fresh 
medium and grown at 37°C with constant agitation until the 0D600 was 0.2. 1 ml of 
culture was removed, centrifuged and the supernatant discarded. The cell pellet was 
then resuspended in 10 ml of prewarmed medium and glucose (this was time = 0). 
The cells were grown at 37°C with constant agitation and the 0D600 was determined 
every 30 minutes. The cultures were diluted 1:10 when the 0D600 reached 0.2. For 
















Fig. 6.4.3 Growth of MGM 100 in various media. MGM 100 was grown overnight in 
an appropriate medium (MM1 SCAA —various amino acids) and ara at 37°C with 
constant agitation. The following day the culture was diluted 1:100 into fresh 
medium and grown at 37°C with constant agitation until the 0D600 was 0.2. 1 ml of 
culture was removed, centrifuged and the supernatant discarded. The cell pellet was 
then resuspended in 10 ml of prewarmed medium and glucose (this was time = 0). 
The cells were grown at 37°C with constant agitation and the 0D600 was determined 
every 30 minutes. The cultures were diluted 1:10 when the 0D600 reached - 0.2. For 
clarity, where the cultures have been diluted 1:10, the OD has been multiplied by 10 
and plotted.  
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6.5 MGM100 in MM1 SCAA —Lys 
When GroE depleted MGM100 is grown in medium lacking lysine, the cells 
do not lyse (though they do eventually stop growing). In chapter 5 it is shown that 
expression from the dapA promoter increases dramatically during GroE depletion in 
lysine deficient medium. Also if GroE depleted cells have enough extra DapA before 
GroE depletion, they do not lyse (see chapter 3.9). Finally, it is also known that 
lysine inhibits DapA activity (Laber et al, 1992). From these facts it was 
hypothesised that during GroE depletion in lysine deficient medium, as DapA started 
to become inactive (due to GroE depletion), DAP levels decrease. Expression from 
the dapA promoter would then increase as DAP is required for the synthesis of both 
peptidoglycan and lysine. The increased synthesis of new DapA would raise the level 
of DapA activity (the cells would not be completely GroE depleted by this time, and 
therefore some percentage of newly synthesised DapA would be folded correctly and 
consequently active; also since lysine levels would be decreased, this DapA would be 
more active). This increased level of DapA activity (relative to DapA activity in 
MGM 100 grown in medium containing lysine) would delay the process of lysis. The 
cells would then stop growing (due to GroE depletion) before lysis occurred, and 
hence there would be no lysis in GroE depleted cells growing in lysine deficient 
medium. 
To determine if this hypothesis was correct a number of experiments were 
performed. 
6.5.1 PdapA  activity in lysine deficient medium 
MGM 1 OOXPdapA lacZ was grown in MM 1 supplemented with either SCAA or 
SCAA —Lys. The cells were grown as described in section 6.4 in the presence of 
either ara or glu. During growth in these media samples were taken, and 13-
galactosidase activity (and hence PdapA  activity) was determined. The results of this 
experiment are shown in figure 6.5.1. These results indicate that in GroE depleted 
cells growing in lysine deficient medium (MM 1 SCAA —Lys) dapA promoter activity 
is significantly higher than in GroE depleted cells growing in medium containing 
lysine. This would result in more DapA being made in GroE depleted cells growing 
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Fig 6.5.1 f3-galactosidase activity in MGM1002PdapA-/acZ growing in MMI 
supplemented with CAA, or SCAA —Lys. MGM100XPcIapA-1acZ was grown 
overnight in an appropriate medium and ara at 37°C with constant agitation. The 
following day the culture was diluted 1:100 into fresh medium and grown at 37°C 
with constant agitation until the 0D600 was 	0.2. 1 ml of culture was removed, 
centrifuged and the supernatant discarded. The cell pellet was then resuspended in 10 
ml of prewarmed medium and ara or glu (this was time = 0). The cells were grown at 
37°C with constant agitation and the f3-galactosidase activity was determined at 
various times. These results show that -galactosidase activity (and hence dapA 
promoter activity) increases as cells become GroE depleted, with dapA promoter 
activity being much higher in lysine deficient medium.  
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6.5.2 DapA activity in lysine deficient medium 
An experiment was performed to determine if DapA activity was higher in 
GroE depleted cells growing in lysine deficient medium than in medium containing 
lysine. MGM 100 was grown as described in section 6.5.1, except that instead of 
taking samples for j3-ga!actosidase assays, samples were taken for DapA activity 
assays (as described in materials and methods). The results of these assays (Fig. 
6.5.2) show that in GroE cells DapA activity is constant (though it is slightly higher 
in lysine deficient medium, this may be because the cells have a lower internal level 
of lysine and therefore DapA is not inhibited to the same degree as a cell growing in 
medium containing lysine). But in GroE cells DapA activity declines; though GroE 
depleted cells growing in lysine deficient medium have a higher level of DapA 
activity at later time points than GroE depleted cells growing in medium containing 
lysine. This is good evidence that the original hypothesis was correct and that GroE 
depleted cells in lysine deficient medium do not lyse because they have enough 
active DapA to prevent them from lysing until the cells stop growing (due to GroE 
depletion). Once the cells have stopped growing they cannot lyse (lysis is due to the 
cells not being able to make peptidoglycan quickly enough; if the cells have stopped 
growing, they no longer need to make new peptidoglycan). 
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Fig 6.5.2 DapA specific activity in MGMI0O under various conditions. MGM100 
was grown overnight in either MM1 SCAA ara or MM1 SCAA —Lys ara at 37°C 
with constant agitation. The following day the culture was diluted 1:100 into fresh 
medium and grown at 37°C with constant agitation until the 0D600 was 0.2. 1 ml of 
culture was removed, centrifuged and the supernatant discarded. The cell pellet was 
then resuspended in 10 ml of prewarmed medium and ara (GroE+) or glu (GroE) this 
was time 0. The cells were grown at 37°C with constant agitation and samples taken 
at various times. The DapA activity was determined per mg of total protein and 
plotted on the graph. The sample SCAA GroE+  was set as 100% and all other 
sample activities are plotted relative to it. 
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6.6 MGM100 in MM1 SCAA —Met 
GroE depleted MGM100 growing in MM! supplemented with SCAA —Met 
acted very much like MGM100 growing in SCAA —Lys. The cells grew at a 
decreasing rate, but did not lyse (though they did stop growing). Unlike GroE 
depletion in lysine deficient medium, nothing was known about what happens at the 
intracellular level to GroE depleted cells growing in methionine deficient medium. 
The biosynthesis of methionine in E. coli (Fig. 6.6.1) and Styphirnurium has 
been extensively reviewed (Cohen et a!, 1987; Old et al, 1991; Saint-Girons et al, 
1988; Flavin, 1975). Briefly, methionine has been classified as a member of the 
aspartate family of amino acids since the atoms of its four-carbon chain are derived 
from aspartic acid. The first three reactions are shared with the biosynthetic pathways 
of several other metabolites, including lysine, threonine and the branched chain 
amino acids. The other reactions of the pathway, which convert homoserine and 
methylenetetrahydrofolate to methionine, are uniquely concerned with methionine 
synthesis. The loss of any or all of the enzymes that catalyse them creates a 
nutritional requirement for methionine only. 
Using two key pieces of information a hypothesis was formed to explain the 
observation the GroE depleted cells growing in methionine deficient medium do not 
lyse. The first piece of information is that during GroE depletion in MGM100 
(growing in LB or minimal medium) there is a large induction of metE [Fig. 6.6.2, 
the metE band was identified by N-terminal sequencing (N. McLennan, pers. 
comm.)] and also metC (though this cannot be seen clearly on the gel images 
obtained) this has also been reported elsewhere (Horwich et al, 1993). The second 
piece of information is the observation that diaminopimelic acid can be replaced by 
cystathionine or lanthionine in the peptidoglycan of E. coli (Mengin-Lecreu!x et a!, 
1994; Richaud et a!, 1993). This is because cystathionine and lanthionine have a very 
similar structure to diaminopimelic acid (Fig. 6.6.3) and can therefore be 
incorporated into peptidoglycan by MurE when meso-DAP levels are low. 
Using these two pieces of information the following hypothesis was 
formulated; in GroE depleted cells DapA activity decreases, consequently meso-
DAP is not made and cannot be incorporated into peptidoglycan. New peptidoglycan 
therefore may utilise either cystathionine or lanthionine (or possibly both) to replace 
DAP. Since cystathionine is on the pathway to methionine biosynthesis, if it were 
diverted to peptidoglycan synthesis, internal levels of homocysteine and methionine 
would decrease. Expression of metE is regulated by levels of both homocysteine and 
of methionine (Greene, 1996; Wu et al, 1993); therefore as the levels of homocystine 
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and methionine decrease there is an increased expression of metE. Also, since the 
cells are growing in methionine deficient medium, and they are possibly not 
synthesising methionine, the cells stop growing (there may also be a problem with 
methionine uptake in GroE depleted cells, which would explain why MetE is also 
induced in medium containing methionine i.e. LB). If the cells stop growing before 
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Fig 6.6.1 Biosynthesis of methionine in E. coli. The product of the metL gene is 
homoserine dehydrogenase II; metA: homoserine transsuccinylase; metB: 
cystathionine y-synthase; metC: f3-cystathionase; metE and metH: methionine 
synthase; thrA: homoserine dehydrogenase I; thrB: homoserine kinase; dapA: 
dihydropicolinate synthetase. 
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Fig. 6.6.2 Coomassie blue stained SDS gel of cell lysate of MGM 100 grown in 
various conditions. Lanes; M: molecular weight markers; 1: GroEr sample, 0 
minutes; 2: GroE sample, 45 minutes; 3: GroE sample, 90 minutes; 4: GroE 
sample, 135 minutes; 5: GroF sample, 45 minutes; 6: GroE sample, 90 minutes; 7: 
GroE sample, 135 minutes. MGM100 was grown overnight in LB and ara at 37°C 
with constant agitation. The following day the culture was diluted 1:100 into fresh 
medium and grown at 37°C with constant agitation until the 0D600 was 0.2. 1 ml of 
culture was removed, centrifuged and the supernatant discarded. The cell pellet was 
then resuspended in 10 ml of prewarmed medium and ara (GroE) or glu (GroE) this 
was time 0. The cells were grown at 37°C with constant agitation and samples taken 
at various times to run on an SDS polyacrylamide gel. In the GroE samples 
(especially lane 7) MetE (84.6 kDa) is clearly induced. 
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Fig. 6.6.3 Structural relationships between stereoisomers of cysteine thioethers and 
of diaminopimelate. 
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To determine if the hypothesis was correct, DAP was added to GroE depleted 
cells. If DAP is present then it should be used preferentially instead of cystathionine 
for peptidoglycan synthesis. Under these conditions cystathionine should then only 
be used for methionine synthesis, and hence methionine levels should not decrease. 
When DAP is added to GroE depleted cells, however, MetE is still induced (Fig. 
6.6.4). 
This observation suggests that MetE induction may be due to GroE depletion 
affecting some aspect of methionine synthesis directly, rather than indirectly (i.e. the 
DapA/cystathionine hypothesis). To determine if the induction was caused by GroE 
depletion or DAP depletion, the strain MGM100AdapA was grown in osmotically 
protected medium and ara (under these conditions the strain will be DAP depleted 
but will remain GroE), and samples were run on an SDS-PAGE gel. The results (Fig 
6.6.5) show that when MOM 100 is DAP depleted but has wild type levels of GroE, 
there is no induction of MetE. Also when homoserine (lOOp.g ml-1) was added to 
GroE depleted cells, MetE was still induced (Fig. 6.6.5). This data suggests that 
GroE depletion is causing MetE induction, but not because cystathionine is being 
diverted to make peptidoglycan, and since even the addition of homoserine (the 
immediate methionine precursor) did not affect MetE induction, there is the 
possibility that methionine levels in GroE depleted cells are not reduced. 
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Fig. 6.6.4 Coomassie blue stained SDS gel of cell lysate of MGM100 grown in LB 
and DAP. Lanes; M: molecular weight markers; 1: GroE sample, 0 minutes; 2: 
GroF sample, 45 minutes; 3: GroE sample, 90 minutes; 4: GroE sample, 135 
minutes. MGM100 was grown overnight in LB and ara at 37°C with constant 
agitation. The following day the culture was diluted 1:100 into fresh medium and 
grown at 37°C with constant agitation until the 0D600 was 0.2. 1 ml of culture was 
removed, centrifuged and the supernatant discarded. The cell pellet was then 
resuspended in 10 ml of prewarmed medium, glu and DAP (GroE) this was time 0. 
The cells were grown at 37°C with constant agitation and samples taken at various 
times to run on an SDS polyacrylamide gel. In the GroE samples (especially lanes 3 
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Fig. 6.6.5 Coomassie blue stained SDS gel of cell lysate of MGM100 and 
MGM100AdapA grown under various conditions. Lanes; M: molecular weight 
markers; 1-3: MGM100 GroE sample, 45, 90 and 135 minutes respectively; 4-6: 
MGM100 GroE sample + homoserine, 45, 90 and 135 minutes respectively; 7: 
MGM100AdapA grown in osmotically protected MM1 and ara, 60 minutes. 
MGM 100 or MGM100AdapA was grown in an appropriate medium at 37°C with 
constant agitation. The following day the culture was diluted 1:100 into fresh 
medium and grown at 37°C with constant agitation until the 0D600 was 0.2. 1 ml of 
culture was removed, centrifuged and the supernatant discarded. The cell pellet was 
then resuspended in 10 ml of prewarmed medium, glu and DAP (GroE) or in the 
case of MGM100AdapA the pellet was resuspended in osmotically protected MM1 
and ara (this was time 0). The cells were grown at 37°C with constant agitation and 
samples taken at various times to run on an SDS polyacrylamide gel. In the GroE 
samples (especially lanes 3 and 6) MetE (84.6 kDa) is clearly induced. MetE is also 
induced homoserine is present. This suggests that methionine feedback activation by 
methionine is not causing MetE induction. In the GroE, DAP depleted sample (lane 
7) there is no induction of MetE, suggesting that MetE induction is caused by GroE 
depletion, and not cystathionine depletion. 
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6.7 Summary and discussion 
In this chapter work has been described that attempts to explain unusual 
phenomena observed when GroE depleted cells are grown in media deficient in 
individual amino acids. 
Initially a supplement was created that contained the same level of amino 
acids as a 100 mg m1' solution of casamino acid. The amount of each amino acid 
was determined from previously published data concerning the composition of casein 
from bovine milk (Swaisgood, 1992). The medium was originally intended to be 
used during radiolabelling of MGM 100 using 35S-methionine. Because the cells 
could be grown in the medium (as they had a growth rate similar to that in LB) and 
also labelled in it as well (without the need for changing media) it was thought 
suitable. But when MGM 100 was grown in this medium under conditions that caused 
GroE depletion, the cells no longer behaved like they would have if growing in LB. 
It was found that when growing GroE depleted MGM100 in media deficient 
in either leucine, lysine or methionine, the cells did not lyse. In this chapter 
experiments are described which attempt to explain why GroE depleted cells do not 
lyse in lysine or methionine deficient media (due to time constraints no experiments 
were performed to try and explain the phenomena in leucine deficient medium). 
While GroE depletion in lysine deficient medium had not been studied 
previously in this work, some observations regarding MGM 100 in lysine deficient 
medium had been made (chapter 5). From these observations the following 
hypothesis was proposed: during GroE depletion, DapA activity decreases (chapter 
3); as DapA activity decreases, DAP levels decrease. Since the cells are growing in 
lysine deficient medium, DAP must be used for both the synthesis of lysine and 
peptidoglycan, consequently DAP levels decrease faster than in equivalent cells 
growing in a medium containing lysine. As DAP levels decrease, dapA promoter 
activity increases (chapter 5), and DapA is made. While most of this DapA will be 
inactive, some fraction will retain activity (chapter 3) and consequently, DapA 
activity in GroE depleted cells will be higher than in equivalent cells growing in 
medium containing lysine (also there will be no inhibition of activity by lysine). As 
DapA activity is higher, this will prevent the cells from lysing long enough so that 
they stop growing (due to some other aspect of GroE depletion; chapter 1). Once the 
cells have stopped growing, lysis cannot occur. 
To determine if this hypothesis was correct, dapA promoter activity was 
measured in MGM 100 growing in medium with or without lysine. The promoter 
activity was higher in GroE depleted cells growing in lysine deficient medium than 
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in cell grown in medium containing lysine. The next step was to measure DapA 
activity in these two media. It was observed that DapA activity was higher in GroE 
depleted cells growing in medium deficient in lysine than in equivalent cells growing 
in medium containing lysine, at all time points (at 360 minutes after GroE depletion, 
MGM100 in MM! SCAA had 10.6% wild type DapA activity, while MGM100 in 
MMI SCAA —Lys had 46.3% wild type DapA activity). Since MGM100 in MM! 
SCAA -Lys stopped growing at 400 minutes after GroE depletion and had not 
lysed by this time, this suggested that the hypothesis might be correct. 
A hypothesis was also created to try and explain why GroE depleted cells 
growing in methionine deficient medium did not lyse. This hypothesis was also, in 
some aspect, related to the decrease of DapA activity in GroE depleted cells. It was 
hypothesised that decreased DAP levels (due to the lack of DapA activity in GroE 
depleted cells) caused cystathionine to be incorporated into peptidoglycan in its 
place. If cystathionine was being incorporated into peptidoglycan, then there would 
be decreased levels and consequently, methionine biosynthesis would be decreased. 
Since both methionine and its immediate precursor, homoserine, regulate expression 
of MetE, this could explain the induction of MetE in GroE depleted cells. If the cells 
were not making methionine, and methionine was not present in the medium, then 
the cells would stop growing. Also, it was observed that methionine uptake was 
greatly reduced in GroE depleted cells; therefore cells growing in medium containing 
methionine (i.e. LB) may still have reduced internal levels of methionine when GroE 
is depleted. If this occurred before lysis due to GroE depletion, then the cells would 
not lyse. 
To determine if this hypothesis was correct, DAP was added to GroE depleted 
cells growing in methionine deficient medium; if exogenous DAP were being 
incorporated into peptidoglycan, then cystathionine would not need to be diverted 
from methionine synthesis, and consequently MetE should not be induced. This did 
not prove to be the case; when exogenous DAP was added, MetE was still induced. 
In an attempt to simulate the state of DapA in MGM 100 without the cell 
being GroE depleted, the strain MGM100AdapA was used. This strain has no DapA 
activity (like GroE depleted MGM 100) but remains GroE. This strain was grown in 
osmotically protected medium (without exogenous DAP) to see if MetE induction 
was caused by DAP depletion or GroE depletion. The strain did not show an 
increased expression of MetE. This data suggests that GroE depletion was causing 
MetE induction through some other pathway that did not involve DapA or DAP. 
When homoserine was added to GroE depleted cells, MetE was still induced. 
This suggests that MetE itself may be affected by GroE depletion (if MetE is inactive 
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in GroE depleted cells, it will not be able to catalyse the transformation of 
homoserine to methionine, consequently methionine will not be made, and MetE will 
be expressed). In all of the above experiments the level of denatured MetE protein 
has been observed, but not the activity of MetE. Another possibility is that MetE 
induction is not being caused by decreased methionine levels, but by some other 
aspect of GroE depletion. Horwich (Horwich et a!, 1993) suggests that MetE 
induction represents a mechanism of regulation of translational initiation in GroE 
depleted cells. Either way, more work is obviously necessary before it will be 
possible to explain either MetE induction in GroE depleted cells, or why GroE 
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